Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024474	li-alb	mg/l (mg/l)	3415	3686	0.00%
3024474	li-alb	— (—)	479	507	100.00%	Distribution not available
3024474	li-alb	g/l (mg/l)	33	34	0.00%
3024474	li-alb	mg/l______ (mg/l)	24	25	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases related-to ILD

1169

2632

3.77

307.65

1.1

235.12

280.51

mg/l

5.93

1027

2350

Postprocedural disorders of nervous system

329

261

13.92

307.65

1.1

1.0

210.20

222.17

mg/l

0.35

289

226

Headache

951

1741

4.29

307.65

1.1

251.49

261.22

mg/l

0.29

839

1562

Other degenerative diseases of the nervous system

938

166

43.64

307.65

1.1

1.0

233.01

255.16

mg/l

0.57

833

147

Neurological diseases, wide definition

482

112

22.09

307.65

1.1

233.50

218.35

mg/l

0.44

424

Other demyelinating diseases of the central nervous system

417

106

53.43

307.65

1.1

220.61

228.35

mg/l

0.18

372

Other symptoms and signs involving the nervous and musculoskeletal systems

963

1235

8.10

307.65

1.1

248.05

253.80

mg/l

0.26

842

1115

Symptoms and signs involving the nervous and musculoskeletal systems

1272

1667

7.89

307.65

1.1

260.02

270.50

mg/l

0.53

1113

1503

Polyneuropathies and other disorders of the peripheral nervous system

470

508

9.65

307.65

1.1

340.67

288.96

mg/l

2.43

432

440

Visual disturbances and blindness

850

1732

5.02

307.65

1.1

270.47

258.43

mg/l

0.31

766

1545

Visual disturbances

818

1637

5.12

307.65

1.1

269.45

258.17

mg/l

0.28

739

1458

Autoimmune diseases excluding thyroid diseases, strict definition

1282

1906

3.71

307.65

1.1

257.77

276.63

mg/l

1.00

1136

1698

Disorders of optic nerve and visual pathways

391

309

13.84

307.65

1.1

246.00

239.87

mg/l

0.08

340

274

Disturbances of skin sensation

749

1045

7.50

307.65

1.1

229.57

248.87

mg/l

0.90

671

921

Autoimmune diseases excluding thyroid diseases

1311

1960

3.67

307.65

1.1

256.94

275.27

mg/l

0.99

1161

1747

Abnormal findings on diagnostic imaging of central nervous system

321

144

26.02

307.65

1.1

263.73

238.73

mg/l

0.55

281

127

Neurological diseases

1166

552

10.80

307.65

1.1

1.0

242.32

241.73

mg/l

0.02

1030

491

Other and unspecified polyneuropathies, also in other diseases

407

421

10.09

307.65

1.1

322.63

292.95

mg/l

1.12

375

365

Optic neuritis

254

136

21.70

307.65

1.1

1.0

206.98

217.22

mg/l

0.42

219

116

MS-disease / Multiple Sclerosis

664

216

38.53

307.65

1.1

215.78

223.56

mg/l

0.38

585

188

Demyelinating diseases of the central nervous system

791

266

37.28

307.65

1.1

221.96

234.95

mg/l

0.57

706

234

Symptoms and signs involving the skin and subcutaneous tissue

980

2510

3.75

302.87

1.1

247.30

268.95

mg/l

1.10

873

2232

Other neurological diseases

902

1713

4.15

301.70

1.1

278.92

279.16

mg/l

0.01

797

1530

ILD medications: immunosuppressive drugs

860

2121

3.73

261.26

1.1

247.31

280.86

mg/l

2.39

752

1889

Concussion

410

420

7.65

258.20

1.1

1.0

254.17

240.34

mg/l

0.27

352

377

Encephalitis

173

27.17

245.70

1.3

1.1

335.77

233.46

mg/l

3.83

163

Intracranial trauma

441

424

7.09

243.99

1.1

1.0

258.91

239.18

mg/l

0.45

384

381

Other encephalitis

166

28.08

238.43

1.3

1.1

341.26

232.83

mg/l

3.98

156

Diplopia

281

338

8.67

217.02

1.1

356.00

281.62

mg/l

0.85

252

286

Autoimmune diseases

1168

1966

3.05

216.84

1.1

253.86

275.09

mg/l

1.30

1044

1751

Symptoms and signs involving cognition, perception, emotional state and behaviour

1093

2467

2.99

216.06

1.1

264.18

267.39

mg/l

0.11

977

2183

General symptoms and signs

1117

1836

3.08

209.97

1.1

259.51

265.45

mg/l

0.20

993

1646

Abnormalities of gait and mobility

229

220

10.83

209.29

1.1

321.78

296.10

mg/l

0.56

192

195

Other symptoms and signs involving cognitive functions and awareness

523

1034

4.55

206.23

1.1

292.95

294.83

mg/l

0.03

468

914

Inflammatory diseases of the central nervous system

241

258

9.93

204.58

1.2

1.1

396.03

274.31

mg/l

3.61

221

223

ILD medications

1213

2339

2.82

202.44

1.1

245.23

274.56

mg/l

2.51

1077

2082

Used for control exclusion in common control thyroid runs

1066

1814

2.99

191.96

1.1

254.99

276.73

mg/l

1.22

951

1617

Subjective visual disturbances

391

798

5.02

179.28

1.1

248.77

257.51

mg/l

0.13

359

705

Spirochaetal infections, other/unspecified

214

243

9.28

173.43

1.1

364.53

266.19

mg/l

4.30

204

211

Malaise and fatigue

549

1130

3.87

169.27

1.1

261.73

270.35

mg/l

0.34

487

1018

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

674

1809

3.28

167.36

1.1

274.90

285.92

mg/l

0.39

596

1617

Other disorders of optic [2nd] nerve and visual pathways

173

180

10.20

150.03

1.2

1.0

300.63

248.56

mg/l

0.40

150

158

Migraine

639

1632

3.09

139.23

1.1

218.58

239.82

mg/l

1.22

577

1452

Episodal and paroxysmal disorders

1012

2060

2.51

133.60

1.1

242.00

268.25

mg/l

1.98

898

1834

Use of teriflunomide

32.80

133.54

1.0

1.1

212.18

223.00

mg/l

0.20

Cerebral cysts

160

180

9.42

130.85

1.2

1.1

299.59

254.97

mg/l

0.31

143

154

Epilepsy

361

889

4.11

129.74

1.1

295.02

263.57

mg/l

0.74

330

799

Other soft tissue disorders, not elsewhere classified

948

2170

2.51

129.12

1.1

251.22

268.81

mg/l

0.79

855

1911

Papilloedema, unspecified

108

17.84

128.66

1.2

1.0

341.57

229.27

mg/l

0.58

Dorsalgia

953

2021

2.52

128.35

1.1

251.60

266.07

mg/l

0.72

854

1783

Dizziness and giddiness

703

1998

2.76

126.24

1.1

252.12

272.25

mg/l

1.28

626

1774

Systemic atrophies primarily affecting the central nervous system

115

14.44

124.68

1.1

270.11

292.82

mg/l

0.37

103

Medical observation and evaluation for suspected diseases and conditions

597

942

3.27

124.56

1.1

254.66

273.16

mg/l

0.92

555

820

Diseases of the eye and adnexa

797

1493

2.70

120.25

1.1

236.67

264.69

mg/l

2.76

708

1322

L04AA Selective immunosuppressants

333

831

4.10

118.61

1.1

236.44

263.02

mg/l

1.22

279

743

Other headache syndromes

464

1443

3.25

117.48

1.1

249.88

245.11

mg/l

0.16

405

1285

Cerebral palsy and other paralytic syndromes

203

340

6.17

116.02

1.2

1.1

339.30

275.64

mg/l

0.77

189

297

Other dorsopathies, not elsewhere classified

936

2031

2.41

114.77

1.1

244.24

265.64

mg/l

1.48

844

1792

Nerve, nerve root and plexus disorders

981

2565

2.31

114.69

1.1

279.37

265.13

mg/l

0.69

867

2285

Pain, not elsewhere classified

323

809

4.05

114.09

1.1

290.56

255.02

mg/l

0.65

283

727

Implicit Sepsis, including avohilmo

767

2191

2.52

112.89

1.1

276.59

268.12

mg/l

0.26

679

1954

Condition for Implicit Sepsis (Organ dysfunction codes)

790

2238

2.47

110.08

1.1

272.53

271.57

mg/l

0.02

700

1996

Low back pain

738

1966

2.56

109.96

1.1

253.82

259.49

mg/l

0.21

661

1731

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

302

293

5.22

109.93

1.1

255.16

280.93

mg/l

0.75

264

267

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

844

2428

2.36

106.82

1.1

274.15

262.77

mg/l

0.37

744

2163

Abnormal involuntary movements

189

322

6.02

105.96

1.1

254.70

268.72

mg/l

0.34

170

283

Care involving use of rehabilitation procedures

627

2180

2.61

104.64

1.1

259.65

262.26

mg/l

0.09

535

1954

ILD medications: prednisolone, methylprednisolone, prednisone

934

2285

2.29

104.27

1.1

256.61

276.54

mg/l

1.17

835

2033

Cerebrovascular diseases (FINNGEN)

372

720

3.68

102.76

1.1

283.01

267.06

mg/l

0.45

314

642

Second line medication for Crohn's disease

601

2326

2.61

102.33

1.1

251.66

265.30

mg/l

0.62

524

2074

Small fibre neuropathy

15.35

101.62

1.1

309.59

257.75

mg/l

1.21

L04AX Other immunosuppressants

582

2227

2.64

101.54

1.1

251.62

266.73

mg/l

0.69

506

1987

Guillain-Barre syndrome

20.91

101.07

1.2

1.1

531.52

238.13

mg/l

4.46

Pain in limb

790

2118

2.39

100.71

1.1

247.71

263.90

mg/l

0.98

703

1863

Pain in joint

527

1103

2.96

100.39

1.1

234.77

276.01

mg/l

4.34

471

972

General examination and investigation of persons without complaint and reported diagnosis

541

942

3.01

99.88

1.1

278.61

273.16

mg/l

0.11

495

820

Other special examinations and investigations of persons without complaint or reported diagnosis

547

942

2.96

97.86

1.1

242.13

273.16

mg/l

2.29

481

820

Infections, IBD-co-morbidities

115

13.18

97.77

1.1

1.0

403.49

231.43

mg/l

1.36

100

Implicit Sepsis

664

1980

2.49

96.14

1.1

280.33

270.88

mg/l

0.25

591

1763

Paralytic strabismus

127

159

8.30

95.03

1.1

402.93

288.38

mg/l

0.66

105

136

Dorsopathies

903

2042

2.25

94.99

1.1

245.60

265.53

mg/l

1.30

811

1802

Anxiety disorders, excluding more controls

743

2045

2.34

90.66

1.1

237.99

282.71

mg/l

4.99

653

1827

Mood disorders, excluding more controls

808

2108

2.27

90.00

1.1

246.61

283.47

mg/l

3.26

712

1882

Cerebrovascular diseases

564

1504

2.62

89.27

1.1

298.39

298.10

mg/l

0.01

489

1343

Migraine with aura

326

979

3.38

88.21

1.1

215.70

227.41

mg/l

0.34

294

871

Convulsions, not elsewhere classified

263

677

3.89

87.70

1.1

233.26

268.21

mg/l

2.22

229

613

Disorders of ocular muscles, binocular movement, accommodation and refraction

534

2092

2.56

87.28

1.1

267.89

246.79

mg/l

0.46

461

1869

Lower back pain or/and sciatica

951

2861

2.08

86.91

1.1

255.60

271.14

mg/l

0.91

850

2530

Other and unspecified visual disturbances

160

287

5.73

85.14

1.1

205.92

256.02

mg/l

3.12

146

245

Bell's palsy

170

327

5.33

83.77

1.1

343.51

266.60

mg/l

1.44

148

288

Depression

865

2770

2.10

82.77

1.1

239.23

278.08

mg/l

3.90

761

2471

Mood [affective] disorders

900

2804

2.07

81.85

1.1

239.51

278.98

mg/l

4.16

793

2502

Mood disorders

901

2804

2.07

81.77

1.1

239.51

278.96

mg/l

4.16

793

2503

Fever of other and unknown origin

458

1479

2.70

81.56

1.1

277.55

267.11

mg/l

0.35

414

1322

Anxiety disorders

831

2714

2.12

81.30

1.1

231.88

276.94

mg/l

5.73

733

2420

Neurotic, stress-related and somatoform disorders

825

2713

2.11

80.23

1.1

231.88

276.66

mg/l

5.65

729

2420

Focal epilepsy, strict definition

241

641

3.83

78.54

1.1

268.73

264.12

mg/l

0.12

223

566

Focal epilepsy

255

713

3.64

77.18

1.1

268.46

259.38

mg/l

0.28

233

634

Focal epilepsy, mode (most common among epilepsy diagnosis)

232

611

3.87

76.70

1.1

270.63

265.44

mg/l

0.13

212

540

Myalgia

283

851

3.38

76.54

1.1

237.84

240.40

mg/l

0.09

259

734

Other antidepressants

825

2009

2.11

74.36

1.1

257.80

282.16

mg/l

1.44

726

1806

STROKE

484

1277

2.57

73.40

1.1

271.91

282.71

mg/l

0.46

417

1138

First line medication for Crohn's disease

939

2559

1.99

73.26

1.1

274.12

256.48

mg/l

0.65

842

2271

Disorders of thyroid, IBD co-morbidities

106

9.14

71.69

1.1

240.89

209.91

mg/l

0.74

Other intervertebral disc disorders

651

1743

2.24

71.04

1.1

268.34

268.58

mg/l

0.01

584

1539

Strabismus

311

1042

3.02

69.85

1.1

302.17

247.49

mg/l

0.83

268

930

Neuromuscular dysfunction of bladder

134

246

5.60

69.63

1.1

333.38

282.87

mg/l

0.38

114

212

Examination and observation for other reasons

442

938

2.68

68.86

1.1

238.07

273.41

mg/l

2.80

416

817

Any reimbursement code in KELA

573

1212

2.39

68.43

1.1

236.96

245.38

mg/l

0.38

508

1087

Oral corticosteroids

882

2652

1.96

68.02

1.1

258.22

271.24

mg/l

0.67

774

2358

Migraine without aura

266

834

3.24

67.33

1.1

231.68

221.71

mg/l

0.19

241

741

Implicit viral Sepsis, including avohilmo

274

875

3.16

66.81

1.2

1.1

296.40

265.86

mg/l

0.72

245

778

Recurrent or chronic depression

380

965

2.76

66.41

1.1

257.79

267.72

mg/l

0.25

336

865

Alzheimer disease, excluding more controls

10.46

66.25

1.1

1.0

268.04

335.87

mg/l

0.62

Speech disturbances, not elsewhere classified

122

217

5.77

65.56

1.1

1.0

287.11

283.57

mg/l

0.05

112

186

Soft tissue disorders

843

2187

1.99

65.02

1.1

241.37

269.23

mg/l

2.51

765

1926

Persons encountering health services for specific procedures and health care

900

2805

1.90

63.88

1.1

274.50

256.50

mg/l

0.75

779

2514

Opioids

824

2155

1.99

63.77

1.1

244.35

254.75

mg/l

0.65

722

1915

Systemic connective tissue disorders

314

1120

2.84

63.22

1.1

266.47

259.27

mg/l

0.16

271

999

Sciatica+with lumbago

431

1572

2.45

63.05

1.1

258.62

270.82

mg/l

0.48

383

1386

Inflammatory bowel disease treatment related agents

937

2780

1.88

63.03

1.1

257.57

267.25

mg/l

0.47

828

2473

Anxiety (asthma-related co-morbidities)

597

2146

2.13

61.10

1.1

220.98

263.92

mg/l

4.59

533

1909

Certain disorders involving the immune mechanism

213

620

3.50

60.84

1.2

1.1

306.40

269.12

mg/l

0.74

191

551

Spirochaetal infections, other/unspecified, including avohilmo

323

1205

2.71

59.75

1.1

318.18

257.16

mg/l

3.92

309

1057

Extrapyramidal and movement disorders

311

1137

2.76

59.75

1.1

249.71

277.13

mg/l

1.67

275

1007

All anxiety disorders

620

2334

2.08

59.65

1.1

218.41

257.52

mg/l

4.31

552

2086

Pain (limb, back, neck, head abdominally)

520

1121

2.34

59.56

1.1

256.34

275.95

mg/l

1.03

465

988

Lyme disease, including avohilmo

320

1194

2.71

59.18

1.1

318.94

256.68

mg/l

4.01

306

1048

Lyme disease

320

1194

2.71

59.18

1.1

318.94

256.68

mg/l

4.01

306

1048

Other spirochaetal diseases

322

1207

2.70

59.01

1.1

318.99

255.71

mg/l

4.16

308

1057

Ischaemic Stroke, excluding all haemorrhages

366

1041

2.61

58.54

1.1

279.28

309.30

mg/l

1.43

314

923

Other spirochaetal diseases, including avohilmo

324

1227

2.67

58.19

1.1

318.02

257.28

mg/l

3.91

310

1076

Any mental disorder

814

2121

1.93

57.94

1.1

239.81

283.17

mg/l

5.44

723

1893

Sarcoidosis

158

390

4.14

57.38

1.2

1.1

304.27

279.08

mg/l

0.45

138

337

Other disorders of eye and adnexa

187

524

3.64

56.71

1.1

239.79

246.31

mg/l

0.18

177

458

Tramadol

626

1830

2.07

56.38

1.1

282.30

258.74

mg/l

1.13

554

1628

Stroke, excluding SAH

389

1139

2.48

56.08

1.1

285.83

307.68

mg/l

0.90

332

1014

Spondylopathies

551

1513

2.17

55.51

1.1

293.11

276.47

mg/l

0.60

486

1334

Persons encountering health services for examination and investigation

450

942

2.41

55.07

1.1

258.55

273.16

mg/l

0.61

401

820

Other general symptoms and signs

124

6.99

54.95

1.1

1.0

196.04

227.23

mg/l

1.44

109

Lumbar disc prolapse

492

1662

2.21

54.80

1.1

262.45

271.16

mg/l

0.29

440

1468

Implicit viral Sepsis

189

546

3.51

54.55

1.2

1.1

298.68

279.36

mg/l

0.35

170

477

Viral Sepsis

189

548

3.49

54.25

1.2

1.1

298.68

279.52

mg/l

0.35

170

478

Other/unspecified dorsalgia

312

1187

2.62

53.93

1.1

239.36

262.93

mg/l

1.21

277

1044

Other disorders of lacrimal gland

333

1335

2.52

53.22

1.1

252.17

257.39

mg/l

0.18

298

1172

Symptoms and signs involving speech and voice

291

1093

2.69

53.16

1.1

246.91

260.16

mg/l

0.58

264

965

Stroke, including SAH

404

1227

2.38

53.13

1.1

285.72

306.52

mg/l

0.86

346

1090

Codeine

748

2121

1.92

53.11

1.1

253.71

254.44

mg/l

0.03

657

1884

Use of glatiramer acetate

10.88

52.04

1.1

206.99

223.37

mg/l

0.35

Other anxiety disorders

485

1952

2.13

50.96

1.1

221.98

251.21

mg/l

2.04

430

1741

Depression or dysthymia

465

1130

2.26

50.81

1.1

258.87

290.43

mg/l

1.38

409

1017

Syncope and collapse

304

976

2.62

50.75

1.1

256.31

277.74

mg/l

0.64

268

881

Ocular pain

128

298

4.41

50.37

1.1

229.67

243.15

mg/l

0.30

120

255

Diagnoses used for exclusion with ILD

215

707

3.08

50.26

1.1

330.35

282.76

mg/l

0.62

189

626

Migraine with aura and triptan purchases

222

746

3.03

50.17

1.1

219.89

221.65

mg/l

0.03

204

662

Certain infectious and parasitic diseases

746

1987

1.89

49.94

1.1

259.40

246.35

mg/l

0.67

675

1747

Depression medications

294

522

2.86

49.65

1.1

219.91

228.18

mg/l

0.33

256

467

Dysphagia

208

676

3.11

49.61

1.1

345.34

276.51

mg/l

1.04

186

597

GASTRO-related operations

644

1640

1.98

49.31

1.1

241.95

247.31

mg/l

0.21

564

1469

Any gastric operation

644

1640

1.98

49.31

1.1

241.95

247.31

mg/l

0.21

564

1469

Other specific joint derangements/joint disorders

658

2147

1.92

48.79

1.1

232.38

258.77

mg/l

2.54

590

1906

Other diseases of spinal cord

9.23

48.75

1.1

335.43

259.43

mg/l

0.59

Disorders of lacrimal system

367

1573

2.31

48.55

1.1

254.97

259.75

mg/l

0.17

330

1387

Diseases of the musculoskeletal system and connective tissue

446

990

2.27

48.17

1.1

232.42

258.88

mg/l

1.15

397

871

Parkinson's disease, excluding more controls

9.43

47.74

1.2

1.1

263.54

300.02

mg/l

0.47

Viral infections of the central nervous system, including avohilmo

116

262

4.55

47.49

1.3

1.1

321.69

263.77

mg/l

1.56

100

227

Abnormalities of breathing

717

2228

1.85

46.58

1.1

239.39

269.44

mg/l

3.40

633

1989

Parkinson's disease, strict definition, excluding more controls

9.94

46.53

1.2

1.1

269.02

306.55

mg/l

0.45

Non-invasive ventilation

231

701

2.87

46.30

1.1

277.69

258.20

mg/l

0.22

194

631

Psychiatric diseases

694

1860

1.88

45.66

1.1

249.13

282.75

mg/l

2.90

613

1665

Hemiplegia

122

6.42

45.48

1.2

1.1

225.14

251.05

mg/l

0.77

105

Other extrapyramidal and movement disorders in other diseases

215

751

2.90

45.22

1.1

242.28

266.01

mg/l

0.98

192

666

Parasetamol

588

1513

1.97

44.87

1.1

248.84

270.28

mg/l

1.09

525

1352

Symptoms and signs involving the circulatory and respiratory systems

788

2239

1.77

43.19

1.1

249.74

269.34

mg/l

0.67

705

2000

Viral infections of the central nervous system

106

245

4.44

42.19

1.3

1.1

322.90

260.96

mg/l

1.59

211

Asthma, excluding more controls

564

1487

1.96

42.19

1.1

241.44

265.71

mg/l

1.74

496

1318

Migraine without aura and triptan purchases

216

790

2.78

41.85

1.1

237.87

225.42

mg/l

0.21

195

698

Asthma

569

1522

1.94

41.44

1.1

241.33

265.65

mg/l

1.79

501

1349

Provisional assignment of new diseases of uncertain etiology

436

2147

2.03

41.44

1.1

274.32

254.76

mg/l

0.42

391

1903

Spondylosis

346

1207

2.25

41.25

1.1

287.54

289.41

mg/l

0.04

299

1059

Codes for special purposes

436

2152

2.02

41.17

1.1

274.32

254.80

mg/l

0.42

391

1908

Status epilepticus

8.23

41.12

1.2

1.0

293.02

270.69

mg/l

0.23

Pain in throat and chest

659

2158

1.82

40.84

1.1

258.59

272.34

mg/l

0.37

581

1927

Somatoform disorder

176

584

3.06

40.72

1.1

203.08

252.87

mg/l

5.89

149

519

Implicit bacterial Sepsis, including avohilmo

287

994

2.42

40.68

1.1

340.11

289.47

mg/l

0.80

243

885

Cardiovascular diseases

592

1668

1.90

40.68

1.1

228.95

238.99

mg/l

0.44

534

1479

Organic, including symptomatic, mental disorders

291

847

2.43

40.18

1.1

287.30

318.40

mg/l

0.95

252

750

Asthma (mode)

559

1537

1.92

39.87

1.1

238.11

266.09

mg/l

2.24

488

1364

Sixth [abducent] nerve palsy

7.93

39.73

1.1

330.77

264.95

mg/l

0.37

Other systemic involvement of connective tissue (FG)

212

776

2.71

39.27

1.1

242.65

262.62

mg/l

0.78

184

689

Visual field defects

193

4.76

39.25

1.1

308.55

274.60

mg/l

0.28

165

Fibromyalgia

118

313

3.85

38.95

1.1

197.35

231.09

mg/l

2.51

105

273

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

13.22

38.30

1.0

297.40

250.42

mg/l

0.60

Radiculopathy

124

344

3.65

38.21

1.1

288.30

272.86

mg/l

0.25

110

298

Cervicalgia

173

592

2.95

37.85

1.1

286.84

250.95

mg/l

0.81

151

514

Oedema, not elsewhere classified

208

766

2.67

37.61

1.1

248.95

275.61

mg/l

0.95

180

683

Symptoms and signs involving the urinary system

524

2135

1.86

36.95

1.1

316.98

268.90

mg/l

1.61

466

1905

Asthma (only as main-diagnosis)

517

1522

1.91

36.87

1.1

235.41

265.65

mg/l

2.49

454

1349

Hypothyroidism, strict autoimmune

456

1529

1.97

36.87

1.1

243.61

265.28

mg/l

1.17

407

1358

Codeine or tramadol medication

835

2751

1.66

36.76

1.1

254.33

266.61

mg/l

0.66

733

2444

Asthma (only as main-diagnosis), excluding more controls

512

1487

1.91

36.69

1.1

234.99

265.71

mg/l

2.50

449

1318

Third [oculomotor] nerve palsy

9.89

36.57

1.0

1.1

359.46

253.80

mg/l

1.31

Malignant neoplasm of brain, including Hilmo

125

5.67

36.54

1.1

564.31

259.19

mg/l

1.33

113

Other systemic involvement of connective tissue

218

858

2.57

36.43

1.1

242.12

251.97

mg/l

0.34

190

772

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

258

1084

2.37

36.30

1.1

223.90

243.50

mg/l

1.12

235

974

COPD differential diagnosis

567

1538

1.86

36.19

1.1

250.74

266.20

mg/l

0.93

508

1365

Cervical disc disorders

237

974

2.45

36.07

1.1

263.45

281.44

mg/l

0.52

214

853

Disorders of vestibular function (Vertigo)

326

1490

2.15

36.04

1.1

250.79

275.52

mg/l

1.61

292

1327

ILD differential diagnosis

565

1537

1.85

35.74

1.1

250.93

266.09

mg/l

0.90

506

1364

Factors influencing health status and contact with health services

185

303

3.08

35.69

1.1

289.55

272.58

mg/l

0.39

162

263

Sequelae of cerebrovascular disease

206

674

2.63

35.08

1.1

299.80

304.60

mg/l

0.07

183

603

Diseases of the myoneural junction and muscle

116

328

3.59

34.85

1.1

352.68

293.79

mg/l

0.70

107

280

Other reaction to severe stress, and adjustment disorders

348

1702

2.06

34.68

1.1

233.66

243.58

mg/l

0.47

302

1515

Symptoms and signs involving the digestive system and abdomen

692

2022

1.72

34.60

1.1

257.35

271.11

mg/l

0.87

624

1802

Chorioretinal inflammation

7.21

34.56

1.2

1.1

236.95

233.95

mg/l

0.05

Excluding asthma or asthma-COPD overlap

560

1538

1.83

34.42

1.1

250.49

265.76

mg/l

0.91

500

1364

Benzodiazepine use

742

3036

1.66

34.33

1.1

255.27

269.17

mg/l

0.58

647

2707

Anaemias

201

475

2.74

34.21

1.1

248.92

225.20

mg/l

0.50

166

424

ILD medications: azathioprine

143

466

3.11

34.20

1.1

333.55

257.46

mg/l

1.38

125

423

Other joint disorders

707

2178

1.70

34.11

1.1

236.51

259.57

mg/l

1.96

635

1935

Other disorders of urethra and urinary system

517

1981

1.82

33.82

1.1

274.08

255.97

mg/l

0.39

454

1759

Triptan medication for migraine, single purchase ok

630

2490

1.72

33.71

1.1

226.74

263.35

mg/l

3.72

562

2216

Migraine, single triptan purchase ok & required. ICD-code if available is included

630

2490

1.72

33.71

1.1

226.74

263.35

mg/l

3.72

562

2216

Asthma, unspecified (mode)

384

1392

2.00

33.37

1.1

244.96

268.89

mg/l

1.28

326

1238

Asthma, unspecified (mode), excluding more controls

380

1362

2.01

33.22

1.1

244.15

269.30

mg/l

1.35

322

1211

SLE (Finngen)

7.49

33.20

1.1

294.00

254.21

mg/l

0.41

Meningitis

152

4.94

33.12

1.1

551.61

266.70

mg/l

3.00

128

Antihypertensive medication - note that there are other indications

570

1669

1.79

33.08

1.1

222.82

249.53

mg/l

1.67

505

1482

Disorders of eyelid, lacrimal system and orbit

613

2628

1.72

32.94

1.1

253.67

272.96

mg/l

1.36

552

2333

Cardiovascular diseases (excluding rheumatic etc)

583

1898

1.77

32.86

1.1

239.33

241.08

mg/l

0.06

524

1686

Malignant neoplasm of brain

6.59

32.57

1.1

616.45

261.67

mg/l

1.14

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

182

4.48

32.50

1.1

551.94

265.33

mg/l

1.50

158

Diseases of inner ear

356

1720

1.99

32.21

1.1

247.91

281.36

mg/l

2.62

319

1532

Other pulmonary diagnosis

551

1538

1.80

32.21

1.1

248.24

265.76

mg/l

1.14

490

1364

Other and unspecified nerve root and plexus disorders, also in other diseases

179

681

2.66

32.16

1.1

283.43

264.57

mg/l

0.30

156

606

Cervicobrachial syndrome

179

681

2.65

32.13

1.1

239.84

250.40

mg/l

0.33

167

597

Implicit bacterial Sepsis

245

912

2.32

31.97

1.2

1.1

353.87

294.08

mg/l

0.83

209

809

Spinal stenosis

265

865

2.27

31.91

1.1

348.27

299.87

mg/l

1.46

234

753

Follow-up examination after treatment for conditions other than malignant neoplasms

272

804

2.26

31.81

1.1

254.90

268.53

mg/l

0.18

244

701

Covid-19 confirmed case

271

1246

2.19

31.71

1.1

304.41

261.45

mg/l

0.67

237

1106

Other disorders of binocular movement

7.03

31.68

1.1

219.34

240.71

mg/l

0.30

Symptoms and signs concerning food and fluid intake

228

3.99

31.57

1.1

258.32

269.38

mg/l

0.17

203

Other sleep disorders

106

302

3.56

31.51

1.1

236.07

274.68

mg/l

1.23

266

Polyuria

165

610

2.73

31.35

1.1

261.78

293.30

mg/l

1.30

143

540

Hypothyroidism, levothyroxine purchases

221

493

2.53

31.24

1.1

229.93

224.19

mg/l

0.15

197

440

Hypothyroidism and >3 levothyroxin purchases

221

493

2.53

31.24

1.1

229.93

224.19

mg/l

0.15

197

440

Hypothyroidism (congenital or acquired)

220

493

2.52

30.75

1.1

235.40

224.19

mg/l

0.32

198

440

Hard cardiovascular diseases

546

1845

1.76

30.48

1.1

259.35

293.60

mg/l

2.80

473

1655

Enlarged lymph nodes

126

408

3.12

30.47

1.2

1.1

264.85

266.07

mg/l

0.02

107

368

Special screening examination for infectious and parasitic diseases

214

644

2.44

30.23

1.1

255.23

250.32

mg/l

0.13

202

566

Other necrotizing vasculopathies (FG)

118

5.27

30.06

1.1

309.41

322.64

mg/l

0.07

102

Delirium, not induced by alcohol and other psychoactive substances

210

4.03

29.98

1.1

1.0

335.64

337.81

mg/l

0.01

180

Abdominal and pelvic pain

668

2022

1.66

29.71

1.1

257.74

271.11

mg/l

0.79

609

1802

Persons encountering health services in other circumstances, wide

785

2542

1.59

29.48

1.1

266.76

272.06

mg/l

0.15

709

2251

Other disorders of nervous system

159

4.56

29.46

1.2

1.1

345.28

298.07

mg/l

0.38

135

Primary_lymphoid and hematopoietic malignant neoplasms

160

607

2.66

28.93

1.2

1.1

400.95

290.96

mg/l

2.17

143

538

Persons encountering health services for other counselling and medical advice, not elsewhere classified

760

2542

1.59

28.86

1.1

266.77

272.06

mg/l

0.15

696

2251

Bacterial Sepsis

270

1050

2.14

28.85

1.2

1.1

351.95

288.70

mg/l

1.02

230

935

Other strabismus

204

868

2.37

28.68

1.1

232.81

244.86

mg/l

0.38

179

778

Selective serotonin reuptake inhibitors

642

2018

1.66

28.49

1.1

248.98

281.82

mg/l

2.66

572

1815

Nausea and vomiting

200

834

2.36

27.87

1.1

306.62

255.07

mg/l

0.46

173

736

Liquid cancers

189

748

2.41

27.53

1.2

1.1

378.31

277.53

mg/l

2.42

169

668

Trigeminal neuralgia

140

4.66

27.36

1.1

312.19

248.14

mg/l

0.44

124

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

128

4.83

27.29

1.2

1.0

287.44

291.73

mg/l

0.05

111

Oxycodone

233

908

2.21

27.18

1.1

378.65

285.37

mg/l

1.71

201

805

Dyspnoea

613

2734

1.62

26.80

1.1

241.75

273.91

mg/l

3.58

545

2422

Malignant neoplasm of eye, brain and central nervous system

108

5.22

26.72

1.1

607.41

261.41

mg/l

1.17

Azathioprine

143

539

2.69

26.31

1.1

333.55

259.12

mg/l

1.33

125

484

Any dementia, excluding more controls

166

443

2.59

26.13

1.1

270.34

324.67

mg/l

2.53

144

396

Other mental disorders due to brain damage and dysfunction and to physical disease

224

3.70

26.00

1.1

1.0

263.09

315.30

mg/l

1.98

192

Dermatitis

441

2499

1.73

25.97

1.1

281.22

267.55

mg/l

0.35

395

2228

Degenerative diseases of the nervous system

161

448

2.60

25.91

1.1

295.27

325.92

mg/l

0.43

139

398

Brachial plexus disorders

103

329

3.18

25.67

1.1

298.63

244.10

mg/l

0.59

297

Other diseases of urinary system

672

2387

1.59

25.39

1.1

283.34

260.11

mg/l

0.80

592

2137

Certain infectious and parasitic diseases, including avohilmo

477

1374

1.75

25.27

1.1

263.42

252.99

mg/l

0.35

424

1201

Diseases of the ear and mastoid process

812

2677

1.52

25.22

1.1

252.66

269.48

mg/l

0.98

721

2375

Irritable bowel syndrome

236

1129

2.11

25.21

1.1

254.95

242.59

mg/l

0.32

209

990

Non-Hodgkin lymphoma, all, including Hilmo

302

3.25

25.16

1.2

1.1

493.90

295.25

mg/l

2.65

273

Other necrotizing vasculopathies

154

4.29

25.14

1.1

313.72

299.47

mg/l

0.08

138

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

672

2912

1.56

24.61

1.1

292.92

261.74

mg/l

1.15

580

2603

Other and unspecified dermatitis

376

2119

1.78

24.56

1.1

285.64

262.11

mg/l

0.61

335

1887

Lesion of lateral popliteal nerve

121

4.73

24.35

1.2

1.1

291.16

279.44

mg/l

0.06

104

Dissociative [conversion] disorders

142

4.42

24.25

1.1

190.41

217.63

mg/l

1.10

121

Pain in thoracic spine

122

443

2.78

24.14

1.1

209.80

251.77

mg/l

2.79

107

386

Disorders of refraction and accommodation

246

1210

2.04

24.14

1.1

216.64

241.97

mg/l

1.73

210

1082

Abnormal findings on diagnostic imaging of lung

249

1166

2.03

24.05

1.1

301.92

309.56

mg/l

0.16

224

1035

Personality disorders, excluding more controls

216

1017

2.14

23.92

1.1

202.12

246.13

mg/l

4.92

189

912

Triptan medication for migraine, min. 3 purchases

493

2234

1.66

23.56

1.1

225.27

235.65

mg/l

0.37

439

1982

Heterophoria

285

3.25

23.48

1.1

216.22

239.55

mg/l

0.61

247

Other symptoms and signs involving the urinary system

275

3.28

23.43

1.2

1.1

340.24

299.34

mg/l

0.29

232

Cervicocranial syndrome

278

3.24

23.01

1.1

297.81

244.45

mg/l

0.81

244

Dementia, including avohilmo

208

651

2.19

22.79

1.1

268.18

323.26

mg/l

3.50

181

571

Any dementia

168

487

2.40

22.73

1.1

274.15

321.95

mg/l

2.09

146

430

Visual impairment including blindness (binocular or monocular)

149

4.16

22.69

1.2

1.1

272.16

265.02

mg/l

0.10

128

Finngen Rheumatological endpoints

697

2594

1.53

22.67

1.1

244.59

262.62

mg/l

1.06

615

2305

Other meningitis

7.27

22.66

1.1

538.12

220.21

mg/l

1.39

Other functional intestinal disorders

306

1508

1.85

22.35

1.1

299.31

257.75

mg/l

1.24

258

1332

Nonorganic sleeping disorders, excluding more controls

172

762

2.28

22.35

1.1

221.11

253.85

mg/l

2.21

152

686

Bacterial infection, other or unspecified

316

1457

1.84

22.24

1.1

339.00

278.19

mg/l

1.35

271

1309

Acute upper respiratory infections

688

2714

1.52

22.22

1.1

247.11

270.85

mg/l

1.89

602

2418

Transient ischemic attack

256

1037

1.97

22.15

1.1

286.36

300.38

mg/l

0.44

227

916

Systemic lupus erythematosus

101

4.88

21.61

1.1

294.00

232.59

mg/l

0.93

Arthropathies

662

2181

1.54

21.59

1.1

241.91

259.38

mg/l

1.15

589

1938

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

357

1994

1.73

21.13

1.1

258.73

275.45

mg/l

0.72

317

1760

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

632

3254

1.52

20.98

1.1

280.43

263.42

mg/l

0.60

571

2881

Shoulder lesions

453

1642

1.66

20.93

1.1

274.05

282.91

mg/l

0.27

410

1448

Cough

273

1364

1.88

20.93

1.1

226.16

272.88

mg/l

4.34

242

1223

Dementia

186

578

2.21

20.92

1.1

264.21

322.81

mg/l

3.81

161

511

Acute upper respiratory infections of multiple and unspecified sites

544

2535

1.57

20.92

1.1

252.04

261.83

mg/l

0.26

482

2265

Liquid cancers, including Hilmo

212

915

2.05

20.86

1.2

1.1

378.25

275.46

mg/l

2.90

190

822

Speech and linguistic disorders, excluding more controls

270

3.10

20.81

1.1

251.21

242.78

mg/l

0.10

233

Abnormalities of heart beat

245

1241

1.92

20.41

1.1

231.71

267.56

mg/l

2.27

211

1105

Cystitis

551

2093

1.57

20.41

1.1

282.93

254.82

mg/l

0.79

485

1864

Sleep disorders (combined)

719

2532

1.49

20.21

1.1

246.07

269.28

mg/l

1.85

628

2268

Dentofacial anomalies [including malocclusion]

544

2760

1.55

19.87

1.1

235.83

258.34

mg/l

1.14

481

2462

Exclusions for E4_PCOS_BROAD

154

686

2.27

19.80

1.1

278.22

251.32

mg/l

0.45

128

605

135

570

2.39

19.71

1.1

231.03

239.13

mg/l

0.21

109

499

Optic atrophy, wide definition

7.07

19.66

1.2

1.0

246.28

202.14

mg/l

0.87

Bacterial infection, other or unspecified, including avohilmo

345

1645

1.72

19.60

1.1

339.66

271.79

mg/l

1.65

297

1482

Benign neoplasm of meninges

254

3.15

19.55

1.1

384.33

265.75

mg/l

1.27

222

Gastro-oesophageal reflux disease

442

2320

1.61

19.51

1.1

268.06

278.52

mg/l

0.31

398

2070

Other disorders of fluid, electrolyte and acid-base balance

178

795

2.12

19.34

1.1

324.24

286.84

mg/l

0.64

152

699

Coxibs

179

422

2.24

19.33

1.1

237.08

277.47

mg/l

1.69

154

371

Optic atrophy

6.93

19.27

1.2

1.1

246.28

207.29

mg/l

0.73

Acute sinusitis

404

2252

1.64

19.20

1.1

253.14

253.62

mg/l

0.01

353

2000

Use of pramipexole

136

583

2.35

19.15

1.2

1.1

255.69

281.22

mg/l

0.79

120

509

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

680

2965

1.47

19.13

1.1

251.64

267.64

mg/l

0.88

610

2628

Asthma (diagnoses ohter than nonallergic)

593

3194

1.50

19.10

1.1

241.88

269.23

mg/l

2.22

515

2846

Disorders of sclera, cornea, iris and ciliary body

378

2292

1.66

19.08

1.1

275.12

265.84

mg/l

0.28

332

2050

Benign neoplasm: Cerebral meninges

228

3.24

18.97

1.1

377.09

265.83

mg/l

1.06

200

Intracranial injury

393

2241

1.64

18.89

1.1

257.00

267.39

mg/l

0.19

333

2013

Obesity related asthma

247

1332

1.87

18.84

1.1

246.06

265.25

mg/l

0.88

207

1187

Other and unspecified types of non-Hodgkin lymphoma, hilmo

5.04

18.82

1.2

1.1

532.53

270.04

mg/l

1.68

SLE, ICD10

101

4.58

18.78

1.1

281.30

226.99

mg/l

0.81

SLE, strict definition

101

4.58

18.78

1.1

281.30

226.99

mg/l

0.81

Cluster headache, strict

4.82

18.75

1.2

1.1

227.44

253.28

mg/l

0.52

Asthma-related infections

401

2416

1.62

18.66

1.1

242.90

265.63

mg/l

1.29

345

2155

Asthma, hospital admission 2, infections

401

2416

1.62

18.66

1.1

242.90

265.63

mg/l

1.29

345

2155

Implicit fungal Sepsis, including avohilmo

173

3.58

18.45

1.2

1.0

258.95

282.23

mg/l

0.36

154

Complications of medical and surgical care

471

2717

1.56

18.42

1.1

259.06

271.94

mg/l

0.32

415

2425

Gastrointestinal diseases

444

1376

1.62

18.21

1.1

230.30

258.68

mg/l

1.77

392

1223

Retention of urine

180

703

2.08

18.13

1.1

375.18

301.05

mg/l

0.86

159

617

Undetermined asthma

336

2.76

18.09

1.1

257.86

268.80

mg/l

0.17

301

Other symptoms and signs involving the circulatory and respiratory systems

196

3.36

17.90

1.1

408.17

300.93

mg/l

0.40

162

Chronic sinusitis

294

1694

1.74

17.89

1.1

260.40

263.30

mg/l

0.06

259

1497

Other diseases of intestines

736

2854

1.44

17.89

1.1

255.17

262.76

mg/l

0.30

663

2534

Other medical care

265

1235

1.81

17.82

1.1

374.62

271.22

mg/l

1.87

230

1111

Cluster headache, wide

4.60

17.79

1.2

1.1

227.44

251.05

mg/l

0.46

Undetermined asthma, excluding more controls

340

2.73

17.69

1.1

257.86

274.14

mg/l

0.26

305

Viral infections characterized by skin and mucous membrane lesions

296

1717

1.73

17.63

1.2

1.1

291.63

256.63

mg/l

1.31

272

1539

Lesion of ulnar nerve

102

399

2.58

17.58

1.1

271.89

279.88

mg/l

0.08

352

Asthma, including avohilmo

781

3037

1.42

17.51

1.1

245.27

272.35

mg/l

2.10

680

2716

Sleep apnoea

588

2492

1.49

17.50

1.1

287.13

278.02

mg/l

0.32

512

2229

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

258

1448

1.79

17.35

1.1

223.90

233.07

mg/l

0.42

235

1285

Non-follicular lymphoma

215

3.20

17.35

1.2

1.0

430.32

297.47

mg/l

1.73

179

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.50

17.32

1.1

335.35

267.73

mg/l

1.19

Bronchitis

717

3013

1.43

17.10

1.1

241.95

269.06

mg/l

2.84

626

2685

Other diseases of upper respiratory tract

681

2449

1.45

17.09

1.1

258.01

275.92

mg/l

1.09

613

2158

Respiratory insufficiency

117

4.04

17.01

1.1

447.78

320.42

mg/l

0.36

100

Diseases of oesophagus, stomach and duodenum

694

2855

1.44

17.00

1.1

252.29

268.39

mg/l

1.21

610

2538

Osteopathies and chondropathies

349

1946

1.65

17.00

1.1

270.84

265.23

mg/l

0.14

297

1744

Sleep disorders

622

2946

1.46

16.81

1.1

246.16

269.97

mg/l

1.26

547

2627

Restless leg syndrome

111

462

2.43

16.80

1.1

231.83

262.49

mg/l

1.06

100

407

Vocal cord dysfunction

103

361

2.53

16.65

1.1

262.48

264.71

mg/l

0.04

319

Behavioural syndromes associated with physiological disturbances and physical factors

637

2986

1.45

16.52

1.1

249.31

270.83

mg/l

1.08

561

2663

Other shoulder lesions

275

2.87

16.49

1.1

266.51

251.20

mg/l

0.19

235

Dental pulpitis, including avohilmo

657

2931

1.44

16.41

1.1

251.70

266.52

mg/l

0.78

572

2618

327

1976

1.65

16.28

1.1

243.17

251.23

mg/l

0.28

283

1761

Temporomandibular joint disorders, including avohilmo

370

2252

1.60

16.18

1.1

221.29

229.92

mg/l

0.46

324

1995

Hypo-osmolality and hyponatraemia

385

2.52

15.94

1.1

371.38

284.60

mg/l

0.92

337

Disorders of other endocrine glands

305

1808

1.67

15.86

1.1

256.08

247.76

mg/l

0.19

259

1621

Dermatitis and eczema

729

3075

1.41

15.83

1.1

273.27

267.55

mg/l

0.18

642

2738

Voice disturbances

177

908

1.96

15.81

1.1

224.50

261.86

mg/l

2.87

161

800

Fourth [trochlear] nerve palsy

6.00

15.80

1.1

669.10

236.74

mg/l

0.47

Hydrocephalus

157

3.48

15.77

1.1

484.44

278.19

mg/l

1.38

131

Other disorders of bladder

277

2.81

15.68

1.1

273.50

312.09

mg/l

0.85

240

COPD/asthma related infections

649

2259

1.44

15.66

1.1

250.86

261.75

mg/l

0.58

573

2016

COPD/asthma/ILD related infections

649

2259

1.44

15.66

1.1

250.86

261.75

mg/l

0.58

573

2016

Exposure to other specified factors

557

3291

1.46

15.59

1.1

275.00

263.43

mg/l

0.31

495

2924

Metabolic disorders

597

2469

1.45

15.59

1.1

283.40

270.09

mg/l

0.58

533

2192

Chronic lower respiratory diseases

797

3034

1.39

15.56

1.1

250.58

269.31

mg/l

0.84

697

2708

Unknown and unspecified causes of morbidity

149

3.53

15.53

1.2

1.1

243.63

276.49

mg/l

0.62

135

Intestinal infectious diseases, including avohilmo, including avohilmo

736

2930

1.40

15.51

1.1

275.36

267.39

mg/l

0.21

659

2599

Other disorders of optic disc

6.67

15.50

1.2

1.1

235.20

218.56

mg/l

0.28

Enthesopathies of lower limb, excluding foot

146

704

2.09

15.50

1.1

270.63

255.37

mg/l

0.39

137

610

Asthma, hospital admissions , main diagnosis only

542

3236

1.46

15.42

1.1

237.51

268.75

mg/l

2.71

475

2880

Intestinal infectious diseases

621

3238

1.43

15.36

1.1

273.40

264.84

mg/l

0.21

548

2878

Adrenocortical insufficiency

4.33

15.31

1.2

1.1

390.48

237.21

mg/l

0.74

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

564

2259

1.46

15.14

1.1

280.79

261.75

mg/l

0.72

497

2016

564

2259

1.46

15.14

1.1

280.79

261.75

mg/l

0.72

497

2016

Constipation

535

2472

1.47

15.12

1.1

294.64

269.75

mg/l

0.90

454

2212

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

295

2.71

15.04

1.1

234.68

258.01

mg/l

0.65

261

Fall on same level

767

2957

1.39

15.00

1.1

258.38

263.01

mg/l

0.20

677

2635

Persons encountering health services in other circumstances

280

1660

1.68

14.91

1.1

298.09

252.73

mg/l

0.73

233

1464

Injuries to the neck

188

1005

1.88

14.89

1.1

272.42

248.45

mg/l

0.25

171

892

Hyperkinetic disorders, excluding more controls

130

566

2.16

14.89

1.1

195.95

227.72

mg/l

1.77

115

502

Non-Hodgkin lymphoma, all

4.66

14.72

1.2

1.1

602.93

261.09

mg/l

1.69

Other symptoms and signs involving the digestive system and abdomen

109

478

2.30

14.70

1.1

285.57

245.20

mg/l

0.65

423

Dental caries

171

839

1.93

14.56

1.1

294.20

296.90

mg/l

0.03

152

740

Diffuse large B-cell lymphoma, including Hilmo

100

4.06

14.54

1.3

1.1

391.79

249.88

mg/l

2.04

Diffuse large B-cell lymphoma

100

4.06

14.54

1.3

1.1

391.79

249.88

mg/l

2.04

Diffuse large B-cell lymphoma, helper endpoint

100

4.06

14.54

1.3

1.1

391.79

249.88

mg/l

2.04

Rotator cuff syndrome

331

1412

1.62

14.53

1.1

283.93

290.16

mg/l

0.18

303

1241

Post-traumatic stress disorder

395

2.44

14.52

1.1

195.56

223.48

mg/l

1.39

349

Diseases of the respiratory system

397

1268

1.57

14.51

1.1

254.36

265.10

mg/l

0.43

349

1128

Dislocation, sprain and strain of joints and ligaments at neck level

144

712

2.04

14.38

1.1

220.21

245.55

mg/l

1.10

130

632

Chronic laryngitis and laryngotracheitis

409

2.39

14.33

1.1

275.98

271.68

mg/l

0.05

359

Cardiac arrhythmias

427

1802

1.52

14.25

1.1

238.66

245.78

mg/l

0.32

368

1619

Use of hypnotics and sedatives

673

2755

1.40

14.16

1.1

259.46

272.10

mg/l

0.74

602

2449

Panic disorder

136

663

2.07

14.11

1.1

203.95

237.31

mg/l

2.14

123

593

Chronic diseases of tonsils and adenoids

530

2304

1.45

14.07

1.1

246.17

269.17

mg/l

1.45

481

2032

Genitourinary diseases

373

1184

1.59

14.07

1.1

263.24

276.92

mg/l

0.51

335

1060

Functional dyspepsia

183

989

1.86

14.03

1.0

1.1

252.43

256.70

mg/l

0.10

163

877

Zoster [herpes zoster]

112

507

2.22

14.02

1.3

1.1

346.33

270.17

mg/l

1.25

447

Caries of dentine

152

745

1.98

13.91

1.1

304.74

300.25

mg/l

0.05

137

659

697

2546

1.39

13.83

1.1

247.70

272.39

mg/l

2.00

612

2277

Iridocyclitis

158

818

1.94

13.83

1.1

272.32

262.03

mg/l

0.18

138

728

Benign paroxysmal vertigo

169

895

1.90

13.80

1.1

268.09

270.59

mg/l

0.05

151

799

Insomnia

599

2963

1.41

13.66

1.1

244.53

268.36

mg/l

1.22

524

2638

Other external causes of accidental injury

517

1772

1.47

13.64

1.1

255.91

260.19

mg/l

0.14

450

1580

Abnormal findings on diagnostic imaging of other body structures

382

2.40

13.60

1.2

1.1

284.35

271.08

mg/l

0.20

338

Falls/tendency to fall

705

2558

1.38

13.56

1.1

255.85

260.33

mg/l

0.17

622

2279

Disorders of muscles

283

2.64

13.47

1.1

380.92

262.70

mg/l

0.58

243

Other specified/unspecified systemic involvement of connective tissue

149

3.34

13.42

1.1

226.04

243.72

mg/l

0.33

131

Rheumatism, unspecified

326

2.50

13.27

1.1

271.67

247.54

mg/l

0.26

284

Hypertensive diseases (excluding secondary)

365

1368

1.56

13.23

1.1

260.57

252.28

mg/l

0.28

323

1219

Exposure to unspecified factor

658

3250

1.38

13.20

1.1

287.67

261.99

mg/l

0.83

570

2901

Infections with a predominantly sexual mode of transmission, including avohilmo

341

2018

1.55

13.17

1.1

222.12

235.80

mg/l

0.68

303

1794

Influenza and pneumonia

695

3137

1.37

13.11

1.1

285.56

258.06

mg/l

1.07

618

2788

Viral meningitis

132

3.48

13.09

1.2

1.0

343.68

242.96

mg/l

1.62

111

Unspecified dementia

120

3.46

13.08

1.1

255.97

322.29

mg/l

2.08

103

Covid-19 suspected case

176

962

1.84

13.07

1.1

275.62

239.81

mg/l

0.39

165

852

Hypermetropia

231

2.80

13.03

1.1

211.47

252.87

mg/l

1.14

200

Accidents

513

1772

1.45

13.03

1.1

256.11

260.19

mg/l

0.14

446

1580

Injuries to the head

720

3142

1.36

13.03

1.1

282.61

262.03

mg/l

0.69

628

2804

All influenza

167

898

1.87

13.03

1.1

251.53

263.12

mg/l

0.40

152

801

Cluster headache, strict, including avohilmo

178

3.09

12.99

1.2

1.1

229.96

250.20

mg/l

0.50

151

Viral meningitis, including avohilmo

138

3.40

12.93

1.2

1.1

340.72

245.17

mg/l

1.55

115

Other respiratory disorders and diseases

105

480

2.20

12.86

1.1

360.46

301.72

mg/l

0.35

422

Other diseases of the respiratory system

105

480

2.20

12.86

1.1

360.46

301.72

mg/l

0.35

422

Vitamin deficiency

129

3.46

12.78

1.1

207.97

230.55

mg/l

0.83

108

Vitamin deficiency, wide

129

3.46

12.78

1.1

207.97

230.55

mg/l

0.83

108

Dystonia

149

3.27

12.74

1.2

1.1

216.19

246.24

mg/l

0.98

128

Urinary track infection

422

1411

1.50

12.63

1.1

225.73

218.36

mg/l

0.36

375

1264

Diarrhoea and gastroenteritis of presumed infectious origin

464

2882

1.44

12.47

1.1

247.06

259.77

mg/l

0.77

409

2558

Endocrine, nutritional and metabolic diseases

553

1971

1.42

12.42

1.1

259.24

256.95

mg/l

0.07

488

1763

Non-selective monoamine reuptake inhibitors

188

1019

1.78

12.41

1.1

253.77

277.22

mg/l

0.63

162

926

Other and unspecified drugs and medicaments

272

2.60

12.40

1.1

233.70

265.44

mg/l

0.92

237

Hypermobility syndrome

227

2.78

12.38

1.1

196.29

207.65

mg/l

0.51

202

Transport accidents

313

1673

1.56

12.32

1.1

262.67

257.15

mg/l

0.08

280

1490

Non-allergic asthma (mode), excluding more controls

107

497

2.14

12.31

1.1

250.99

269.21

mg/l

0.30

441

Implicit fungal Sepsis

3.95

12.30

1.2

1.0

288.40

279.65

mg/l

0.07

Inflammatory diseases of female pelvic organs

440

2066

1.46

12.25

1.1

218.43

230.07

mg/l

0.66

380

1836

Non-allergic asthma (mode)

107

498

2.14

12.25

1.1

250.99

267.78

mg/l

0.27

442

Disorders of synovium and tendon

317

1736

1.55

12.22

1.1

249.76

270.92

mg/l

1.02

284

1527

Neoplasms

559

2084

1.41

12.22

1.1

267.89

238.14

mg/l

0.88

497

1845

Sleep apnoea, including avohilmo

605

2650

1.38

12.13

1.1

278.26

274.08

mg/l

0.14

530

2375

Fungal Sepsis

3.81

12.03

1.2

1.0

289.77

296.88

mg/l

0.05

Ptosis of eyelid

259

2.61

11.98

1.3

1.0

249.64

280.97

mg/l

0.98

221

Hypothyroidism, drug reimbursement

295

2.29

11.97

1.1

228.35

217.73

mg/l

0.23

264

Disorders of adult personality and behaviour

234

1423

1.65

11.96

1.1

209.30

237.93

mg/l

2.58

203

1276

Other viral diseases, including avohilmo

298

1901

1.56

11.92

1.1

246.69

239.46

mg/l

0.17

267

1690

Other bacterial diseases

552

2625

1.40

11.87

1.1

338.55

267.88

mg/l

2.76

477

2347

Cluster headache, wide,, including avohilmo

188

2.92

11.83

1.2

1.1

229.96

259.37

mg/l

0.80

159

Hypothyreosis and Thyroxine purchase for inclusion criteria

569

2692

1.39

11.80

1.1

243.76

259.53

mg/l

1.01

506

2388

Abnormal findings on examination of blood, without diagnosis

247

1377

1.63

11.76

1.0

1.1

257.17

300.67

mg/l

2.60

218

1230

Sicca syndrome [Sjögren]

216

2.76

11.75

1.2

1.1

209.56

241.84

mg/l

1.24

192

Osteoporosis

125

578

2.00

11.75

1.1

338.08

277.13

mg/l

0.97

102

518

N06DA Anticholinesterases

122

464

2.03

11.71

1.1

267.35

323.15

mg/l

2.71

104

410

Use of anticholinesterases

122

464

2.03

11.71

1.1

267.35

323.15

mg/l

2.71

104

410

Anterior Iridocyclitis

138

724

1.92

11.70

1.1

265.48

262.49

mg/l

0.04

120

644

Hypertension, essential

492

1953

1.43

11.69

1.1

281.88

267.55

mg/l

0.60

434

1745

Faecal incontinence

200

2.82

11.67

1.0

1.1

268.24

248.21

mg/l

0.32

181

Disorders of lens

335

1357

1.53

11.63

1.1

296.84

307.25

mg/l

0.22

294

1203

Zoster [herpes zoster], including avohilmo

278

1710

1.57

11.59

1.1

309.67

267.41

mg/l

1.06

244

1520

Complications of surgical and medical care, not elsewhere classified

611

2990

1.37

11.57

1.1

260.72

269.06

mg/l

0.22

542

2652

Injuries to the wrist and hand

651

3197

1.35

11.57

1.1

270.76

265.03

mg/l

0.15

577

2844

Chronic iridocyclitis

148

3.16

11.56

1.2

1.1

270.50

252.82

mg/l

0.10

127

Benign neoplasm of brain and other parts of central nervous system

169

3.00

11.54

1.1

305.84

274.16

mg/l

0.40

146

Irregular menses

375

1904

1.49

11.49

1.1

215.75

221.00

mg/l

0.15

335

1677

Disorders of psychological development

119

552

2.02

11.46

1.1

227.43

224.51

mg/l

0.05

111

480

Deforming dorsopathies

158

871

1.82

11.44

1.1

237.08

253.92

mg/l

0.60

131

756

Hypothyroidism, other/unspecified

549

2614

1.38

11.24

1.1

242.47

259.94

mg/l

1.16

487

2317

Any death

298

1346

1.55

11.16

1.1

431.30

296.29

mg/l

2.08

260

1204

Diseases of pulp and periapical tissues, including avohilmo

647

2475

1.35

11.11

1.1

250.43

270.01

mg/l

1.28

574

2199

Undefined dementia

138

3.09

11.09

1.1

255.97

304.28

mg/l

1.39

115

Speech and linguistic disorders

388

2.22

11.08

1.1

250.48

214.20

mg/l

0.64

340

Pain and other conditions associated with female genital organs and menstrual cycle

183

883

1.74

11.07

1.1

200.05

209.04

mg/l

0.39

162

778

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

347

2308

1.48

10.87

1.1

267.50

269.30

mg/l

0.03

304

2058

Intermittent heterotropia

226

2.64

10.78

1.1

221.81

227.81

mg/l

0.08

194

Generalized anxiety disorder

139

752

1.86

10.72

1.1

204.74

233.74

mg/l

2.46

130

672

Metatarsalgia

268

2.48

10.71

1.1

255.67

249.71

mg/l

0.09

231

Other diseases of blood and blood-forming organs, wide

132

704

1.89

10.68

1.1

330.22

271.87

mg/l

0.46

111

624

External causes of morbidity and mortality

417

1442

1.45

10.68

1.1

255.42

264.72

mg/l

0.29

359

1287

Acetic acid derivatives and related substances

148

406

1.89

10.57

1.1

271.19

271.21

mg/l

0.00

131

356

Asthma, hospital admissions 3, pneumonia

194

1158

1.68

10.53

1.1

243.83

267.63

mg/l

1.23

164

1035

Asthma-related pneumonia or sepsis

194

1158

1.68

10.53

1.1

243.83

267.63

mg/l

1.23

164

1035

Acute bronchitis

240

1487

1.59

10.49

1.0

1.1

273.82

259.95

mg/l

0.16

200

1331

Nonorganic sleeping disorders

172

1001

1.73

10.44

1.1

221.11

240.91

mg/l

1.11

152

886

Other and unspecified effects of external causes

206

1260

1.64

10.36

1.1

222.27

243.48

mg/l

1.21

178

1127

Personality disorders

216

1339

1.62

10.31

1.1

202.12

240.69

mg/l

4.31

189

1204

Asthma-related pneumonia

193

1158

1.67

10.29

1.1

243.83

267.63

mg/l

1.23

164

1035

Bipolar affective disorders

141

778

1.82

10.28

1.1

236.04

248.86

mg/l

0.42

126

695

Infections with a predominantly sexual mode of transmission

253

1625

1.56

10.27

1.1

230.40

229.26

mg/l

0.03

231

1435

Injuries to the ankle and foot

497

3095

1.37

10.24

1.1

246.27

256.69

mg/l

0.44

428

2766

Other heart diseases

318

1378

1.50

10.22

1.1

243.87

252.31

mg/l

0.31

284

1225

Other viral diseases

219

1360

1.61

10.21

1.1

258.81

239.87

mg/l

0.39

194

1211

Acute and subacute iridocyclitis

127

680

1.88

10.19

1.1

270.44

261.69

mg/l

0.13

112

605

Benign neoplasms

633

2583

1.34

10.10

1.1

256.53

258.65

mg/l

0.07

569

2280

Specific personality disorders

189

1140

1.67

10.07

1.1

210.18

238.62

mg/l

2.13

163

1018

Other specified/unspecified arthritis

165

959

1.73

10.06

1.1

352.42

265.02

mg/l

0.92

148

843

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

228

1423

1.59

10.06

1.1

211.39

224.93

mg/l

0.75

193

1264

Trochanteric bursitis

364

2.21

10.03

1.1

226.14

253.16

mg/l

0.79

314

Substance abuse, excluding more controls

299

1667

1.50

9.99

1.1

293.86

285.67

mg/l

0.14

270

1484

Other diseases of pleura

196

1033

1.65

9.95

1.1

380.65

299.10

mg/l

0.66

170

921

Presence of other functional implants

266

1178

1.55

9.92

1.1

310.11

307.56

mg/l

0.05

215

1050

Mycoses, including avohilmo

579

3300

1.34

9.89

1.1

253.88

269.26

mg/l

0.95

522

2922

Other diseases of stomach and duodenum

146

2.98

9.88

1.1

1.0

262.40

305.12

mg/l

0.61

128

Hypopituitarism

267

2.42

9.85

1.1

251.13

284.25

mg/l

0.61

232

Fitting and adjustment of other devices

153

768

1.76

9.78

1.2

1.1

348.04

290.05

mg/l

0.58

139

684

Other disorders of adrenal gland

142

3.00

9.75

1.2

1.1

392.52

243.63

mg/l

0.78

124

Hypertensive diseases

495

2030

1.38

9.73

1.1

276.80

265.02

mg/l

0.47

437

1814

Unspecific neurodegenerative disorder

145

550

1.81

9.72

1.1

272.33

321.86

mg/l

2.17

123

486

Diseases of male genital organs

274

892

1.55

9.65

1.1

314.08

342.26

mg/l

0.75

248

796

Hypertension

494

2028

1.38

9.64

1.1

276.95

265.21

mg/l

0.47

436

1812

Other arthritis (FG)

183

1109

1.66

9.57

1.1

339.03

262.37

mg/l

0.89

165

979

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

183

1112

1.66

9.51

1.1

234.42

227.04

mg/l

0.20

166

983

Other complications of surgical and medical care, not elsewhere classified

309

2.29

9.49

1.2

1.1

228.32

258.11

mg/l

0.97

275

Other hearing loss

122

639

1.86

9.44

1.1

245.74

305.66

mg/l

3.44

108

567

Emotional disorders starting during childhood or adolecense, excluding more controls

161

2.80

9.42

1.1

1.0

159.54

218.50

mg/l

2.62

134

Other nutritional deficiencies

442

2935

1.38

9.41

1.1

237.66

261.22

mg/l

1.63

385

2616

Other and unspecified mononeuropathies, also in other diseases

4.28

9.40

1.3

1.1

233.79

258.76

mg/l

0.29

Urticaria and erythema

253

1663

1.53

9.38

1.1

263.24

238.45

mg/l

0.55

217

1484

Diseases of the skin and subcutaneous tissue

603

2274

1.33

9.37

1.1

257.28

260.93

mg/l

0.14

536

2040

Injuries to the knee and lower leg

733

3066

1.29

9.36

1.1

273.36

263.26

mg/l

0.44

660

2718

Alzheimer disease

102

365

2.00

9.36

1.0

1.1

277.43

323.50

mg/l

1.30

322

Other bacterial diseases, including avohilmo

608

2878

1.32

9.25

1.1

325.62

258.36

mg/l

2.87

530

2566

Disorders of choroid and retina

411

2060

1.40

9.22

1.1

298.13

284.22

mg/l

0.54

354

1843

Complications of procedures, not elsewhere classified

480

2850

1.36

9.21

1.1

263.63

271.27

mg/l

0.16

429

2533

Disorders of the thyroid gland

568

2772

1.33

9.19

1.1

248.03

263.28

mg/l

0.97

506

2462

Other enthesopathy of foot (+metatarsalgia)

302

2.27

9.10

1.1

256.16

251.84

mg/l

0.07

263

Other disorders of bone

137

779

1.77

9.09

1.1

207.89

256.08

mg/l

4.35

119

694

Unspecified/other endometriosis

457

2.01

9.09

1.1

192.49

209.79

mg/l

0.89

410

Explicit Sepsis, including avohilmo

215

1240

1.58

9.08

1.1

382.26

271.52

mg/l

1.78

180

1103

Injuries to the thorax

244

1602

1.53

9.06

1.1

328.37

278.31

mg/l

0.74

210

1437

Other skin changes

102

532

1.93

8.91

1.2

1.1

276.73

282.90

mg/l

0.07

472

Chronic apical periodontitis

689

2989

1.29

8.90

1.1

257.96

267.13

mg/l

0.41

620

2645

Vestibular neuronitis

249

2.39

8.89

1.1

226.12

296.79

mg/l

3.03

212

Abnormal weight loss

262

2.35

8.83

1.1

274.14

274.59

mg/l

0.00

225

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

151

891

1.71

8.81

1.1

208.17

206.02

mg/l

0.08

129

800

Explicit Sepsis

209

1214

1.57

8.76

1.1

368.17

271.71

mg/l

1.55

175

1083

Senile cataract

275

1117

1.50

8.71

1.1

290.97

316.56

mg/l

0.88

242

992

Hyperhidrosis

3.59

8.69

1.0

272.43

215.10

mg/l

0.83

All kidney diseases

602

3088

1.31

8.68

1.1

305.20

254.18

mg/l

1.95

529

2739

Myopia

106

566

1.89

8.67

1.1

225.04

238.84

mg/l

0.38

504

Use of levodopa decarboxylase inhibitor

284

2.27

8.59

1.2

1.1

339.11

312.95

mg/l

0.13

244

Soft tissue disorders related to use, overuse and pressure

141

822

1.72

8.58

1.1

245.87

277.27

mg/l

1.41

127

713

Spondyloarthritis

520

1.91

8.49

1.1

255.47

265.87

mg/l

0.13

459

Carpal tunnel syndrome

314

1898

1.44

8.48

1.1

273.81

272.63

mg/l

0.02

281

1696

Scleritis and episcleritis

200

2.53

8.48

1.0

1.1

250.31

247.84

mg/l

0.02

178

Disorders of speech understanding and production

162

2.70

8.45

1.2

1.1

246.02

204.22

mg/l

1.16

146

Candidiasis, including avohilmo

200

1280

1.57

8.43

1.1

245.63

241.95

mg/l

0.10

178

1143

Internal derangement of knee

218

1407

1.54

8.43

1.0

1.1

256.61

267.09

mg/l

0.40

193

1248

Other acute lower respiratory infections

309

2055

1.44

8.42

1.1

277.79

260.14

mg/l

0.27

261

1840

Pneumonia, organism unspecified

549

2862

1.32

8.39

1.1

304.42

263.41

mg/l

1.40

480

2540

Reimbursement for rheumatic diseases

322

2258

1.42

8.35

1.1

279.02

259.03

mg/l

0.52

289

2004

Other enthesopathies

167

1026

1.63

8.34

1.1

273.72

267.82

mg/l

0.08

147

895

Inflammatory disease of uterus

114

632

1.82

8.30

1.1

224.60

206.27

mg/l

0.49

567

Anomalies of pupillary function

3.89

8.29

1.0

1.1

237.96

228.26

mg/l

0.11

Other peripheral vascular diseases

239

2.36

8.26

1.1

218.71

257.74

mg/l

1.43

206

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

608

3127

1.30

8.24

1.1

297.84

260.60

mg/l

1.41

536

2780

Pneumonias (Asthma/COPD co-morbidities)

623

3152

1.29

8.22

1.1

295.74

259.12

mg/l

1.42

552

2801

Convergent concomitant strabismus

204

2.48

8.15

1.1

222.22

239.84

mg/l

0.31

176

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

312

2194

1.42

8.15

1.1

267.87

268.74

mg/l

0.01

274

1954

Septicaemia

196

1144

1.57

8.13

1.1

382.50

277.55

mg/l

1.63

165

1029

All pneumoniae

626

3158

1.29

8.12

1.1

295.45

258.90

mg/l

1.43

555

2807

Cerebral aneurysm, nonruptured

217

2.42

8.06

1.1

1.0

327.12

285.90

mg/l

0.22

193

Oxicams

111

338

1.87

8.01

1.1

262.80

284.63

mg/l

0.48

295

Persistent mood disorders

116

654

1.78

7.98

1.1

263.89

264.48

mg/l

0.01

104

589

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

201

1133

1.56

7.98

1.1

247.74

219.52

mg/l

0.24

175

1009

Weight loss

295

2.19

7.89

1.1

270.83

268.94

mg/l

0.02

255

Benign neoplasm of colon, rectum, anus and anal canal

283

1661

1.44

7.86

1.1

326.92

297.77

mg/l

0.75

264

1461

Anti-inflammatory and antirheumatic products, non-steroids

152

450

1.70

7.86

1.1

259.92

270.75

mg/l

0.23

128

399

Alzheimer’s disease, strict definition

303

2.06

7.85

1.0

1.1

285.50

329.57

mg/l

0.96

266

Other disorders of ear

514

2528

1.32

7.77

1.1

264.92

279.11

mg/l

0.56

462

2242

3.58

7.73

1.1

240.61

247.80

mg/l

0.07

Retinal detachments and breaks

156

962

1.63

7.72

1.1

305.15

288.67

mg/l

0.33

134

859

Chronic rhinitis, nasopharyngitis and pharyngitis

202

1323

1.53

7.71

1.1

231.68

250.72

mg/l

0.57

183

1166

Persons with potential health hazards related to communicable diseases

286

1992

1.43

7.65

1.1

269.45

233.77

mg/l

0.54

239

1781

Disorders of vitreous body and globe

240

1542

1.48

7.60

1.1

284.73

287.09

mg/l

0.06

222

1361

Astigmatism

217

2.37

7.59

1.1

176.56

248.25

mg/l

3.27

184

Injury, poisoning and certain other consequences of external causes

332

1179

1.41

7.56

1.0

1.1

255.97

265.03

mg/l

0.24

286

1058

Supplementary factors related to causes of morbidity and mortality classified elsewhere

193

1258

1.54

7.56

1.1

237.64

256.92

mg/l

0.97

169

1122

Paroxysmal tachycardia

131

641

1.70

7.52

1.1

234.45

258.88

mg/l

0.99

110

573

Alzheimer disease, including avohilmo

115

447

1.78

7.52

1.1

279.18

320.56

mg/l

1.28

394

Impingement syndrome of shoulder

110

622

1.78

7.52

1.1

317.90

287.32

mg/l

0.32

539

Polymyalgia rheumatica

243

2.27

7.51

1.0

1.1

292.50

308.69

mg/l

0.21

216

Use of donepezil

286

2.14

7.50

1.1

278.65

310.51

mg/l

0.79

249

Deviated nasal septum

174

1109

1.57

7.48

1.1

288.50

299.65

mg/l

0.22

160

985

Phobic anxiety disorders

107

600

1.79

7.48

1.1

208.16

238.14

mg/l

1.18

536

Urticaria

208

1381

1.51

7.48

1.1

240.48

239.07

mg/l

0.03

177

1228

Herpesviral [herpes simplex] infections

403

1.97

7.46

1.2

1.1

266.18

256.76

mg/l

0.14

354

Disorders of vitreous body

233

1504

1.48

7.45

1.1

286.62

287.15

mg/l

0.01

216

1328

Other disorders of eyelid

185

1128

1.55

7.44

1.2

1.1

264.70

289.21

mg/l

0.96

162

989

Asthma/COPD (KELA code 203)

582

3031

1.28

7.43

1.1

250.45

269.49

mg/l

0.62

514

2705

Propionic acid derivatives

150

450

1.68

7.42

1.1

264.54

270.75

mg/l

0.11

129

399

Paracetamol or NSAID medication

241

1.95

7.41

1.1

242.82

263.34

mg/l

0.33

215

Tonsillectomy and adenotomy

432

2254

1.34

7.39

1.1

225.79

240.09

mg/l

0.80

388

2010

Benign neoplasm of other and unspecified endocrine glands

405

1.96

7.36

1.1

247.46

269.56

mg/l

0.61

349

Other problems related to primary support group, including family circumstances

525

1.83

7.32

1.1

222.97

216.91

mg/l

0.15

470

Pain associated with micturition

379

1.99

7.28

1.1

358.23

259.24

mg/l

0.46

327

Superficial injury of abdomen, lower back and pelvis

107

607

1.77

7.26

1.1

270.78

255.57

mg/l

0.26

532

Emotionally unstable personality disorder

110

630

1.76

7.25

1.1

206.24

227.86

mg/l

1.06

556

Other predominantly sexually transmitted diseases, not elsewhere classified

142

872

1.64

7.22

1.1

244.67

226.62

mg/l

0.50

132

771

Other heart diseases, wide

592

2805

1.28

7.19

1.1

238.74

268.15

mg/l

2.83

518

2502

Memory loss

174

2.49

7.16

1.2

1.1

230.68

316.88

mg/l

2.96

149

Social phobias

375

1.99

7.14

1.1

210.42

239.00

mg/l

1.03

334

Other arrhythmias

386

2140

1.35

7.13

1.1

244.30

273.72

mg/l

2.11

330

1913

Other septicaemia

169

1021

1.56

7.09

1.1

382.40

281.79

mg/l

1.25

143

917

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

273

1201

1.44

7.09

1.1

250.87

251.75

mg/l

0.02

246

1072

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

202

1350

1.50

7.07

1.1

244.41

247.89

mg/l

0.10

174

1201

Mycoses

167

1071

1.57

7.07

1.1

266.80

260.41

mg/l

0.17

148

952

Fracture of rib(s), sternum and thoracic spine

147

915

1.61

7.05

1.1

355.69

291.60

mg/l

0.58

124

817

Aneurysms, operations, SAH

412

1.93

7.01

1.1

310.47

289.80

mg/l

0.16

363

Other septicaemia, including avohilmo

173

1049

1.55

7.00

1.1

400.53

279.73

mg/l

1.51

146

944

Other and unspecified mood [affective] disorders

284

2.13

6.98

1.1

207.78

228.97

mg/l

0.55

249

Fibroblastic disorders

542

1.80

6.93

1.1

267.97

283.83

mg/l

0.43

482

Hypothyroidism, strict autoimmune, 3 medication purchases required

487

2521

1.30

6.85

1.1

244.87

252.04

mg/l

0.33

435

2235

Disturbance of activity and attention

127

751

1.66

6.81

1.1

197.02

217.95

mg/l

0.99

112

660

Episcleritis

173

2.45

6.77

1.0

1.1

260.47

248.07

mg/l

0.08

152

Ovarian cyst

234

913

1.47

6.77

1.1

211.49

229.25

mg/l

0.80

207

803

Drug-induced adrenocortical insufficiency

3.96

6.74

1.2

1.1

276.54

213.80

mg/l

0.43

Problems related to lifestyle

398

1.92

6.70

1.2

1.1

232.69

259.02

mg/l

0.98

348

Other viral diseases, not elsewhere classified, including avohilmo

190

1261

1.50

6.70

1.1

240.29

239.59

mg/l

0.01

174

1122

Raynaud syndrome

343

2.00

6.69

1.1

219.69

246.18

mg/l

0.75

301

Injuries to the abdomen, lower back, lumbar spine and pelvis

221

1500

1.46

6.65

1.1

275.23

263.43

mg/l

0.22

195

1341

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

187

2.37

6.62

1.1

211.35

290.21

mg/l

2.77

161

Adverse effects, not elsewhere classified

137

853

1.61

6.62

1.1

219.03

239.27

mg/l

0.79

121

759

Other erythematous conditions

100

2.94

6.60

1.1

386.04

257.63

mg/l

0.39

Disorders of skin appendages

326

2394

1.36

6.57

1.1

248.22

245.34

mg/l

0.08

290

2121

Use of rivastigmine

231

2.21

6.56

1.0

1.1

234.41

312.87

mg/l

3.19

199

Benign neoplasm: Colon

228

1485

1.44

6.54

1.1

327.95

303.84

mg/l

0.47

214

1306

Disorders of lipoprotein metabolism and other lipidaemias

412

1895

1.32

6.53

1.1

308.47

287.27

mg/l

0.82

374

1688

Early onset COPD, excluding more controls

444

1.85

6.49

1.2

1.1

384.43

311.56

mg/l

0.35

403

Type of accident

173

1142

1.52

6.47

1.1

236.07

256.48

mg/l

1.01

150

1017

Disorders of conjunctiva

518

3150

1.28

6.47

1.1

245.56

261.13

mg/l

0.77

474

2792

Allergic asthma (mode)

145

898

1.58

6.44

1.1

226.44

240.62

mg/l

0.48

130

793

Other CVD (FINNGEN)

204

2.14

6.44

1.2

1.1

336.06

291.95

mg/l

0.35

178

Poisoning by drugs, medicaments and biological substances

167

1096

1.53

6.43

1.1

251.82

240.75

mg/l

0.34

143

981

Thyroiditis, ILD-related definition

337

1.97

6.28

1.2

1.1

211.76

234.51

mg/l

0.54

304

Adhesive capsulitis of shoulder

400

1.88

6.27

1.1

251.31

268.72

mg/l

0.39

346

Spondylolisthesis/Spondylolysis

472

1.81

6.25

1.0

1.1

252.10

258.71

mg/l

0.15

407

Allergic asthma (mode), excluding more controls

145

905

1.57

6.24

1.1

226.44

241.54

mg/l

0.52

130

800

Keratitis

207

1428

1.45

6.23

1.1

267.83

259.96

mg/l

0.21

180

1286

Poisoning by medicine

154

1002

1.54

6.19

1.1

255.88

243.22

mg/l

0.37

131

894

Hypokalaemia

305

2.01

6.16

1.1

283.98

265.14

mg/l

0.35

264

Abnormal results of function studies

265

2.09

6.15

1.2

1.0

243.38

284.08

mg/l

0.69

232

Polycystic ovarian syndrome, consortium definition

459

2038

1.29

6.14

1.1

222.84

229.37

mg/l

0.23

413

1796

Disorders of mineral metabolism

239

2.15

6.12

1.2

1.1

269.84

255.73

mg/l

0.24

208

Infections of the skin and subcutaneous tissue

354

2632

1.33

6.12

1.1

276.36

267.31

mg/l

0.24

312

2343

Other disorders of the genitourinary system

306

2.00

6.11

1.0

1.1

272.31

256.44

mg/l

0.25

270

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

585

2956

1.25

6.08

1.1

258.20

262.30

mg/l

0.16

514

2631

Injuries to the shoulder and upper arm

471

2843

1.28

6.06

1.1

262.24

282.48

mg/l

1.18

414

2525

Diseases of the digestive system

216

1501

1.43

6.00

1.1

264.39

273.03

mg/l

0.24

192

1341

Heartburn

350

1.93

5.99

1.1

227.89

262.78

mg/l

1.07

309

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.15

5.91

1.1

250.03

254.47

mg/l

0.03

Hyperkinetic disorders

130

803

1.59

5.89

1.1

195.95

216.22

mg/l

0.98

115

701

Schizophrenia or delusion, excluding more controls

160

1049

1.51

5.85

1.0

1.1

223.13

274.55

mg/l

4.59

138

943

Haemorrhage from respiratory passages

149

861

1.54

5.79

1.1

274.82

302.85

mg/l

0.69

133

765

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

172

1163

1.48

5.78

1.1

260.22

267.84

mg/l

0.22

152

1045

Psychotic depression

131

2.54

5.78

1.2

1.1

313.25

295.03

mg/l

0.07

119

Suicide or other Intentional self-harm

162

1083

1.50

5.77

1.1

251.06

246.48

mg/l

0.12

143

967

Early lumbar disc prolapse, operated

384

1.86

5.74

1.1

243.59

249.99

mg/l

0.17

338

Tinnitus

125

790

1.59

5.73

1.1

234.47

274.19

mg/l

2.00

118

706

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

273

1981

1.36

5.73

1.1

257.60

242.70

mg/l

0.43

235

1767

Bleeding

407

2207

1.29

5.69

1.1

304.66

276.50

mg/l

0.68

367

1967

Parkinson's disease, including avohilmo

329

1.92

5.65

1.2

1.1

267.96

317.49

mg/l

1.18

283

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

277

1276

1.37

5.63

1.1

195.26

200.73

mg/l

0.27

256

1114

Appendectomy

398

2944

1.29

5.61

1.1

251.26

260.81

mg/l

0.28

352

2620

Other and unspecified coagulation defects

183

2.26

5.59

1.1

199.92

230.44

mg/l

0.81

160

Glaucoma suspect

155

1033

1.50

5.58

1.1

287.86

282.38

mg/l

0.10

133

910

Hyperplasia of prostate

144

522

1.56

5.53

1.1

345.53

373.87

mg/l

0.54

125

461

Coagulation defects, purpura and other haemorrhagic conditions

114

712

1.61

5.51

1.1

257.31

258.83

mg/l

0.02

629

Oter anti-inflammatory and antirheumatic agents, non-steroids

265

1.79

5.50

1.1

268.34

304.84

mg/l

0.82

232

Acute pharyngitis

116

722

1.60

5.46

1.1

229.65

241.98

mg/l

0.32

647

Other and unspecified tonsillitis

247

1492

1.38

5.46

1.1

262.43

245.40

mg/l

0.35

221

1327

Retinal vascular occlusion

237

2.08

5.46

1.1

361.84

289.23

mg/l

0.71

207

Other and unspecified iron deficiency

170

1160

1.47

5.42

1.1

276.25

257.07

mg/l

0.39

150

1034

Acute tubulo-interstitial nephritis

333

2139

1.32

5.42

1.1

332.42

254.77

mg/l

1.69

297

1892

Contact with and exposure to communicable diseases

232

1671

1.39

5.41

1.1

234.97

224.79

mg/l

0.19

194

1493

Retinal vascular disorders

238

2.07

5.40

1.1

361.84

289.23

mg/l

0.71

207

Superficial injury of lower leg

162

1100

1.48

5.37

1.1

225.59

244.48

mg/l

0.96

142

977

Rash and other nonspecific skin eruption

267

2.00

5.31

1.1

218.57

272.96

mg/l

2.14

237

Volume depletion

200

2.16

5.30

1.1

275.19

268.29

mg/l

0.07

171

Leisure time condition

108

673

1.61

5.29

1.1

240.08

262.27

mg/l

0.69

591

Other coagulation defects

247

2.04

5.29

1.1

209.14

234.37

mg/l

0.64

215

Agranulocytosis

316

1.91

5.29

1.1

411.96

265.50

mg/l

0.58

277

Diabetic neuropathy

239

2.05

5.28

1.1

331.03

326.03

mg/l

0.04

207

Herpesviral [herpes simplex] infections, including avohilmo

168

1154

1.46

5.26

1.1

253.97

234.84

mg/l

0.50

154

1027

Sequelae of external causes of morbidity and mortality

129

839

1.54

5.26

1.1

369.68

265.82

mg/l

0.81

107

742

Other disorders of white blood cells

150

2.35

5.25

1.2

1.1

259.50

270.22

mg/l

0.13

131

Misadventures to patients during surgical and medical care

441

1.75

5.19

1.1

235.17

263.26

mg/l

0.90

387

Dementia in Alzheimer disease

172

2.14

5.18

1.0

1.1

276.77

325.38

mg/l

0.97

149

Other noninfective gastroenteritis and colitis

138

914

1.51

5.16

1.1

277.57

251.68

mg/l

0.42

125

815

Maltreatment syndromes

223

2.08

5.14

1.2

1.1

221.19

253.62

mg/l

0.75

190

Osteoporosis with pathological fracture (FG)

115

2.54

5.12

1.2

1.1

263.14

270.16

mg/l

0.06

101

Dislocation, sprain and strain of joints and ligaments of knee

385

2729

1.28

5.08

1.1

275.07

263.44

mg/l

0.39

348

2420

Missing teeth due to accident, extraction or parodontitis

287

1932

1.33

5.07

1.1

315.38

286.55

mg/l

0.70

262

1718

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

367

2217

1.29

5.06

1.1

236.62

239.57

mg/l

0.07

325

1968

Parkinson's disease

315

1.88

5.00

1.2

1.1

263.54

311.19

mg/l

1.08

271

Ménière disease

232

2.04

5.00

1.1

261.01

280.74

mg/l

0.34

200

Spondylopathies (FG)

522

1.68

4.98

1.1

254.60

259.31

mg/l

0.05

460

Calculus of kidney and ureter

139

931

1.50

4.96

1.1

275.01

284.88

mg/l

0.24

129

829

Urolithiasis

145

980

1.48

4.95

1.0

1.1

297.59

289.50

mg/l

0.11

133

874

Abnormal blood-pressure reading, without diagnosis

136

2.37

4.91

1.2

1.1

226.56

301.35

mg/l

1.94

114

Procreative management

226

1359

1.37

4.90

1.1

254.03

265.23

mg/l

0.20

207

1192

Diseases of external ear

186

1321

1.41

4.89

1.1

282.53

264.89

mg/l

0.32

167

1183

Dermatographic urticaria

262

1.96

4.88

1.0

1.1

197.97

229.99

mg/l

0.99

231

Unspecified fall

266

1964

1.33

4.85

1.1

259.21

262.81

mg/l

0.09

228

1750

Iron deficiency anaemia

204

1445

1.39

4.84

1.1

273.36

260.71

mg/l

0.27

176

1291

Noninfective enteritis and colitis

266

2003

1.33

4.80

1.1

269.97

256.23

mg/l

0.36

234

1792

Renal tubulo-interstitial diseases

472

2787

1.24

4.80

1.1

320.65

254.30

mg/l

2.10

416

2469

Pure hypercholesterolaemia

346

1703

1.29

4.77

1.1

321.81

292.52

mg/l

1.05

318

1522

Sudden idiopathic hearing loss

278

1.92

4.77

1.1

247.72

296.48

mg/l

1.15

245

Other obstetric conditions, not elsewhere classified

275

1305

1.33

4.75

1.1

197.05

202.48

mg/l

0.27

253

1139

Assault by bodily force

343

1.82

4.74

1.1

239.24

257.46

mg/l

0.32

302

Conjunctivitis (acute, non atopic), including avohilmo

578

2869

1.22

4.73

1.1

247.51

275.49

mg/l

2.31

526

2537

Polyarthropathies

359

1799

1.28

4.72

1.1

326.40

265.51

mg/l

1.45

326

1596

Conjunctivitis

468

3045

1.24

4.71

1.1

235.77

257.39

mg/l

1.44

431

2699

Other and unspecified disorders of vitreous body

178

1235

1.41

4.70

1.1

276.38

286.33

mg/l

0.27

164

1092

Fall on and from stairs and steps

143

977

1.47

4.66

1.1

290.36

261.18

mg/l

0.56

121

871

Meniscus derangement

265

1320

1.33

4.66

1.1

289.71

284.57

mg/l

0.11

236

1166

Ganglion

115

753

1.53

4.61

1.1

253.80

241.98

mg/l

0.25

103

653

Glaucoma

221

1381

1.36

4.60

1.1

318.71

290.74

mg/l

0.65

190

1220

Vascular dementia

105

2.49

4.59

1.2

1.1

291.30

316.93

mg/l

0.29

Persons encountering health services for specific procedures, not carried out

297

1.86

4.55

1.2

1.1

266.66

255.50

mg/l

0.10

257

Behavioural disorders, excluding more controls

3.00

4.55

1.2

1.1

919.69

283.72

mg/l

0.44

Parkinson's disease, strict definition

297

1.86

4.54

1.2

1.1

269.02

312.73

mg/l

0.89

256

Conjunctivitis (acute, non atopic)

174

1236

1.41

4.50

1.1

251.97

245.12

mg/l

0.20

163

1093

Diseases of tongue

161

2.19

4.49

1.1

254.90

286.93

mg/l

0.46

138

Diseases of middle ear and mastoid

377

2445

1.26

4.48

1.1

262.71

244.50

mg/l

0.57

332

2180

Autoimmune hepatitis, wide definition

2.54

4.47

1.2

1.1

222.65

279.35

mg/l

1.18

Diaphragmatic hernia

152

1060

1.44

4.46

1.1

273.46

283.91

mg/l

0.13

139

934

Pulmonary heart disease

120

800

1.50

4.42

1.1

330.50

282.63

mg/l

0.47

107

706

Pulmonary embolism

120

801

1.50

4.40

1.1

330.50

282.56

mg/l

0.47

107

707

Vasomotor and allergic rhinitis

234

1717

1.33

4.38

1.1

230.29

246.80

mg/l

0.68

207

1510

Monoamine oxidase A inhibitors

294

1.85

4.36

1.0

1.1

240.47

284.69

mg/l

1.26

261

Superficial injury of wrist and hand

137

943

1.46

4.34

1.1

293.52

241.21

mg/l

0.45

123

843

Obesity and other hyperalimentation

385

2902

1.25

4.30

1.1

243.75

259.85

mg/l

0.81

341

2584

Car occupant injured in other and unspecified transport accidents

123

831

1.49

4.29

1.1

291.10

245.82

mg/l

0.35

116

731

Lung diseases due to external agents

303

1.82

4.28

1.1

414.96

311.45

mg/l

0.34

258

Presbyopia

240

1.93

4.25

1.1

232.70

276.49

mg/l

1.33

215

Methotrexate

400

1.71

4.24

1.1

252.00

262.19

mg/l

0.14

358

Other cataract

178

951

1.39

4.23

1.2

1.1

310.12

295.73

mg/l

0.20

158

849

Exclusions for E4_PCOS_CONSORTIUM

448

2271

1.23

4.22

1.1

238.32

235.68

mg/l

0.08

392

2010

Secondary and unspecified malignant neoplasm of lymph nodes

220

1.97

4.20

1.1

335.32

268.72

mg/l

0.69

195

Glomerular diseases

555

1.59

4.20

1.1

340.67

287.72

mg/l

0.47

481

Other female pelvic inflammatory diseases

571

1.58

4.19

1.1

213.94

221.91

mg/l

0.16

517

Emotional disorders and disorders of social functioning with onset specific to childhood

257

1.88

4.18

1.1

162.87

217.13

mg/l

2.36

224

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

387

1.71

4.17

1.1

329.97

287.37

mg/l

0.57

349

Sequelae of injuries, of poisoning and of other consequences of external causes

134

926

1.45

4.17

1.1

321.22

267.91

mg/l

0.44

118

827

Other retinal disorders

275

1609

1.30

4.16

1.1

302.29

290.88

mg/l

0.37

239

1445

Obesity

382

2896

1.24

4.13

1.1

244.18

259.78

mg/l

0.77

338

2578

Endometriosis of rectovaginal septum and vagina

257

1.88

4.12

1.1

230.26

220.64

mg/l

0.11

235

Endometriosis of pelvic peritoneum

108

650

1.52

4.11

1.1

206.32

219.42

mg/l

0.61

574

Colour vision deficiencies

8.31

4.10

1.0

1.1

182.75

240.50

mg/l

—

Emotional disorders starting during childhood or adolescence

241

1.91

4.09

1.1

159.54

207.57

mg/l

2.09

212

Otitis externa

131

905

1.45

4.09

1.1

279.78

256.86

mg/l

0.31

120

806

Decubitus ulcer and pressure area

116

2.34

4.08

1.1

758.52

285.42

mg/l

0.74

102

Diseases of pulp and periapical tissues and dental caries

318

1273

1.28

4.08

1.1

266.79

291.80

mg/l

0.97

272

1139

Acute lymphadenitis

223

1.94

4.06

1.2

1.1

217.50

251.14

mg/l

0.86

192

Mouth breathing

199

1476

1.35

4.06

1.1

288.66

281.84

mg/l

0.16

164

1328

Spinal instabilities

2.78

4.03

1.1

1.0

238.95

258.98

mg/l

0.19

Pulmonary heart disease, diseases of pulmonary circulation

124

850

1.46

4.02

1.2

1.1

328.61

285.39

mg/l

0.42

110

750

Presence of other devices

567

1.57

4.02

1.1

270.54

296.56

mg/l

0.69

513

Other disorders of conjunctiva

369

1.71

4.02

1.1

315.46

282.48

mg/l

0.28

322

Other and unspecified urticaria

122

835

1.47

4.01

1.1

272.55

242.10

mg/l

0.57

106

740

Haemorrhoids and perianal venous thrombosis

152

1075

1.41

4.00

1.1

294.33

270.94

mg/l

0.37

140

947

Chondropathies

586

1.56

3.99

1.1

205.56

256.49

mg/l

3.31

515

Other viral diseases, not elsewhere classified

116

785

1.48

3.97

1.2

1.1

254.56

247.71

mg/l

0.08

105

695

Appendicitis, broad definition

423

3102

1.22

3.97

1.1

269.38

267.16

mg/l

0.04

369

2766

Diseases of appendix

426

3115

1.22

3.97

1.1

269.75

267.15

mg/l

0.05

372

2778

Excessive attrition of teeth

370

2956

1.24

3.96

1.1

244.12

253.85

mg/l

0.46

328

2630

Sensorineural hearing loss

326

1718

1.27

3.96

1.1

289.08

295.65

mg/l

0.14

288

1525

Venous thromboembolism

226

1652

1.32

3.95

1.1

306.38

288.15

mg/l

0.28

204

1467

Open wound of wrist and hand

259

1937

1.29

3.94

1.1

262.46

271.08

mg/l

0.27

227

1734

Sequelae with surgical and medical care as external cause

612

1.54

3.93

1.1

399.48

276.54

mg/l

0.71

537

Dental operations

281

1117

1.30

3.91

1.1

269.27

290.38

mg/l

0.72

241

1005

Other disorders of skin and subcutaneous tissue

361

2452

1.24

3.90

1.1

309.29

274.05

mg/l

0.69

311

2183

Ankylosing spondylitis

241

1.88

3.87

1.1

297.12

263.29

mg/l

0.21

204

Excessive, frequent and irregular menstruation

237

959

1.32

3.85

1.1

197.15

225.27

mg/l

1.99

216

845

Dental caries, including avohilmo

351

1431

1.26

3.85

1.1

266.97

289.32

mg/l

0.88

302

1282

Flat foot [pes planus] (acquired)

263

1.83

3.85

1.1

240.60

250.49

mg/l

0.22

235

Endometriosis

205

887

1.35

3.83

1.1

229.57

231.29

mg/l

0.04

174

783

False labour

230

1083

1.32

3.82

1.1

189.05

215.98

mg/l

2.22

207

951

Lung cancer and mesothelioma

265

1.76

3.81

1.0

1.1

369.71

327.41

mg/l

0.53

235

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

308

1.76

3.80

1.1

283.76

252.43

mg/l

0.15

267

Superficial injury of head

124

860

1.44

3.80

1.1

270.36

263.26

mg/l

0.14

110

772

Other inflammation of eyelid

445

1.62

3.77

1.2

1.1

239.70

261.04

mg/l

0.75

385

Dermatitis due to substances taken internally

160

2.08

3.77

1.1

1.0

238.84

253.92

mg/l

0.15

139

Other bacterial intestinal infections

539

1.56

3.76

1.1

485.23

278.10

mg/l

1.19

470

Viral warts, including avohilmo

136

963

1.42

3.75

1.1

248.84

245.46

mg/l

0.07

124

850

Arthrosis

354

1554

1.25

3.74

1.1

255.49

276.26

mg/l

1.43

312

1377

Inflammatory diseases of prostate (prostatitis)

317

1.74

3.74

1.0

1.1

282.46

336.01

mg/l

1.65

281

DVT of lower extremities and pulmonary embolism

168

1228

1.36

3.72

1.1

315.38

281.72

mg/l

0.45

151

1092

Unspecified urinary incontinence

216

1.91

3.72

1.1

305.91

261.45

mg/l

0.27

188

Diseases of liver

165

1210

1.37

3.70

1.1

248.91

274.35

mg/l

1.31

139

1088

Diseases of arteries, arterioles and capillaries (FINNGEN)

100

456

1.52

3.70

1.1

275.15

292.34

mg/l

0.41

404

Recurrent dislocation and subluxation of joint

260

1.82

3.68

1.1

294.37

257.25

mg/l

0.16

224

Melanocytic naevi

179

1333

1.35

3.64

1.1

266.17

244.02

mg/l

0.80

153

1187

Hernia of abdominal wall, postoperative

469

1.59

3.64

1.1

318.13

273.42

mg/l

0.38

423

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

113

779

1.46

3.63

1.1

254.43

242.28

mg/l

0.29

694

Bacterial pneumonia, not elsewhere classified

172

1117

1.35

3.59

1.2

1.1

353.94

272.33

mg/l

1.00

160

1002

Disease of hard tissues of teeth, NOS

254

1028

1.30

3.58

1.1

247.56

298.20

mg/l

3.12

234

906

Other CVD

428

1.62

3.57

1.1

334.93

300.01

mg/l

0.33

371

Congenital malformations, deformations and chromosomal abnormalities

368

2848

1.23

3.57

1.1

247.41

249.91

mg/l

0.07

334

2531

Menorrhagia

198

827

1.34

3.55

1.1

221.80

233.66

mg/l

0.39

172

733

Bacterial intestinal infections, IBD co-morbidities

531

1.55

3.55

1.1

488.74

280.84

mg/l

1.15

459

Convergence insufficiency and excess

3.10

3.55

1.3

1.1

197.79

203.13

mg/l

0.08

Hypotension

345

1.69

3.53

1.2

1.1

346.25

311.12

mg/l

0.28

293

Alcohol abuse, main dg, excluding more controls

453

1.60

3.53

1.2

1.1

251.43

290.78

mg/l

1.37

404

Secondary hypertension

203

1.90

3.51

1.0

1.1

269.10

266.89

mg/l

0.02

179

Sequelae of injuries of upper limb

331

1.70

3.51

1.1

272.85

285.13

mg/l

0.15

288

Obesity due to excess calories

292

2334

1.25

3.49

1.1

247.18

247.45

mg/l

0.01

256

2068

Acute appendicitis, no complications

327

2633

1.24

3.46

1.1

243.85

258.56

mg/l

0.45

287

2338

Conductive and sensorineural hearing loss

352

1897

1.23

3.44

1.1

284.57

295.92

mg/l

0.28

311

1689

Unspecified haematuria

162

972

1.36

3.44

1.1

411.43

290.35

mg/l

1.39

153

865

Caries of enamel

561

3113

1.18

3.44

1.1

264.41

269.19

mg/l

0.09

517

2759

Other and unspecified acne

2.81

3.44

1.6

1.1

167.54

254.49

mg/l

1.71

Divergent concomitant strabismus

244

1.81

3.44

1.1

224.23

264.69

mg/l

0.66

211

Hyperlipidaemia, other/unspecified

145

946

1.38

3.43

1.1

327.29

314.52

mg/l

0.25

118

837

Other pleural conditions

201

1.90

3.43

1.1

245.88

304.38

mg/l

1.33

169

Melanocytic naevi of trunk

457

1.58

3.42

1.1

284.40

258.82

mg/l

0.51

404

Bacterial pneumonia (organism specified)

195

1342

1.32

3.42

1.1

343.89

271.31

mg/l

0.98

179

1206

Other superficial mycoses, including avohilmo

481

1.57

3.42

1.2

1.1

229.54

247.03

mg/l

0.50

423

Other bacterial intestinal infections, including avohilmo

114

797

1.43

3.41

1.1

432.39

267.96

mg/l

1.25

712

Bacterial, viral and other infectious agents, including avohilmo

357

1.66

3.40

1.1

252.27

273.90

mg/l

0.49

312

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

133

2.12

3.40

1.1

220.64

269.87

mg/l

1.03

111

Other disorders of patella

100

683

1.47

3.39

1.0

1.1

238.90

244.64

mg/l

0.11

599

Nutritional anaemias

222

1641

1.29

3.38

1.1

274.96

263.99

mg/l

0.24

189

1465

Fenamates

286

1.62

3.38

1.1

244.56

269.66

mg/l

0.55

250

Specific development disorders of scholastic skills

205

1.88

3.38

1.1

1.0

179.65

231.13

mg/l

1.55

174

Disorders of breast

283

1988

1.25

3.38

1.1

241.01

233.76

mg/l

0.15

249

1761

Diseases of oral cavity, salivary glands and jaws

257

1034

1.28

3.37

1.1

269.75

297.52

mg/l

0.94

225

912

Assault

635

1.49

3.37

1.1

234.89

253.89

mg/l

0.51

567

Fracture at wrist and hand level

194

1477

1.31

3.35

1.1

309.30

270.51

mg/l

0.93

167

1330

Chronic kidney disease

106

705

1.45

3.35

1.0

1.1

315.64

304.65

mg/l

0.18

613

Acute appendicitis

395

3035

1.21

3.34

1.1

272.13

267.40

mg/l

0.09

346

2704

Ovarian dysfunction

421

1.60

3.34

1.1

190.70

197.14

mg/l

0.23

373

Injury of muscle and tendon at shoulder and upper arm level

151

1112

1.36

3.34

1.1

293.65

309.51

mg/l

0.38

138

995

Chronic gastritis

669

1.47

3.33

1.1

291.02

290.37

mg/l

0.01

596

Malignant melanoma of skin, including Hilmo

344

1.66

3.32

1.1

487.74

282.18

mg/l

0.79

309

Other diseases of arteries and capillaries

240

1.80

3.30

1.1

333.03

285.58

mg/l

0.23

207

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

396

2997

1.20

3.25

1.1

245.10

254.03

mg/l

0.31

359

2658

Other diseases of liver

624

1.48

3.24

1.1

220.94

271.91

mg/l

3.02

557

Other keratitis

448

1.57

3.24

1.1

262.23

259.57

mg/l

0.03

394

Other disorders of breast

544

1.51

3.23

1.1

207.83

219.89

mg/l

0.38

484

Iron deficiency

137

2.06

3.18

1.0

1.1

201.50

210.70

mg/l

0.14

122

Collagenous colitis

288

1.71

3.17

1.0

1.1

269.33

259.46

mg/l

0.06

251

Localized swelling, mass and lump of skin and subcutaneous tissue

139

1020

1.37

3.17

1.1

319.48

266.88

mg/l

0.59

125

898

Malignant neoplasm of digestive organs, including Hilmo

867

0.67

3.16

1.1

353.31

294.39

mg/l

0.83

782

Other metabolic disorders

491

1.53

3.14

1.1

236.19

236.75

mg/l

0.01

437

Vascular dementia (subcortical)

3.27

3.14

1.2

1.1

281.08

281.30

mg/l

0.00

Fall on same level involving ice and snow

297

2409

1.23

3.13

1.1

280.21

261.83

mg/l

0.54

261

2149

Cardiodefibrillation

854

0.62

3.13

1.1

282.40

320.11

mg/l

1.00

758

Superficial injury of hip and thigh

444

1.56

3.12

1.1

218.50

277.85

mg/l

3.13

380

Ischemic heart diseases

386

1902

1.21

3.11

1.1

266.15

297.71

mg/l

1.99

336

1703

Nail disorders

290

1.70

3.10

1.1

267.28

272.59

mg/l

0.06

248

Malignant melanoma, including Hilmo

414

1.57

3.08

1.1

482.51

284.50

mg/l

0.93

375

Other and unspecified anaemias

158

1114

1.33

3.07

1.1

327.23

287.36

mg/l

0.52

124

994

Enterocolitis due to Clostridium difficile

261

1.73

3.05

1.1

617.25

291.30

mg/l

0.94

226

Anogenital herpesviral [herpes simplex] infection, including avohilmo

584

1.48

3.05

1.2

1.1

201.05

216.96

mg/l

0.73

510

Nontraumatic intracranial haemmorrhage

407

1.58

3.04

1.1

351.79

302.15

mg/l

0.88

359

Disorders of orbit

119

2.12

3.04

1.2

1.1

308.84

249.19

mg/l

0.52

100

Deep endometriosis

369

1.61

3.03

1.1

228.23

215.00

mg/l

0.20

325

Cerebral oedema

10.55

3.02

1.0

1.2

279.00

260.20

mg/l

—

Asthma and allergy

521

1.50

3.02

1.1

224.27

229.28

mg/l

0.09

458

Contusion of other and unspecified parts of foot

218

1.80

3.01

1.1

196.13

230.82

mg/l

1.28

186

Other diseases of anus and rectum

129

940

1.37

3.01

1.1

273.07

275.67

mg/l

0.05

115

824

Ehlers-Danlos syndrome, including avohilmo

2.79

3.01

1.1

196.64

205.93

mg/l

0.16

Asthma and allergy, excluding more controls

522

1.50

3.00

1.1

224.27

231.03

mg/l

0.12

457

L04AC Interleukin inhibitors

248

1.75

2.99

1.1

224.39

268.58

mg/l

0.74

215

Budesonide

505

1.51

2.99

1.1

237.80

256.04

mg/l

0.49

452

Gastroduodenal ulcer

584

1.47

2.99

1.1

282.22

306.21

mg/l

0.53

522

Diseases of salivary glands

169

1290

1.31

2.98

1.2

1.1

236.84

252.20

mg/l

0.74

148

1145

Other anaemias

159

1124

1.33

2.98

1.1

326.53

286.66

mg/l

0.53

125

1004

Malignant neoplasm of digestive organs

797

0.66

2.97

1.1

391.11

289.53

mg/l

1.47

719

Other noninflammatory disorders of vulva and perineum

379

1.59

2.96

1.1

224.62

212.38

mg/l

0.21

336

Preterm labour and delivery

147

1101

1.34

2.96

1.1

255.08

226.98

mg/l

0.37

131

969

Helminthiases, including avohilmo

162

1.93

2.95

1.1

250.58

233.23

mg/l

0.16

139

Tongue abnormality

155

1.95

2.94

1.2

1.1

259.36

272.08

mg/l

0.12

132

Striking against or struck by other objects

199

1554

1.28

2.93

1.1

306.07

266.57

mg/l

0.46

172

1397

Conduct disorder

2.34

2.92

1.2

1.1

919.69

253.98

mg/l

0.47

Other diseases of hard tissues of teeth

251

1034

1.26

2.91

1.1

274.16

297.52

mg/l

0.74

221

912

Bacterial pneumoniae

179

1211

1.30

2.90

1.2

1.1

345.27

271.87

mg/l

0.90

166

1087

Gonarthrosis

283

1292

1.24

2.89

1.1

266.77

286.24

mg/l

0.90

254

1136

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

281

1.68

2.88

1.1

280.59

273.41

mg/l

0.11

241

Candidiasis

526

1.49

2.88

1.1

273.26

249.60

mg/l

0.51

466

Purpura and other haemorrhagic conditions

438

1.54

2.86

1.1

284.19

275.81

mg/l

0.09

375

Complications of internal orthopaedic prosthetic devices, implants and grafts

543

1.48

2.85

1.1

275.06

287.93

mg/l

0.29

479

Atopic dermatitis

376

2507

1.20

2.84

1.1

219.35

247.57

mg/l

2.46

335

2240

Glomerulonephritis

290

1.66

2.84

1.1

279.64

294.23

mg/l

0.16

250

Other disorders of skin and subcutaneous tissue, not elsewhere classified

423

1.54

2.83

1.1

272.66

272.61

mg/l

0.00

370

All influenza (not pneumonia)

528

1.48

2.83

1.1

249.84

269.94

mg/l

0.47

463

Other arthrosis

231

1230

1.26

2.83

1.0

1.1

257.34

290.19

mg/l

2.02

202

1083

Viral warts

376

1.58

2.82

1.1

267.69

252.38

mg/l

0.21

329

Caries of dentine, including avohilmo

377

1605

1.20

2.82

1.1

264.23

280.78

mg/l

0.65

326

1445

Thrombocytopenia, unspecified

201

1.80

2.81

1.1

361.90

280.80

mg/l

0.70

174

Benign neoplasm: Choroid

165

1.89

2.80

1.0

1.1

264.12

292.03

mg/l

0.30

141

Rheumatoid arthritis

137

906

1.34

2.79

1.1

287.23

270.32

mg/l

0.27

123

797

Behavioural disorders

2.29

2.78

1.2

1.1

919.69

220.83

mg/l

0.50

Other conditions related to polyarteritis nodosa

8.72

2.78

1.0

1.2

249.80

251.50

mg/l

—

Mental and behavioural disorders due to psychoactive substance use

309

2337

1.21

2.77

1.1

294.91

278.72

mg/l

0.33

277

2084

Injury of nerves at wrist and hand level

131

2.00

2.76

1.1

213.10

262.77

mg/l

1.11

114

Acute generalized exanthematous pustulosis

131

2.00

2.76

1.0

1.1

255.30

250.73

mg/l

0.03

111

Other diseases of the digestive system

118

865

1.37

2.75

1.1

266.54

289.40

mg/l

0.61

105

770

Substance abuse

299

2289

1.21

2.75

1.1

293.86

279.54

mg/l

0.28

270

2040

GI-bleeding

117

857

1.37

2.74

1.1

280.29

289.69

mg/l

0.16

104

762

Fracture of lower leg, including ankle

273

2190

1.23

2.74

1.1

309.50

271.22

mg/l

1.20

247

1946

Fracture of foot, except ankle

144

1090

1.32

2.73

1.1

240.48

243.68

mg/l

0.07

122

976

Autoimmune hyperthyroidism

139

1.95

2.70

1.1

261.76

243.60

mg/l

0.19

126

Coeliac disease

437

1.52

2.68

1.2

1.1

260.05

257.75

mg/l

0.03

386

Other disorders of the musculoskeletal system and connective tissue

437

1.52

2.68

1.2

1.1

266.90

282.29

mg/l

0.33

381

Superficial injury of ankle and foot

552

1.46

2.66

1.1

228.36

228.18

mg/l

0.00

487

Other sexually transmitted chlamydial diseases, including avohilmo

577

1.45

2.66

1.1

206.48

219.06

mg/l

0.38

498

Dermatophytosis

430

1.52

2.65

1.1

259.81

286.53

mg/l

0.63

373

Polyarthrosis

452

1.48

2.63

1.1

252.16

283.78

mg/l

0.93

400

Hypoglycaemia, other or unspecified

213

1.75

2.63

1.1

255.23

275.35

mg/l

0.32

182

Gingivitis and periodontal diseases

524

2336

1.16

2.60

1.1

252.17

274.24

mg/l

1.57

476

2079

Injury of muscle and tendon at wrist and hand level

473

1.49

2.59

1.1

333.59

273.44

mg/l

0.63

423

Drug-induced neutropenia

192

1.78

2.58

1.1

567.32

269.24

mg/l

0.65

169

Other contact dermatitis

260

1.66

2.57

1.1

256.47

273.02

mg/l

0.26

232

Retinal detachment with retinal break

322

1.59

2.56

1.1

261.82

304.04

mg/l

1.27

284

Acute renal failure

532

1.45

2.55

1.2

1.1

377.54

306.46

mg/l

0.69

462

Unspecified mental disorder

226

1828

1.24

2.54

1.1

224.51

260.29

mg/l

2.81

195

1635

Childhood asthma (age<16), excluding more controls

504

1.41

2.54

1.2

1.1

256.34

223.77

mg/l

0.51

439

KRA_PSY_EATING, excluding more controls

344

1.56

2.52

1.1

195.17

210.82

mg/l

0.25

307

Symptoms and signs involving emotional state

2.18

2.51

1.1

273.95

207.47

mg/l

0.85

Statin medication

408

1953

1.18

2.51

1.1

278.64

264.80

mg/l

0.48

367

1730

Orchitis and epididymitis

239

1.68

2.50

1.1

289.46

339.54

mg/l

0.84

211

Childhood asthma (age<16)

507

1.41

2.47

1.2

1.1

256.34

223.38

mg/l

0.52

442

FESS (DNB20)

446

1.49

2.46

1.1

330.29

267.18

mg/l

0.44

394

Aplastic and other anaemias

171

1229

1.27

2.46

1.1

326.69

287.00

mg/l

0.57

135

1102

Superficial injury of thorax

512

1.45

2.45

1.1

395.32

275.17

mg/l

0.56

446

All chronic kidney diseases

235

1524

1.23

2.45

1.1

303.15

274.77

mg/l

0.69

207

1355

Other local infections of skin and subcutaneous tissue

342

1.56

2.45

1.1

239.98

276.31

mg/l

0.85

293

Other and unspecified injuries of lower leg

295

1.60

2.44

1.1

285.71

251.18

mg/l

0.48

256

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

485

1.46

2.44

1.1

189.08

227.31

mg/l

0.74

428

Disorders of parathyroid gland

490

1.46

2.44

1.1

273.11

272.76

mg/l

0.00

433

Medical abortion

354

1614

1.19

2.43

1.1

219.37

226.32

mg/l

0.38

314

1423

Other and unspecified nonorganic psychotic disorders

123

929

1.33

2.42

1.0

1.1

223.61

258.49

mg/l

1.43

107

833

Other disorders of glucose regulation and pancreatic internal secretion

273

1.62

2.40

1.1

258.94

275.92

mg/l

0.27

234

COPD (mode)

509

1.40

2.39

1.1

393.27

321.17

mg/l

0.39

457

Endometriosis diagnosis and infertility diagnosis occurring together

532

1.44

2.39

1.2

1.1

205.36

206.15

mg/l

0.02

476

Other inflammation of eyelid, including avohilmo

258

2133

1.21

2.38

1.1

210.42

242.12

mg/l

4.37

231

1879

Streptococcal septicaemia

220

1.69

2.37

1.2

1.1

535.63

306.53

mg/l

0.56

193

Benign neoplasm: Anus and anal canal

2.43

2.37

1.1

281.36

264.88

mg/l

0.14

Acute peritonitis

146

1.86

2.37

1.1

641.76

280.85

mg/l

0.58

130

Maternal care for other conditions predominantly related to pregnancy

151

1147

1.29

2.36

1.1

207.68

207.07

mg/l

0.02

128

1006

Bacterial, viral and other infectious agents

330

1.55

2.35

1.1

254.83

275.14

mg/l

0.40

287

Heart failure, not strict

313

1765

1.19

2.33

1.2

1.1

277.69

297.12

mg/l

0.81

273

1571

Biological medication for rheuma

109

814

1.34

2.33

1.1

241.35

251.80

mg/l

0.20

736

Ethmoidectomy

460

1.46

2.33

1.1

327.26

265.69

mg/l

0.44

407

Dislocation, sprain and strain of joints and ligaments of thorax

2.05

2.32

1.3

1.1

409.60

253.95

mg/l

0.47

Substance use, excluding alcohol

114

858

1.33

2.31

1.1

311.94

260.83

mg/l

0.57

100

775

Malignant melanoma

371

1.51

2.31

1.1

508.30

282.72

mg/l

0.90

335

Any event in cancer register

512

2607

1.15

2.31

1.1

300.62

250.94

mg/l

1.52

455

2320

Exposure to other and unspecified man-made environmental factors

2.40

2.30

1.1

249.64

221.00

mg/l

0.32

Recurrent dislocation of patella

238

1.65

2.29

1.1

221.28

215.19

mg/l

0.11

206

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.97

2.29

1.1

1034.90

262.93

mg/l

—

Perforation of tympanic membrane

333

1.54

2.26

1.1

269.63

272.66

mg/l

0.03

289

Endometriosis ASRM stages 1,2

108

810

1.34

2.26

1.1

206.32

212.36

mg/l

0.26

732

Medicines for HER+ breast cancer

1127

0.73

2.24

1.2

1.1

300.73

252.63

mg/l

0.50

1001

Ingrowing nail

186

1.73

2.24

1.1

317.04

257.56

mg/l

0.59

158

Nonsuppurative otitis media, including avohilmo

204

1432

1.23

2.23

1.1

265.97

239.92

mg/l

0.50

183

1270

Acne conglobata

5.65

2.22

1.2

1.0

244.32

288.11

mg/l

—

Respiratory disorders in diseases classified elsewhere

2.89

2.22

1.1

313.50

234.66

mg/l

—

Suppurative and unspecified otitis media

240

1757

1.21

2.21

1.1

255.43

240.69

mg/l

0.29

217

1562

Peroneal tendinitis

2.71

2.21

1.0

191.73

243.46

mg/l

1.04

Phlebitis and thrombophlebitis (not including DVT)

736

1.35

2.20

1.2

1.1

270.53

264.96

mg/l

0.09

654

Amenorrhoea

344

1.52

2.19

1.1

293.80

201.58

mg/l

0.59

308

Lagophthalmos

3.37

2.19

1.4

1.0

264.25

241.67

mg/l

—

Other and unspecified local infections of skin and subcutaneous tissue

320

1.54

2.18

1.1

233.23

275.74

mg/l

1.10

274

Streptococcal septicaemia, including avohilmo

226

1.64

2.17

1.2

1.1

535.63

306.86

mg/l

0.56

197

Follicular cysts of skin and subcutaneous tissue

661

1.37

2.17

1.1

252.27

265.66

mg/l

0.30

585

Postprocedural endocrine and metabolic disorders, not elsewhere classified

451

1.45

2.16

1.2

1.1

226.12

232.70

mg/l

0.15

400

Alcohol use disorder, Swedish definition

259

1965

1.20

2.16

1.1

281.79

283.22

mg/l

0.03

230

1744

Secondary uncertain malignant neoplasm

313

1.54

2.15

1.1

351.37

282.47

mg/l

0.70

279

Other specified/unspecified disorders of bone/cartilage

2.18

2.15

1.0

1.1

218.82

286.39

mg/l

1.22

Ehlers-Danlos syndrome

2.82

2.15

1.0

1.1

201.20

211.16

mg/l

—

Necrosis of pulp, including avohilmo

334

2822

1.17

2.14

1.1

253.92

261.57

mg/l

0.24

290

2511

Hallux rigidus

338

1.51

2.13

1.0

1.1

319.17

271.39

mg/l

0.61

299

Myeloid leukaemia

2.38

2.12

1.4

1.1

236.15

262.74

mg/l

0.26

Viral and other specified intestinal infections, including avohilmo

177

1373

1.24

2.12

1.1

225.36

242.71

mg/l

0.70

157

1222

Fissure and fistula of anal and rectal regions

113

862

1.31

2.12

1.1

280.45

269.54

mg/l

0.24

763

Diseases of peritoneum

267

1.58

2.11

1.1

1.0

459.49

275.11

mg/l

0.47

233

Viral and other specified intestinal infections

132

1004

1.29

2.10

1.1

218.56

241.19

mg/l

1.07

118

890

Rosacea

479

1.42

2.10

1.1

250.40

240.99

mg/l

0.15

426

Dialysis, with operation codes

372

1.48

2.09

1.2

1.1

374.38

307.54

mg/l

0.96

318

Crohn's disease of small intestine

268

1.57

2.09

1.1

246.24

269.21

mg/l

0.34

232

Atrial fibrillation and flutter with reimbursement

420

1.37

2.09

1.1

413.49

291.15

mg/l

0.72

376

Otitis externa, unspecified

447

1.44

2.07

1.1

317.39

262.48

mg/l

0.40

390

Abnormal findings in secretions and smears from cervix uteri vagina vulva

306

1912

1.18

2.07

1.1

207.90

222.09

mg/l

0.88

274

1694

Other congenital malformations of brain

4.09

2.05

1.0

275.00

330.80

mg/l

—

Other bursopathies

301

1.53

2.05

1.0

1.1

284.89

275.03

mg/l

0.10

257

Open wound of head

248

1950

1.20

2.04

1.1

305.32

284.20

mg/l

0.40

218

1741

Superficial injury of shoulder and upper arm

424

1.44

2.03

1.1

209.72

257.70

mg/l

2.61

370

Cellulitis

109

833

1.31

2.03

1.1

345.81

265.54

mg/l

1.19

737

Other (seronegative) rheumatoid arthritis, wide

533

1.39

2.02

1.1

280.26

263.94

mg/l

0.25

470

Endocrine disorders, other/unspecified

2.52

2.02

1.2

1.0

279.33

224.06

mg/l

—

Other and specified injuries of hip and thigh

2.52

2.01

1.0

1.1

261.91

242.11

mg/l

0.17

L04AD Calcineurin inhibitors

384

1.46

2.01

1.1

295.37

280.83

mg/l

0.18

335

Pruritus

384

1.46

2.00

1.1

282.98

241.28

mg/l

0.45

341

Diabetic retinopathy, excluding more controls

101

423

1.34

1.99

1.1

310.51

312.23

mg/l

0.02

373

Gastric ulcer

401

1.45

1.99

1.1

283.83

309.82

mg/l

0.41

354

Procedures for purposes other than remedying health state

2.30

1.98

1.0

1.1

240.08

233.23

mg/l

0.07

Degeneration of macula and posterior pole

143

873

1.26

1.97

1.1

315.23

306.23

mg/l

0.20

129

776

Noninflammatory disorders of female genital tract

232

964

1.21

1.97

1.1

201.37

225.97

mg/l

1.31

206

850

DVT of lower extremities

502

1.40

1.97

1.1

269.37

278.50

mg/l

0.15

440

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

318

2613

1.17

1.97

1.1

226.27

249.24

mg/l

1.21

293

2311

Female infertility, associated with anovulation

444

1.43

1.97

1.1

193.24

204.61

mg/l

0.28

394

Explicit bacterial Sepsis

272

1.55

1.97

1.2

1.1

517.22

295.44

mg/l

0.65

239

Allergic rhinitis

192

1557

1.22

1.96

1.1

229.07

239.09

mg/l

0.35

170

1384

Vulvovaginal ulceration/inflammation in other diseases

305

1.52

1.95

1.1

262.56

202.78

mg/l

1.17

275

Mental disorders, not otherwise specified

362

1.47

1.95

1.0

1.1

211.24

233.31

mg/l

0.71

319

Blepharochalasis

743

1.32

1.94

1.1

276.04

284.87

mg/l

0.15

655

Smoking dependency

281

1.54

1.94

1.1

295.38

283.33

mg/l

0.15

244

Torticollis

2.47

1.93

1.2

1.1

280.00

232.51

mg/l

0.21

Intracerebral haemorrhage

242

1.57

1.92

1.1

388.03

301.34

mg/l

1.22

207

Vasomotor rhinitis (mode)

227

1.59

1.90

1.1

219.48

278.39

mg/l

1.30

199

Rheumatoid arthritis, including avohilmo

159

1286

1.24

1.90

1.1

274.16

262.81

mg/l

0.20

143

1136

Noninfectious colitis NAS

498

1.39

1.89

1.1

258.94

263.01

mg/l

0.05

443

Female infertility

177

862

1.23

1.89

1.1

226.78

222.60

mg/l

0.09

162

759

Generalized skin eruption due to drugs and medicaments

121

1.83

1.88

1.0

1.1

267.71

246.33

mg/l

0.16

105

Other inflammatory liver diseases

189

1.65

1.87

1.2

1.1

244.96

280.44

mg/l

0.57

165

Mental and behavioural disorders due to tobacco

284

1.52

1.87

1.1

295.38

283.87

mg/l

0.14

248

Pregnancy with abortive outcome

361

1627

1.16

1.86

1.1

220.26

226.01

mg/l

0.27

322

1434

Other hammer toe(s) (acquired)

354

1.44

1.86

1.1

283.73

284.51

mg/l

0.01

314

Enterobiasis, including avohilmo

100

1.92

1.86

1.2

1.1

196.84

215.76

mg/l

0.26

Renal failure

159

1095

1.24

1.86

1.1

324.43

303.82

mg/l

0.32

136

970

Atrial fibrillation and flutter

122

614

1.28

1.86

1.1

298.30

288.13

mg/l

0.17

101

546

Obesity, other/unspecified

197

1633

1.21

1.86

1.1

231.39

244.73

mg/l

0.61

181

1445

Follow-up care involving plastic surgery

1.99

1.85

1.1

293.12

242.17

mg/l

0.69

Acne, including avohilmo

168

1107

1.23

1.84

1.1

225.37

209.02

mg/l

0.35

150

969

Gout

538

1.34

1.83

1.0

1.1

442.28

338.19

mg/l

1.25

470

Enteritis due to Yersinia enterocolitica

4.24

1.83

1.0

1.1

464.80

245.92

mg/l

—

Other abnormal products of conception

219

1199

1.20

1.83

1.1

191.39

206.04

mg/l

1.36

196

1059

Crohn disease (strict definition, all UC cases excluded)

191

1.63

1.81

1.0

1.1

214.12

262.10

mg/l

0.89

161

Other diseases of oesophagus

230

1.57

1.81

1.1

277.32

296.11

mg/l

0.18

196

Nephropathy related operations

360

1.45

1.80

1.2

1.1

385.16

305.56

mg/l

1.14

310

Congenital malformations of the circulatory system

555

1.35

1.79

1.1

240.21

258.90

mg/l

0.51

493

Lateral epicondylitis

386

1.43

1.78

1.1

322.48

264.96

mg/l

0.34

332

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

165

1351

1.22

1.78

1.1

243.84

246.47

mg/l

0.05

146

1210

Disorders of continuity of bone

353

1.45

1.78

1.1

241.66

265.56

mg/l

0.36

313

Invasive ventilation

200

1.61

1.77

1.1

419.04

299.98

mg/l

0.53

169

Other disorders of veins

184

1499

1.21

1.77

1.1

311.69

262.99

mg/l

0.60

165

1328

Cholecystectomy

325

2393

1.15

1.76

1.1

271.46

268.59

mg/l

0.08

292

2120

Abnormal findings on antenatal screening of mother

514

1.37

1.76

1.1

186.04

191.05

mg/l

0.13

452

278

2129

1.17

1.76

1.1

281.80

283.79

mg/l

0.04

245

1894

Explicit bacterial Sepsis, including avohilmo

280

1.50

1.76

1.2

1.1

517.22

296.40

mg/l

0.64

245

Generalized epilepsy, strict definition

2.04

1.75

1.0

1.1

175.67

233.58

mg/l

0.91

Infectious mononucleosis

438

1.40

1.75

1.1

265.25

226.61

mg/l

0.36

380

Infectious mononucleosis, including avohilmo

438

1.40

1.75

1.1

265.25

226.61

mg/l

0.36

380

Fracture of lumbar spine and pelvis

582

1.34

1.73

1.1

249.18

281.43

mg/l

1.02

507

Acute lymphocytic leukaemia

2.96

1.73

1.0

169.29

178.42

mg/l

—

Acute lymphocytic leukaemia, including Hilmo

2.96

1.73

1.0

169.29

178.42

mg/l

—

Acute lymphocytic leukaemia, helper endpoint

2.96

1.73

1.0

169.29

178.42

mg/l

—

Other disorders of carbohydrate metabolism

3.92

1.72

1.0

1.2

226.80

196.92

mg/l

—

Anomalies of dental arch relationship, including avohilmo

118

844

1.27

1.72

1.1

222.40

239.22

mg/l

0.38

100

749

Disorders of tooth development and eruption

558

1.31

1.72

1.1

333.41

262.93

mg/l

0.26

498

Seronegative rheumatoid arthritis

298

1.48

1.72

1.0

1.1

277.00

266.53

mg/l

0.09

263

Other infestations, including avohilmo

0.00

1.71

0.0

1.1

—

231.34

—

294

2209

1.16

1.70

1.1

278.17

281.73

mg/l

0.08

260

1965

Inflammatory bowel disease

166

1368

1.22

1.69

1.1

246.40

253.84

mg/l

0.24

143

1222

Diabetic retinopathy, strict definition

420

1.38

1.69

1.0

1.1

319.65

286.87

mg/l

0.52

370

Injuries to the hip and thigh

197

1477

1.20

1.69

1.1

263.55

273.41

mg/l

0.23

172

1324

Mental and behavioural disorders due to opioids

156

1.68

1.69

1.0

1.1

380.81

253.50

mg/l

0.33

132

Allergic conjunctivitis

330

2771

1.15

1.68

1.1

225.87

250.36

mg/l

1.41

303

2455

Heart failure and coronary heart disease

738

0.76

1.68

1.1

304.18

325.92

mg/l

0.44

658

Alcohol use disorder, ICD-based

188

1570

1.20

1.67

1.1

281.26

288.82

mg/l

0.13

168

1410

Other and unspecified disorders of psychological development

2.51

1.67

1.0

1.1

156.70

249.47

mg/l

—

Other gastritis (incl. Duodenitis)

623

1.32

1.65

1.1

259.17

292.04

mg/l

1.04

557

Mental and behavioural disorders due to alcohol, excluding acute intoxication

203

1695

1.19

1.64

1.1

282.53

289.75

mg/l

0.13

182

1518

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

452

0.64

1.63

1.1

336.71

286.64

mg/l

0.37

414

Other vitreous opacities

1.85

1.62

1.0

1.1

244.56

262.59

mg/l

0.30

Abnormal serum enzyme levels

103

781

1.27

1.61

1.0

1.1

258.14

330.08

mg/l

3.58

688

Injury of muscle and tendon at hip and thigh level

344

1.43

1.61

1.1

294.21

286.72

mg/l

0.09

301

Sulfonylureas

548

0.71

1.61

1.0

1.1

343.15

307.13

mg/l

0.64

486

Gout, FINNGEN

639

1.31

1.61

1.0

1.1

442.28

325.08

mg/l

1.53

558

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

1.97

1.60

1.1

192.93

201.99

mg/l

0.17

Testicular dysfunction

136

1.70

1.59

1.0

1.1

258.83

352.84

mg/l

2.88

117

Mental and behavioural disorders due to alcohol

243

1985

1.17

1.59

1.1

277.50

282.60

mg/l

0.11

218

1768

Crohn disease

524

1.34

1.58

1.1

238.86

255.68

mg/l

0.37

465

Early onset COPD

628

1.31

1.58

1.2

1.1

384.43

300.02

mg/l

0.42

552

conjunctival degenerations and deposits

2.22

1.57

1.0

1.1

220.27

225.07

mg/l

0.09

Diabetic retinopathy

118

583

1.26

1.57

1.1

320.63

311.10

mg/l

0.17

513

Acute suppurative otitis media

178

1388

1.20

1.56

1.1

257.41

239.47

mg/l

0.28

160

1238

Background retinopathy and retinal vascular changes

2.29

1.56

1.0

1.1

295.10

225.13

mg/l

—

Viral pneumonia

414

1.38

1.56

1.1

284.92

272.70

mg/l

0.19

363

Female infertility, cervical, vaginal, other or unspecified origin

160

844

1.21

1.55

1.1

224.35

223.44

mg/l

0.02

146

743

Nonsuppurative otitis media

143

1016

1.22

1.55

1.1

282.38

243.20

mg/l

0.54

128

901

Early lumbar disc prolapse operation

535

1.33

1.54

1.1

243.59

250.11

mg/l

0.19

474

Erysipelas, including avohilmo

319

2068

1.14

1.54

1.1

368.24

269.50

mg/l

2.26

284

1854

Xerosis cutis

2.44

1.54

1.0

1.1

268.25

233.50

mg/l

—

Pleural effusion

323

1.43

1.52

1.1

309.82

307.04

mg/l

0.02

278

Glucosamine medication

135

878

1.23

1.52

1.1

295.39

307.11

mg/l

0.17

120

785

Perineal laceration during delivery

872

0.78

1.52

1.0

1.1

215.43

198.38

mg/l

0.35

763

Malignant melanoma of skin

290

1.45

1.52

1.1

544.53

276.38

mg/l

0.73

257

Type 2 diabetes, wide definition

355

1972

1.14

1.52

1.1

305.40

283.15

mg/l

0.74

306

1763

Stomatitis and related lesions

101

800

1.27

1.51

1.1

247.72

250.45

mg/l

0.06

708

Adenomyosis (Endometriosis of uterus)

467

1.35

1.51

1.1

220.57

230.07

mg/l

0.29

415

Cholecystitis

349

1.41

1.50

1.1

316.31

289.11

mg/l

0.17

302

Superficial injury of forearm

409

1.37

1.49

1.1

242.60

246.63

mg/l

0.06

356

Disorder of lipoprotein metabolism, unspecified

283

1.45

1.49

1.1

286.57

296.96

mg/l

0.15

246

Fracture of skull and facial bones

104

829

1.26

1.49

1.1

345.95

268.30

mg/l

0.54

744

Benign neoplasm of eye and adnexa

292

1.44

1.48

1.0

1.1

241.06

273.17

mg/l

0.52

256

Dislocation, sprain and strain of joints and ligaments of head

147

1.64

1.47

1.0

1.1

412.84

252.18

mg/l

0.38

122

Crohn's disease NAS

251

1.48

1.47

1.0

1.1

257.54

259.00

mg/l

0.02

218

Other maternal disorders predominantly related to pregnancy

325

1786

1.14

1.47

1.1

210.27

228.95

mg/l

1.26

294

1567

Major coronary heart disease event

353

1864

1.13

1.46

1.1

260.73

302.27

mg/l

3.33

309

1664

Malignant neoplasm of breast, HER-positive

809

0.78

1.46

1.2

1.1

307.70

251.42

mg/l

0.58

716

Allergic contact dermatitis

514

1.33

1.46

1.1

318.84

242.79

mg/l

0.95

457

Mixed conductive and sensorineural hearing loss

301

1.43

1.46

1.1

266.84

284.23

mg/l

0.35

268

Sequelae of other external causes

171

1.59

1.46

1.0

1.1

273.15

266.53

mg/l

0.04

146

Female genital prolapse

134

607

1.23

1.45

1.1

215.29

252.66

mg/l

1.69

117

536

Ankylosing spondylitis, ICD10

310

1.42

1.45

1.1

297.12

282.92

mg/l

0.08

264

Benign neoplasm of other and ill-defined parts of digestive system

480

1.34

1.45

1.1

231.63

276.63

mg/l

1.81

422

Open wound of lower leg

515

1.32

1.44

1.2

1.1

262.03

261.98

mg/l

0.00

451

Other and unspecified injuries of ankle and foot

156

1.61

1.44

1.0

1.1

171.90

224.74

mg/l

1.89

135

Otitis media, unspecified

474

1.32

1.43

1.1

268.63

231.31

mg/l

0.26

411

Malignant neoplasm of breast, ER-positive, including Hilmo

813

0.79

1.42

1.2

1.1

305.82

251.13

mg/l

0.57

720

Care involving dialysis

188

1.55

1.42

1.1

382.91

310.20

mg/l

0.70

157

Trigger finger

396

1.37

1.42

1.2

1.1

299.70

266.49

mg/l

0.46

348

Intestinal stricture

109

880

1.24

1.41

1.1

276.60

285.51

mg/l

0.19

780

Speech therapy

103

828

1.25

1.39

1.1

272.57

266.39

mg/l

0.12

737

Paralytic ileus and intestinal obstruction

694

1.27

1.38

1.1

272.74

295.08

mg/l

0.61

606

Other respiratory diseases principally affecting the interstitium

398

1.36

1.38

1.1

279.21

306.34

mg/l

0.50

346

Acute laryngitis and tracheitis

572

1.29

1.37

1.1

204.53

239.01

mg/l

1.46

508

Malignant neoplasm of breast, HER2-negative

132

1029

0.83

1.36

1.1

274.16

243.49

mg/l

0.44

119

911

Seropositive rheumatoid arthritis

701

1.26

1.36

1.1

304.20

272.16

mg/l

0.38

621

Scabies, including avohilmo

723

1.26

1.36

1.2

1.1

274.08

238.04

mg/l

0.88

642

Myocardial infarction, strict

107

933

0.81

1.35

1.1

334.41

335.45

mg/l

0.01

832

Bicipital tendinitis

112

1.70

1.35

1.1

272.00

293.09

mg/l

0.18

Erysipelas

216

1606

1.16

1.34

1.1

395.88

280.69

mg/l

1.66

189

1440

Malignant neoplasm of breast, including Hilmo

137

1055

0.83

1.34

1.1

285.42

242.70

mg/l

0.64

124

934

Malignant neoplasm of breast, HER2-negative, including Hilmo

137

1055

0.83

1.34

1.1

285.42

242.70

mg/l

0.64

124

934

Early syphilis, including avohilmo

2.16

1.34

1.1

271.67

253.18

mg/l

—

Use of memantine

328

1.35

1.33

1.1

300.64

321.20

mg/l

0.37

288

Use of other anti-dementia drugs

328

1.35

1.33

1.1

300.64

321.20

mg/l

0.37

288

Schizophrenia

639

0.73

1.32

1.0

1.1

245.13

266.72

mg/l

0.57

569

Dermatophytosis, including avohilmo

332

2895

1.12

1.32

1.1

258.83

272.36

mg/l

0.59

301

2562

Other congenital malformations

367

1.37

1.32

1.1

179.03

225.39

mg/l

2.70

321

Other puerperal infections

454

1.33

1.31

1.0

1.1

191.29

197.04

mg/l

0.21

402

Primary open-angle glaucoma, strict

548

1.29

1.31

1.1

342.90

295.11

mg/l

0.75

486

Infections of genitourinary tract in pregnancy

428

1.34

1.31

1.1

193.02

212.85

mg/l

0.98

378

Disorders of gallbladder, biliary tract and pancreas

481

2711

1.10

1.31

1.1

272.49

273.77

mg/l

0.03

427

2410

Malignant neoplasm of breast

133

1031

0.83

1.31

1.1

273.20

243.32

mg/l

0.43

120

913

Glomerular disorders in diseases classified elsewhere

334

1.38

1.30

1.1

403.28

289.36

mg/l

0.56

286

Corneal ulcer

737

1.25

1.30

1.1

235.20

260.80

mg/l

0.93

658

Other disorders of kidney and ureter

360

1.36

1.29

1.1

470.63

304.37

mg/l

0.50

313

Sulfasalazine

125

1035

1.21

1.29

1.0

1.1

295.49

261.18

mg/l

0.63

110

921

Infective dermatitis

326

1.38

1.29

1.1

262.71

279.55

mg/l

0.27

284

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

465

2661

1.10

1.28

1.1

275.01

275.64

mg/l

0.01

418

2365

Cyst of kidney

161

1.56

1.28

1.2

1.1

348.05

311.59

mg/l

0.28

139

Prolonged pregnancy

822

0.79

1.28

1.1

181.45

212.71

mg/l

1.55

726

Artrosis, including avohilmo

431

2127

1.11

1.28

1.1

243.91

282.11

mg/l

4.00

379

1891

Other condition

535

1.29

1.27

1.1

229.70

263.21

mg/l

1.47

468

Percutaneous Coronary Intervention

327

1767

1.13

1.27

1.1

264.44

303.35

mg/l

2.74

286

1580

Seborrhoeic dermatitis

294

1.40

1.26

1.2

1.1

315.95

294.37

mg/l

0.19

252

Postpartum care and examination

104

529

1.24

1.25

1.1

184.46

210.04

mg/l

1.30

447

Early syphilis

2.24

1.25

1.1

274.13

261.00

mg/l

—

Tumor necrosis factor alpha inhibitors

733

1.24

1.1

235.54

249.11

mg/l

0.26

661

Complications predominantly related to the puerperium

152

1288

1.18

1.24

1.1

188.18

214.71

mg/l

2.73

133

1147

Excessive vomiting in pregnancy

398

1.34

1.24

1.1

185.82

209.41

mg/l

1.09

347

Injury of eye and orbit

591

1.27

1.23

1.1

245.70

265.61

mg/l

0.52

530

Macular pucker

338

1.36

1.23

1.1

348.76

288.83

mg/l

0.91

304

Toxic effects of substances chiefly nonmedicinal as to source

434

1.32

1.21

1.1

202.27

261.62

mg/l

3.69

381

Peripheral arterial reconstruction

313

0.64

1.21

1.1

445.67

322.19

mg/l

0.85

273

Colorectal cancer

526

0.73

1.21

1.1

341.11

294.06

mg/l

0.57

476

Other diseases of blood and blood-forming organs

180

1.50

1.20

1.1

274.95

294.63

mg/l

0.22

154

Kela-code for severe mental illness

185

1598

1.16

1.20

1.1

230.12

260.32

mg/l

1.76

160

1432

Endometriosis ASRM stages 3,4

115

954

1.21

1.19

1.1

238.14

221.41

mg/l

0.38

103

858

Colonic or urogenital fistula

121

1009

1.20

1.19

1.1

278.86

263.17

mg/l

0.39

107

894

Coronary revascularization (ANGIO or CABG)

326

1768

1.12

1.19

1.1

264.53

303.31

mg/l

2.72

285

1581

Event of undetermined intent

247

1.42

1.19

1.2

1.1

197.53

269.83

mg/l

3.70

212

L02BG Aromatase inhibitors

885

0.79

1.19

1.1

324.77

259.25

mg/l

0.56

784

Chronic pancreatitis

349

1.35

1.18

1.2

1.1

318.49

313.47

mg/l

0.03

298

Unspecified acute lower respiratory infection

559

1.27

1.18

1.2

1.1

277.21

274.01

mg/l

0.04

489

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

258

1977

1.13

1.18

1.1

203.82

225.20

mg/l

1.96

241

1742

Acute alcohol intoxication

110

910

1.21

1.18

1.2

1.1

257.61

284.60

mg/l

0.98

818

Primary open-angle glaucoma

649

1.25

1.17

1.1

344.75

299.78

mg/l

0.77

575

Periapical abscess

225

1974

1.14

1.17

1.1

275.03

271.62

mg/l

0.06

195

1772

Extracorporeal dialysis

157

1.53

1.17

1.1

435.35

288.59

mg/l

1.54

137

LSIL lesion of the cervix uteri, vagina or vulva

695

1.24

1.16

1.0

1.1

196.65

211.83

mg/l

0.80

621

Galactorrhea

2.07

1.16

1.3

1.1

169.38

190.10

mg/l

—

Malignant neoplasm, wide definition

447

2367

1.10

1.15

1.1

308.87

257.12

mg/l

1.34

398

2108

Malignant neoplasm

430

2287

1.10

1.15

1.1

315.48

259.27

mg/l

1.42

378

2037

Asthma mixed form (mode)

126

1.59

1.14

1.3

1.0

299.40

246.51

mg/l

0.37

107

Polycythaemia vera

1.85

1.13

1.0

1.1

284.17

239.17

mg/l

0.70

Other benign neoplasms of skin

147

1254

1.17

1.13

1.1

273.88

265.08

mg/l

0.16

134

1107

Pedestrian injured in other and unspecified transport accidents

2.35

1.12

1.0

1.1

297.14

239.88

mg/l

—

Atopic dermatitis, strict definition with reimbursement

183

1527

1.15

1.11

1.1

217.28

229.02

mg/l

0.44

164

1355

Scoliosis

276

1.38

1.11

1.1

1.0

209.43

241.96

mg/l

0.47

241

Later onset COPD

388

0.72

1.11

1.0

1.1

315.13

320.66

mg/l

0.06

339

Other and unspecified psoriasis

184

1.47

1.10

1.1

290.45

289.27

mg/l

0.01

155

Bitten or struck by other mammals

503

1.28

1.10

1.1

212.59

242.93

mg/l

1.69

444

Malignant neoplasm

429

2288

1.10

1.09

1.1

315.73

259.23

mg/l

1.43

378

2038

Cholelithiasis, broad definition with cholecystitis

405

2450

1.10

1.09

1.1

272.67

273.84

mg/l

0.03

355

2182

ILD, hospital admissions

337

1.34

1.09

1.1

299.60

301.41

mg/l

0.02

293

Foreign body in alimentary tract

160

1.51

1.09

1.1

196.42

278.09

mg/l

2.43

138

Dysplasia of cervi uteri

137

817

1.18

1.09

1.1

193.38

224.96

mg/l

1.95

121

719

Familial hypercholesterolemia

294

1.36

1.09

1.1

347.86

303.39

mg/l

0.52

261

Toxic liver disease

1.96

1.09

1.3

1.1

275.12

216.86

mg/l

—

Ulcerative rectosigmoiditis

303

1.36

1.09

1.0

1.1

259.19

281.41

mg/l

0.39

261

Malignant neoplasm, including Hilmo

445

2366

1.10

1.08

1.1

310.21

256.64

mg/l

1.41

396

2107

Other follicular disorders

312

1.35

1.08

1.2

1.1

253.14

261.88

mg/l

0.11

270

Redundant prepuce, phimosis and paraphimosis

699

1.23

1.08

1.2

1.1

353.07

327.85

mg/l

0.33

630

COPD-related respiratory insufficiency

227

1.41

1.07

1.0

1.1

606.96

312.33

mg/l

0.59

193

Loose body in joint

1.93

1.06

1.1

322.20

298.91

mg/l

—

Other interstitial pulmonary diseases

339

1.33

1.06

1.1

299.60

301.06

mg/l

0.02

294

Adalimumab

418

1.30

1.05

1.2

1.1

231.86

255.33

mg/l

0.46

367

Asthma mixed form (mode), excluding more controls

129

1.55

1.05

1.3

1.0

299.40

249.51

mg/l

0.34

110

Acute alcohol intoxication, ICD10

795

1.21

1.05

1.2

1.1

258.33

270.37

mg/l

0.31

710

Atopic dermatitis, strict definition

183

1563

1.15

1.05

1.1

216.12

229.30

mg/l

0.52

164

1393

Burns and corrosions

534

1.26

1.04

1.1

245.03

264.40

mg/l

0.37

470

Hallux valgus (acquired)

129

782

1.18

1.04

1.1

279.18

261.77

mg/l

0.19

114

689

Interstitial lung disease endpoints

340

1.33

1.04

1.1

299.60

300.74

mg/l

0.01

295

Interstitial lung disease

340

1.33

1.04

1.1

299.60

300.74

mg/l

0.01

295

Other and unspecified mental retardation

1.92

1.04

1.1

158.77

207.51

mg/l

—

Contact with sharp glass

146

1.51

1.03

1.1

202.31

265.04

mg/l

1.43

124

Benign neoplasm: Long bones of lower limb

106

1.61

1.03

1.0

1.1

225.82

255.30

mg/l

0.52

Gonarthrosis [arthrosis of knee](FG)

309

1599

1.11

1.03

1.1

265.20

290.87

mg/l

1.44

274

1411

Insulin, fast-acting

159

1378

1.15

1.02

1.1

303.10

262.31

mg/l

1.25

137

1240

Allergic urticaria

307

1.34

1.01

1.1

184.78

245.93

mg/l

2.88

266

Acne

578

1.24

1.01

1.2

1.1

259.84

208.99

mg/l

0.58

504

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

386

1.30

1.01

1.1

187.38

211.20

mg/l

1.16

346

Superficial injury of neck

1.78

1.01

1.2

1.1

186.00

212.20

mg/l

0.42

Presbycusis

194

1.43

1.00

1.1

294.87

311.78

mg/l

0.23

171

Family history of malignant neoplasm

457

1.27

1.00

1.0

1.1

274.60

234.01

mg/l

0.38

412

Schizophrenia or delusion

160

1391

1.15

1.00

1.0

1.1

223.13

261.89

mg/l

2.49

138

1243

Polycystic ovarian syndrome, broad definition

673

1.22

0.99

1.1

195.64

199.99

mg/l

0.12

601

Persons encountering health services in circumstances related to reproduction

310

1877

1.11

0.98

1.1

250.52

275.80

mg/l

1.21

286

1647

Endometriosis of ovary

651

1.22

0.98

1.0

1.1

230.51

223.29

mg/l

0.13

578

2.19

0.98

1.0

1.1

213.40

264.17

mg/l

—

Arthropathy in ulcerative colitis

1.96

0.97

1.0

1.1

196.29

224.71

mg/l

—

Emergency coronary revascularization (for ACS)

340

1863

1.10

0.97

1.1

265.21

303.51

mg/l

2.79

298

1661

Personal history of other diseases and conditions

546

1.24

0.97

1.1

211.92

213.74

mg/l

0.04

489

Papulosquamous disorders

169

1480

1.14

0.96

1.1

271.05

264.67

mg/l

0.12

148

1319

Schizophrenia, schizotypal and delusional disorders

160

1396

1.15

0.96

1.0

1.1

223.13

262.16

mg/l

2.52

138

1247

Pregnancy hypertension

237

1893

1.12

0.96

1.1

203.71

218.54

mg/l

1.12

221

1671

IBD patients in KELA-register

121

1034

1.17

0.95

1.0

1.1

234.89

253.99

mg/l

0.77

106

929

Pollen allergy

118

992

1.17

0.95

1.1

215.87

222.47

mg/l

0.22

103

885

Nasal polyp

586

1.23

0.95

1.0

1.1

274.83

285.78

mg/l

0.19

518

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.79

0.94

1.0

1.1

195.73

202.35

mg/l

0.10

Other and unspecified nail disorders

1.78

0.94

1.2

1.1

190.18

217.34

mg/l

0.61

Hereditary retinal dystrophy

1.90

0.94

1.0

1.1

227.71

211.00

mg/l

—

Primary gonarthrosis, bilateral

168

1231

1.14

0.94

1.1

270.48

313.25

mg/l

1.67

149

1095

Primary biliary cholangitis (PBC)

1.90

0.94

1.1

213.43

213.19

mg/l

—

Ischaemic heart disease, wide definition

294

1634

1.11

0.94

1.1

283.65

305.06

mg/l

0.78

250

1451

Skin changes due to chronic exposure to nonionizing radiation

102

778

1.19

0.94

1.0

1.1

312.50

309.91

mg/l

0.03

690

Other diseases of intestine

435

1.27

0.93

1.0

1.1

281.68

299.45

mg/l

0.25

379

Idiopathic pulmonary fibrosis

144

0.55

0.93

1.3

1.0

204.38

302.81

mg/l

—

122

Suggestive for eosinophilic asthma

260

1.35

0.93

1.0

1.1

246.04

293.60

mg/l

0.77

225

Ulcer of lower limb, not elsewhere classified

347

1.30

0.93

1.2

1.1

498.33

315.42

mg/l

0.48

302

Effects of foreign body entering through natural orifice

116

991

1.17

0.93

1.1

329.68

269.17

mg/l

0.41

107

882

Erosion and ectropion of cervix uteri

1.72

0.92

1.0

232.92

225.71

mg/l

0.09

Foreign body in genitourinary tract

2.16

0.92

1.0

1.1

737.50

223.17

mg/l

—

Periodontitis

487

2872

1.08

0.92

1.1

278.14

272.23

mg/l

0.23

443

2547

Colorectal cancer, including Hilmo

580

0.79

0.92

1.1

312.55

288.49

mg/l

0.30

525

Other salmonella infections, including avohilmo

134

1.50

0.91

1.1

214.95

260.24

mg/l

1.32

115

Malignant neoplasm of bronchus and lung

312

1.29

0.91

1.0

1.1

351.29

303.60

mg/l

0.60

284

5-aminosalicylic acid

100

845

1.19

0.91

1.1

269.03

255.78

mg/l

0.16

760

Lactose intolerance

1.60

0.90

1.1

218.00

210.24

mg/l

0.06

Open wound of forearm

331

1.30

0.90

1.0

1.1

230.00

272.32

mg/l

1.63

286

Other specified and unspecified disorders of eye and adnexa

1.60

0.90

1.1

248.20

229.00

mg/l

0.23

Malignant neoplasm of respiratory system and intrathoracic organs

369

1.26

0.90

1.0

1.1

367.80

303.31

mg/l

0.93

333

Diseases of arteries, arterioles and capillaries

238

1565

1.12

0.90

1.1

320.84

294.84

mg/l

0.30

201

1401

Other appendicitis

279

1.33

0.90

1.1

228.10

283.18

mg/l

2.32

243

Insulin, fast-acting or short human

159

1394

1.14

0.90

1.1

303.10

264.07

mg/l

1.17

137

1248

Acne vulgaris

455

1.25

0.90

1.1

271.51

213.80

mg/l

0.49

392

Hypertrophic cardiomyopathy

102

0.49

0.89

1.0

1.1

244.00

293.42

mg/l

—

111

852

1.17

0.89

1.1

301.65

305.58

mg/l

0.05

101

757

Abnormal findings in nipple discharge synovial fluid wound secretions

1.92

0.89

1.3

1.0

177.38

239.11

mg/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

177

1.42

0.88

1.1

273.94

292.69

mg/l

0.18

154

Peritonsillar abscess

107

913

1.17

0.88

1.1

242.13

242.47

mg/l

0.01

810

Certain conditions originating in the perinatal period

358

1.27

0.87

1.0

1.1

252.96

203.75

mg/l

0.40

312

Cholelithiasis

383

2404

1.09

0.86

1.1

274.84

274.05

mg/l

0.02

338

2139

Chronic periodontitis, including avohilmo

485

2872

1.08

0.86

1.1

277.50

272.48

mg/l

0.19

440

2547

Antenatal screening

107

701

0.85

0.86

1.1

239.83

218.57

mg/l

0.23

600

Melanocytic naevi, other sites/unspecified

299

1.31

0.85

1.2

1.1

239.77

260.40

mg/l

0.28

258

Retinal breaks without detachment

450

1.25

0.85

1.1

280.28

283.34

mg/l

0.03

405

Open wound of ankle and foot

370

1.27

0.85

1.1

208.03

255.34

mg/l

2.18

321

Torsion of ovary, ovarian pedicle and fallopian tube

1.57

0.84

1.1

220.13

212.81

mg/l

0.11

Polyarthritis, unspecified

1.57

0.84

1.1

167.47

280.76

mg/l

3.75

Impacted cerumen

300

1.30

0.84

1.0

1.1

312.44

294.35

mg/l

0.27

259

Inflammatory bowel disease, strict (require KELA)

121

1048

1.16

0.84

1.0

1.1

234.89

252.97

mg/l

0.71

106

939

Hypocalcemia

1.76

0.84

1.6

1.1

169.30

235.63

mg/l

—

Oligomenorrhoea

154

1.43

0.83

1.2

1.1

223.50

212.99

mg/l

0.22

139

Left ventricular outflow tract obstruction, narrow definition

166

0.60

0.83

1.1

308.50

296.02

mg/l

—

142

Olecranon bursitis

121

1.49

0.82

1.2

1.1

270.89

320.75

mg/l

0.98

104

Other fall from one level to another

108

929

1.16

0.81

1.1

247.67

255.60

mg/l

0.18

822

Salpingitis and oophoritis

589

1.21

0.81

1.1

214.90

229.97

mg/l

0.52

524

Single spontaneous delivery

153

917

0.88

0.81

1.1

218.78

230.54

mg/l

0.40

132

803

Insulin, combination of fast acting with intermediate-acting or long-acting

256

2109

1.10

0.80

1.1

327.58

277.03

mg/l

1.97

221

1893

Heart failure and antihypertensive medication

446

1.19

0.80

1.1

256.03

307.84

mg/l

1.31

398

All dysplastic lesions of the cervix uteri, vagina or vulva

180

1567

1.12

0.80

1.0

1.1

196.68

212.24

mg/l

1.27

158

1396

Erythema intertrigo

1.73

0.80

1.4

1.0

288.60

271.10

mg/l

—

Respiratory tuberculosis, confirmed

1.82

0.79

1.3

1.1

236.33

251.41

mg/l

—

Ulcerative colitis

118

1026

1.15

0.79

1.1

255.43

254.51

mg/l

0.02

106

919

Other specific arthropathies, wide

1.67

0.79

1.0

1.1

199.13

224.12

mg/l

—

Heart failure and bmi 25plus

582

0.84

0.78

1.1

305.73

330.14

mg/l

0.45

516

1.57

0.78

1.1

153.75

201.05

mg/l

—

Acute nasopharyngitis (common cold)

452

1.23

0.78

1.0

1.1

266.64

280.26

mg/l

0.31

405

Postmenopausal osteoporosis with pathological fracture

115

1.48

0.76

1.1

307.64

275.45

mg/l

0.19

Diverticular disease of intestine

269

1527

1.10

0.76

1.1

275.40

296.05

mg/l

0.88

250

1353

Other viral hepatitis, including avohilmo

270

1.30

0.76

1.1

217.93

267.14

mg/l

1.74

236

Lichen sclerosus et atrophicus

323

1.27

0.76

1.2

1.1

282.37

239.12

mg/l

0.50

283

Gestational [pregnancy-induced] hypertension

153

1356

1.13

0.75

1.1

197.14

211.52

mg/l

0.75

142

1199

Nontoxic goitre/thyroid nodule

919

0.85

0.75

1.1

268.94

254.89

mg/l

0.23

812

Heart failure, strict

144

1130

0.88

0.75

1.1

275.69

324.10

mg/l

2.13

123

1006

Calcaneal spur

2.09

0.74

1.4

1.1

182.00

248.21

mg/l

—

Benign leiomyoma with endometriosis

450

1.22

0.74

1.1

289.09

232.72

mg/l

1.16

407

Family history of other specific disorders

1.85

0.73

1.1

194.29

199.06

mg/l

—

Diabetes, insulin treatment (Kela reimbursement)

433

2760

0.93

0.73

1.1

305.76

273.26

mg/l

1.78

387

2456

Ulcerative colitis, NAS

533

1.20

0.73

1.1

243.32

263.04

mg/l

0.48

477

Seminoma of testis

2.02

0.73

1.0

1.1

257.60

278.55

mg/l

—

Frostbite

2.01

0.73

1.0

1.1

251.40

266.45

mg/l

—

Eustachian salpingitis and obstruction

379

1.24

0.73

1.0

1.1

264.69

234.19

mg/l

0.52

337

Alcoholic liver disease

263

1.30

0.73

1.1

299.33

317.13

mg/l

0.23

231

Viral agents as the cause of diseases classified to other chapters

1.61

0.72

1.0

1.1

218.33

239.06

mg/l

—

Other salmonella infections

1.53

0.72

1.1

1.0

229.71

262.21

mg/l

0.62

Deep bite

412

1.22

0.72

1.1

198.02

253.58

mg/l

2.11

357

Actinic keratosis

745

1.16

0.72

1.1

321.15

310.02

mg/l

0.12

659

Burn and corrosion confined to eye and adnexa

1.59

0.72

1.0

1.1

234.92

258.26

mg/l

0.29

Other congenital malformations, including avohilmo

571

1.19

0.71

1.1

196.02

239.02

mg/l

2.21

505

Obstructed labour due to maternal pelvic abnormality

489

1.21

0.71

1.1

237.48

233.67

mg/l

0.07

434

Hypertrophy of breast

701

1.17

0.70

1.2

1.1

267.34

221.83

mg/l

0.38

626

Alcohol-induced chronic pancreatitis

177

1.36

0.70

1.1

267.47

324.22

mg/l

1.10

154

All-cause Heart Failure

141

1103

0.89

0.70

1.1

276.38

322.80

mg/l

1.96

120

980

Alcohol abuse counselling and surveillance

1.71

0.70

1.0

1.1

304.57

265.94

mg/l

—

Aortic aneurysm

511

0.80

0.70

1.0

1.1

264.79

331.99

mg/l

2.01

448

Alcohol abuse, main dg

610

1.18

0.69

1.2

1.1

251.43

271.87

mg/l

0.59

539

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

409

1.23

0.69

1.1

187.38

204.28

mg/l

0.76

367

Urethral stricture

118

1.44

0.69

1.1

1.0

283.58

313.68

mg/l

0.17

103

Diabetic nephropathy, excluding more controls

310

1.24

0.69

1.1

349.08

320.35

mg/l

0.28

273

Open bite that required surgery (Lefort1 or BSSO)

1.68

0.68

1.0

1.1

206.43

226.89

mg/l

—

Mandibular retrognathia

274

1.28

0.68

1.1

210.33

233.04

mg/l

0.46

244

Type 1 diabetes

125

1104

1.13

0.68

1.1

308.76

250.42

mg/l

1.54

108

995

Intrahepatic Cholestasis of Pregnancy (ICP)

356

1.24

0.67

1.1

180.22

204.58

mg/l

1.17

320

Artificial joint operation, meniscal resection

378

2251

1.07

0.67

1.1

284.98

291.87

mg/l

0.19

332

2004

Diabetic maculopathy, excluding more controls

365

1.23

0.67

1.1

359.78

272.71

mg/l

1.42

318

Myocardial infarction

127

1001

0.89

0.67

1.1

315.85

329.36

mg/l

0.24

113

894

Hypertrophy of breast in women and men

789

1.15

0.66

1.2

1.1

282.11

235.25

mg/l

0.45

703

Seminoma of testis, including Hilmo

1.80

0.66

1.0

1.1

257.60

276.22

mg/l

—

Diabetic nephropathy

379

1.23

0.66

1.1

349.08

318.92

mg/l

0.32

333

Benign thyroid growths and nodules

1002

0.87

0.66

1.1

278.91

257.94

mg/l

0.42

885

Foreign body or object entering through skin

241

1.29

0.66

1.1

263.52

288.16

mg/l

0.47

207

Pre-eclampsia

107

940

1.14

0.65

1.2

1.1

204.89

215.57

mg/l

0.47

836

In situ neoplasms

151

1355

1.12

0.65

1.1

272.53

257.87

mg/l

0.28

132

1204

Single delivery by caesarean section

629

0.87

0.65

1.1

203.77

208.40

mg/l

0.11

553

Pre-eclampsia or eclampsia

113

997

1.13

0.65

1.2

1.1

202.96

216.61

mg/l

0.70

103

883

Diabetic maculopathy

329

1.24

0.65

1.1

350.89

283.47

mg/l

0.98

288

Injury of unspecified body region

233

1.29

0.64

1.0

1.1

228.08

267.04

mg/l

0.65

202

Pre-eclampsia or poor fetal growth

178

1607

1.10

0.64

1.1

204.88

209.46

mg/l

0.20

160

1424

Contraceptive management

226

1446

1.09

0.64

1.1

241.18

266.08

mg/l

1.09

200

1271

Other bursal cyst

1.73

0.64

1.0

1.1

226.60

273.91

mg/l

—

Iron deficiency anaemia secondary to blood loss (chronic)

414

1.21

0.63

1.1

239.88

270.64

mg/l

0.79

359

Delivery

157

919

0.90

0.63

1.1

218.71

230.27

mg/l

0.40

136

805

Use of disulfiram, acamprosate or naltrexone

315

1.24

0.62

1.2

1.1

267.06

301.17

mg/l

0.70

271

Gestational diabetes (for exclusion)

244

1545

1.09

0.61

1.1

203.92

206.33

mg/l

0.10

227

1369

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

431

1.18

0.61

1.0

1.1

379.11

298.05

mg/l

1.36

392

Mucosal proctocolitis

507

1.19

0.61

1.1

236.55

267.12

mg/l

0.98

451

Molar incisor enamel hypoplasia, with caries

1.66

0.61

1.2

1.1

120.00

208.88

mg/l

—

Unspecified maternal hypertension

1.58

0.60

1.0

1.1

158.25

214.53

mg/l

—

Congenital malformations of cardiac chambers and connections

0.00

0.60

0.0

1.0

—

241.20

—

Congenital malformations of aortic and mitral valves

137

0.66

0.60

1.1

334.33

287.89

mg/l

—

118

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

564

1.17

0.60

1.1

461.93

286.56

mg/l

1.63

509

Thyrotoxicosis with diffuse goitre

527

1.18

0.60

1.1

250.22

235.23

mg/l

0.25

469

LSIL lesion of the cervix uteri

592

1.17

0.60

1.0

1.1

191.23

204.67

mg/l

0.59

529

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

426

1.20

0.60

1.0

1.1

263.60

272.09

mg/l

0.14

375

Injuries to the elbow and forearm

352

2823

1.07

0.59

1.1

264.89

268.20

mg/l

0.09

294

2531

Other congenital malformations of male genital organs

0.00

0.59

0.0

1.1

—

257.57

—

Other disorders of iris and ciliary body

1.57

0.58

1.1

245.90

234.81

mg/l

—

Myocardial infarction, unclassifiable

347

0.80

0.58

1.1

316.22

327.22

mg/l

0.10

301

Cerebral palsy

1.52

0.58

1.1

221.63

249.47

mg/l

—

Alcohol dependence

102

903

1.13

0.58

1.2

1.1

266.13

304.19

mg/l

1.40

814

Malignant neoplasm of bronchus and lung, including Hilmo

371

1.19

0.58

1.0

1.1

366.00

304.87

mg/l

0.87

336

Spontaneous abortion

241

1490

1.08

0.58

1.1

223.33

224.64

mg/l

0.04

214

1317

Respiratory tuberculosis, confirmed, including avohilmo

1.72

0.57

1.3

1.1

236.33

247.31

mg/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.67

0.56

1.3

1.1

236.33

252.23

mg/l

—

Abscess of anal and rectal regions

301

1.23

0.56

1.2

1.1

267.67

296.39

mg/l

0.29

258

Erosion of teeth , including avohilmo

147

1333

1.10

0.56

1.1

245.92

243.86

mg/l

0.03

135

1193

Struck by thrown, projected or falling objec

194

1.29

0.56

1.1

226.90

272.70

mg/l

0.75

167

Venous complications and haemorrhoids in the puerperium

1.63

0.55

1.3

1.1

186.33

200.10

mg/l

—

Pediculosis, acariasis and other infestations, including avohilmo

831

1.13

0.55

1.2

1.1

269.71

246.65

mg/l

0.50

737

Psoriatic arthropathies

293

1.23

0.55

1.0

1.1

245.16

269.80

mg/l

0.43

253

Abnormal spermatozoa

275

1.24

0.55

1.1

398.19

354.26

mg/l

0.33

247

Granuloma annulare

1.58

0.54

1.0

1.1

201.67

203.39

mg/l

—

Angina pectoris

185

1124

1.09

0.54

1.1

283.48

326.70

mg/l

1.96

159

1006

Pregnancy, childbirth and the puerperium

108

632

0.89

0.53

1.1

191.19

219.70

mg/l

1.76

553

Acute pancreatitis

599

1.15

0.53

1.1

253.68

291.89

mg/l

1.03

522

Complications following abortion and ectopic and molar pregnancy

1.43

0.53

1.1

1.0

242.08

231.47

mg/l

0.09

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

146

0.68

0.52

1.3

1.1

252.30

253.65

mg/l

—

133

Ascites

152

1.32

0.52

1.0

443.13

293.62

mg/l

0.41

133

Anorexia

1.50

0.51

1.2

1.0

210.33

217.09

mg/l

—

Benign neoplasm: Short bones of upper limb

1.50

0.51

1.0

1.1

155.17

218.50

mg/l

—

Primary biliary cholangitis, wide definition

1.50

0.51

1.2

1.1

205.00

216.37

mg/l

—

Seropositive rheumatoid arthritis, wide

789

1.13

0.51

1.1

304.20

265.89

mg/l

0.48

710

Other/unspecified seropositive rheumatoid arthritis

780

1.13

0.51

1.1

305.68

266.26

mg/l

0.49

702

Other viral hepatitis

251

1.24

0.51

1.1

204.08

266.96

mg/l

3.00

219

Other endocrine disorders

180

1.28

0.51

1.1

188.06

218.29

mg/l

0.55

157

Psoriatic and enteropathic arthropathies

379

1.19

0.50

1.0

1.1

234.85

274.93

mg/l

1.03

331

Amiodarone users

225

0.75

0.50

1.0

1.1

392.41

312.80

mg/l

0.76

194

Corneal scars and opacities

1.39

0.50

1.1

220.44

244.19

mg/l

—

Lesion of plantar nerve

127

1.34

0.49

1.2

1.1

311.24

246.91

mg/l

0.62

114

Sub-endpoint used in defining T1D endpoints

127

1134

1.10

0.49

1.1

307.15

256.73

mg/l

1.24

109

1014

Burns and corrosions of external body surface, specified by site

408

1.18

0.49

1.0

1.1

240.33

264.10

mg/l

0.33

356

Lactose intolerance, other/unspecified

1.43

0.49

1.1

225.33

210.08

mg/l

0.11

Viral hepatitis, including avohilmo

307

1.21

0.49

1.1

221.90

268.75

mg/l

1.72

268

Coxarthrosis [arthrosis of hip](FG)

181

1147

1.09

0.49

1.1

295.13

303.04

mg/l

0.18

156

1015

Psoriasis

118

1068

1.11

0.49

1.1

257.11

261.68

mg/l

0.08

101

952

Other and unspecified injuries of abdomen, lower back and pelvis

1.53

0.48

1.3

1.1

204.14

228.82

mg/l

—

Malignant neoplasm of testis

1.53

0.48

1.0

1.2

272.86

286.78

mg/l

—

Thyrotoxicosis, other and/or unspecified

756

1.13

0.48

1.1

243.68

244.14

mg/l

0.01

673

Congenital deformities of hip, including avohilmo

1.45

0.48

1.2

1.1

130.18

182.58

mg/l

2.09

COPD, hospital admissions 3, with asthma pneumonia sepsis

470

1.15

0.47

1.1

433.28

323.42

mg/l

0.41

415

Atherosclerosis, excluding cerebral and coronary sclerosis

699

0.89

0.47

1.1

325.14

321.92

mg/l

0.04

620

Idiopathic thrombocytopenic purpura

1.42

0.47

1.2

1.1

211.17

236.15

mg/l

0.31

Complications of labour and delivery

319

1669

1.06

0.46

1.1

218.41

228.11

mg/l

0.51

288

1463

Schizoid personality disorder

1.43

0.46

1.0

1.1

222.29

259.20

mg/l

—

Thoracic aortic aneurysm

374

0.83

0.45

1.1

266.17

333.96

mg/l

1.45

328

Presence of cardiac and vascular implants and grafts

799

0.90

0.45

1.1

314.10

328.32

mg/l

0.26

718

Bursitis of shoulder

1.37

0.44

1.4

1.1

285.13

271.64

mg/l

—

Peripheral artery disease

782

0.90

0.44

1.1

416.07

318.99

mg/l

0.54

696

Insulin, intermediate and long-acting

214

1930

1.07

0.43

1.1

321.10

280.60

mg/l

1.55

185

1732

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

772

1.11

0.43

1.1

302.30

265.90

mg/l

0.43

695

malignant neoplasm of female genital organs, including Hilmo

457

0.85

0.43

1.1

286.83

248.95

mg/l

0.44

409

Acquired haemolytic anaemia

1.43

0.42

1.0

347.25

224.80

mg/l

—

Malignant neoplasm of cervix uteri

1.41

0.42

1.0

199.50

195.23

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

378

1.17

0.42

1.1

180.22

198.03

mg/l

0.78

338

Heart failure,strict

140

1060

0.92

0.42

1.1

277.00

324.86

mg/l

1.95

120

943

Unstable angina pectoris

704

1.10

0.42

1.1

308.91

326.07

mg/l

0.35

627

Renal agenesis and other reduction defects of kidney, including avohilmo

0.00

0.41

0.0

1.1

—

292.67

—

Thyrotoxicosis

102

928

1.10

0.41

1.1

250.74

246.55

mg/l

0.08

832

Ectopic testis

0.00

0.41

0.0

1.1

—

262.45

—

Blood alcohol or alcohol intoxication level

1.40

0.41

1.3

1.1

273.18

264.99

mg/l

0.07

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.48

0.40

1.0

1.1

255.00

197.88

mg/l

—

Atrophic disorders of skin

558

1.13

0.40

1.2

1.1

246.11

244.11

mg/l

0.02

496

COPD

126

940

1.09

0.40

1.1

355.21

307.52

mg/l

0.35

108

840

Arterial embolism and thrombosis

105

0.67

0.39

1.0

1.1

192.86

261.71

mg/l

—

Other adrenocortical overactivity

0.00

0.39

0.0

1.1

—

216.53

—

Motorcycle rider injured in other and unspecified transport accidents

233

1.20

0.38

1.0

1.1

295.23

282.47

mg/l

0.10

201

Evidence of alcohol involvement determined by blood alcohol level

1.39

0.38

1.0

1.1

255.20

248.83

mg/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.39

0.38

1.0

1.1

253.00

227.58

mg/l

—

Congenital deformities of hip

1.32

0.37

1.1

132.67

183.73

mg/l

—

Clear cell adenocarcinoma of kidney

1.33

0.37

1.2

1.1

339.23

255.41

mg/l

0.67

Melanocytic naevi of scalp and neck

1.31

0.37

1.1

312.33

218.81

mg/l

—

Acute pancreatitis (for exclusion)

619

1.12

0.37

1.1

253.68

287.31

mg/l

0.87

538

Poor fetal growth

705

1.11

0.37

1.2

1.1

204.59

197.15

mg/l

0.21

633

Conduction disorders

686

1.10

0.37

1.1

299.64

295.25

mg/l

0.05

607

Other abnormal uterine and vaginal bleeding

622

1.10

0.36

1.1

216.75

228.61

mg/l

0.46

548

All dysplastic lesions of the cervix uteri

156

1433

1.07

0.36

1.1

192.03

208.55

mg/l

1.30

136

1278

Maternal care for known or suspected malpresentation of fetus

108

837

0.92

0.36

1.1

202.22

214.06

mg/l

0.44

101

744

Major anomalies of jaw size

1.34

0.36

1.2

1.1

176.00

241.47

mg/l

2.51

Acute alcohol intoxication ICD-9

0.66

0.35

1.0

1.1

184.20

305.44

mg/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

423

2614

0.96

0.35

1.1

304.77

271.54

mg/l

1.78

379

2335

Supervision of normal pregnancy

111

688

0.92

0.35

1.1

196.03

219.44

mg/l

1.20

101

588

Duodenal ulcer

226

1.20

0.35

1.1

1.0

298.27

328.00

mg/l

0.45

193

Hyphaema and other vascular disorders of iris and ciliary body

1.40

0.35

1.2

1.1

177.33

224.29

mg/l

—

Other chronic obstructive pulmonary disease, including avohilmo

162

1244

1.07

0.35

1.1

360.68

306.47

mg/l

0.47

137

1104

Haemorrhage in early pregnancy

148

1342

1.07

0.34

1.1

207.17

216.98

mg/l

0.31

139

1181

Benign lipomatous neoplasm

109

1007

1.08

0.34

1.1

256.27

271.11

mg/l

0.46

899

Inflammation of lacrimal passages (acute and unspecified)

1.34

0.34

1.5

1.0

448.33

219.82

mg/l

—

Pervasive developmental disorders excl. Autism + Asperger

1.32

0.33

1.3

1.0

170.33

244.40

mg/l

—

HSIL lesion of the vagina

1.31

0.33

1.0

228.50

209.57

mg/l

—

Oral lichen planus and hypothyroidism or thyroxine medication

1.31

0.33

1.0

1.1

197.83

217.00

mg/l

—

Foreign body on external eye

568

1.11

0.32

1.1

381.38

293.91

mg/l

0.32

503

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

769

1.09

0.32

1.1

232.99

257.61

mg/l

0.91

687

Eating disorder

482

1.12

0.32

1.1

195.17

200.02

mg/l

0.07

422

Acute and transient psychotic disorders

445

1.12

0.32

1.1

217.39

263.02

mg/l

1.83

391

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

313

1.15

0.32

1.2

1.1

299.06

252.04

mg/l

0.24

275

Maternal care related to the fetus and amniotic cavity and possible delivery problems

246

1370

1.05

0.32

1.1

194.35

231.85

mg/l

3.83

220

1203

Postprocedural disorders of digestive system, not elsewhere classified

1.33

0.32

1.1

231.45

261.88

mg/l

0.42

Chronic viral hepatitis

220

1.18

0.31

1.1

201.48

257.50

mg/l

2.27

190

Family history of other conditions

1.35

0.31

1.0

1.1

312.14

219.19

mg/l

—

Other diseases of lip and oral mucosa

182

1720

1.06

0.31

1.1

260.08

260.34

mg/l

0.00

164

1534

Benign neoplasm of middle ear and respiratory system

202

1.19

0.31

1.0

1.1

313.06

296.33

mg/l

0.14

173

Arthropod-borne viral fevers and viral haemorrhagic fevers

286

1.16

0.31

1.3

1.1

282.04

293.64

mg/l

0.11

248

Congenital malformations of the respiratory system

1.32

0.31

1.1

179.29

222.77

mg/l

—

Pure hyperglyceridaemia

1.32

0.31

1.1

368.00

267.77

mg/l

—

Medical treatment for female infertility

117

1243

0.93

0.31

1.1

201.21

206.05

mg/l

0.09

101

1100

Postmenopausal bleeding

414

0.91

0.30

1.1

222.61

278.90

mg/l

1.54

362

Puerperal sepsis

428

1.12

0.30

1.0

1.1

201.36

234.98

mg/l

1.27

387

Malignant neoplasm of testis, including Hilmo

1.30

0.30

1.0

1.1

272.86

286.75

mg/l

—

Parapsoriasis

1.30

0.30

1.0

1.1

158.14

228.65

mg/l

—

Later onset COPD, excluding more controls

232

1.15

0.30

1.0

1.1

315.13

329.47

mg/l

0.15

205

Anorexia (incl.atypical)

277

1.16

0.30

1.1

1.0

233.19

210.00

mg/l

0.25

246

Inguinal hernia

218

1524

0.95

0.30

1.1

321.70

294.24

mg/l

0.78

195

1365

COPD related to multimorbidity

766

1.08

0.30

1.1

384.48

317.11

mg/l

0.38

680

Biguanides

420

2628

0.96

0.30

1.1

296.09

268.77

mg/l

1.52

374

2337

Postmenopausal atrophic vaginitis

451

1.09

0.30

1.1

241.31

271.59

mg/l

0.61

395

Insulin medication

256

2028

1.05

0.29

1.1

327.58

270.69

mg/l

2.38

221

1819

Injuries to unspecified part of trunk, limb or body region

344

1.13

0.29

1.0

1.1

236.38

269.15

mg/l

0.55

298

Peripheral artery operations in Hilmo

260

0.85

0.29

1.1

716.29

323.89

mg/l

0.49

224

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

148

1.22

0.29

1.2

1.1

486.94

223.17

mg/l

0.57

128

Seropositive rheumatoid arthritis, strict definition

430

0.88

0.29

1.1

257.47

265.00

mg/l

0.06

380

Solid cancers, including Hilmo

410

2303

1.04

0.29

1.1

301.28

258.94

mg/l

0.94

362

2051

Malignant neoplasm of stomach, including Hilmo

109

0.73

0.29

1.0

1.1

490.37

271.06

mg/l

—

Non-ischemic cardiomyopathy

656

0.92

0.29

1.1

248.90

313.97

mg/l

2.93

582

Type 2 diabetes, strict (exclude DM1)

433

2606

0.97

0.28

1.1

288.31

265.26

mg/l

1.26

388

2321

Impacted maxillary molar

344

0.87

0.28

1.1

212.21

200.61

mg/l

0.18

295

Toxic effect of ethanol

140

0.78

0.28

1.0

1.1

180.45

268.85

mg/l

1.61

117

Post-traumatic wound infection, not elsewhere classified

1.32

0.28

1.0

1.1

351.60

237.71

mg/l

—

Postpartum haemorrhage due to anatomy

617

0.91

0.28

1.1

175.44

195.86

mg/l

1.29

550

Nontoxic diffuse goitre

1.29

0.28

1.3

1.0

204.38

258.41

mg/l

—

Other benign neoplasms of connective and other soft tissue

299

1.14

0.27

1.2

1.1

240.41

276.12

mg/l

0.68

263

D07AA Corticosteroids, weak (group I)

680

1.09

0.27

1.1

222.70

235.81

mg/l

0.30

603

Dislocation, sprain and strain of joints and ligaments of elbow

252

1.15

0.27

1.1

253.04

243.73

mg/l

0.07

219

Haemorrhagic and haematological disorders of fetus and newborn

1.31

0.27

1.1

156.60

186.08

mg/l

—

Lesion of sciatic nerve

1.23

0.27

1.1

271.50

249.53

mg/l

—

Other and unspecified injuries of head

224

1.16

0.27

1.2

1.1

276.25

294.28

mg/l

0.19

192

Leiomyoma of uterus

283

1523

1.04

0.26

1.1

252.03

242.27

mg/l

0.31

252

1353

Other and unspecified disease of Bartholin gland

1.20

0.26

1.1

1.0

209.75

232.60

mg/l

—

Ulcerative colitis (strict definition, require KELA)

702

1.08

0.26

1.1

236.09

257.49

mg/l

0.70

628

Maxillary retrognathism

0.69

0.26

1.4

1.1

172.20

237.41

mg/l

—

Malignant neoplasm of oesophagus, including Hilmo

0.69

0.26

1.0

1.1

304.40

272.68

mg/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

683

1.08

0.26

1.1

236.97

257.12

mg/l

0.63

610

Other chronic obstructive pulmonary disease

117

899

1.06

0.25

1.1

363.64

308.23

mg/l

0.38

100

804

Maternal care for cervical incompetence

132

1.21

0.25

1.3

1.1

155.91

230.62

mg/l

2.88

116

Injury of muscle and tendon at lower leg level

511

1.10

0.25

1.1

298.10

281.88

mg/l

0.28

446

Congenital malformations of breast

1.20

0.25

1.1

201.56

199.80

mg/l

—

Pedestrian injured in collision with pedal cycle

1.27

0.24

1.1

205.27

220.60

mg/l

0.42

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

637

1.08

0.24

1.1

252.98

257.41

mg/l

0.08

564

Combinations of oral blood glucose lowering drugs

828

0.93

0.24

1.1

391.32

306.34

mg/l

1.00

743

Coxarthrosis, primary

177

1401

1.05

0.24

1.1

298.40

310.44

mg/l

0.30

156

1243

Squamous cell neoplasms and carcinomas of the skin

161

1.18

0.24

1.1

389.47

299.69

mg/l

0.33

147

Diabetes mellitus

528

2966

1.03

0.23

1.1

288.46

260.22

mg/l

1.77

467

2647

Eating disorders

551

1.09

0.23

1.1

218.31

207.30

mg/l

0.14

483

Other congenital malformations of female genitalia

1.32

0.23

1.0

1.1

246.40

190.94

mg/l

—

Routine general health check-up of defined subpopulation

1.32

0.23

1.6

1.1

226.80

234.70

mg/l

—

malignant neoplasm of female genital organs

392

0.90

0.23

1.1

276.63

246.00

mg/l

0.30

354

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.21

0.0

1.1

—

205.70

—

Bilateral cryptorchidism (undescended testicles)

0.00

0.21

0.0

1.1

—

338.27

—

Congenital malformation of biliary tract

0.00

0.21

0.0

1.1

—

340.70

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.1

—

266.40

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

0.21

0.0

1.1

—

254.27

—

Other specified/unspecified spondylopathies

1.19

0.21

1.0

290.00

244.29

mg/l

—

Paget disease

0.00

0.21

0.0

1.0

—

232.00

—

Malaria

0.00

0.21

0.0

1.1

—

251.18

—

Other and unspecified medical devices associated with adverse incidents

0.00

0.21

0.0

1.1

—

248.18

—

Wilms' tumor, including Hilmo

0.00

0.21

0.0

1.1

—

231.20

—

Benign neoplasm of ovary

507

1.09

0.21

1.1

309.68

233.02

mg/l

0.79

457

Yaws, including avohilmo

0.00

0.21

0.0

1.0

—

234.08

—

Benign neoplasm of male genital organs

1.16

0.21

1.0

1.1

263.00

310.82

mg/l

—

Pregnancy examination and test

572

1.06

0.21

1.1

204.82

213.48

mg/l

0.23

483

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.1

—

303.77

—

Congenital aortic valve stenosis

0.00

0.21

0.0

1.1

—

359.15

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.1

—

224.31

—

Arthropathic psoriasis

373

1.10

0.21

1.0

1.1

278.92

273.79

mg/l

0.04

326

Polyp of the female genital tract

116

693

0.95

0.20

1.1

236.10

244.56

mg/l

0.18

101

614

Viral hepatitis

287

1.12

0.20

1.1

205.15

271.16

mg/l

3.41

249

Gonarthrosis,primary

328

1917

1.03

0.20

1.1

274.26

302.57

mg/l

1.66

289

1696

Total colectomy

123

0.81

0.20

1.0

1.1

220.70

263.09

mg/l

—

105

Total colectomy operation

123

0.81

0.20

1.0

1.1

220.70

263.09

mg/l

—

105

Left hemicolectomy

1.25

0.20

1.0

1.1

247.33

251.49

mg/l

—

Type 2 diabetes, definitions combined

434

2590

0.97

0.20

1.1

288.31

265.31

mg/l

1.26

388

2311

Need for immunization against other single viral diseases

1.23

0.20

1.3

1.1

330.00

276.55

mg/l

—

Other complications of labour and delivery, not elsewhere classified

699

0.94

0.19

1.1

179.87

197.29

mg/l

0.83

610

Other malignant neoplasms of skin (=non-melanoma skin cancer)

118

842

0.95

0.19

1.1

309.59

285.20

mg/l

0.41

102

761

Burns and corrosions of multiple and unspecified body regions

1.18

0.19

1.2

1.1

442.00

230.55

mg/l

—

COPD, hospital admission 2, with asthma infections

631

1.06

0.19

1.1

403.81

314.52

mg/l

0.40

560

341

1.09

0.19

1.0

1.1

340.89

311.45

mg/l

0.33

302

Maternal care for known or suspected fetal abnormality and damage

806

0.94

0.19

1.1

178.45

213.49

mg/l

2.83

713

HSIL lesion of the cervix uteri, vagina or vulva

113

1076

1.05

0.18

1.0

1.1

196.43

214.00

mg/l

1.06

958

Malignant neoplasm of breast, HER-negative

519

1.07

0.18

1.1

216.90

248.84

mg/l

1.38

465

Coxarthrosis

161

997

1.04

0.18

1.1

284.67

297.19

mg/l

0.37

139

877

Foreign body in ear

1.21

0.18

1.0

1.1

251.57

227.12

mg/l

—

Congenital malformations of the respiratory system, including avohilmo

1.19

0.18

1.1

179.29

220.36

mg/l

—

Hernia

433

2809

1.02

0.17

1.1

283.89

276.75

mg/l

0.17

395

2494

Melanocytic naevi of other and unspecified parts of face

195

0.87

0.17

1.1

246.76

250.11

mg/l

0.02

172

Acute appendicitis, with complications

639

1.06

0.17

1.1

409.69

272.94

mg/l

0.85

560

Basal cell carcinoma, including Hilmo

132

855

1.05

0.17

1.1

360.39

284.69

mg/l

0.64

114

771

Use of levodopa decarbox-comt-inhibitor

1.13

0.17

2.1

1.1

338.00

307.19

mg/l

—

Other disorders of amniotic fluid and membranes

768

1.06

0.17

1.0

1.1

208.58

213.68

mg/l

0.13

681

Inguinal hernia, unilateral

1.11

0.17

1.0

1.1

176.86

245.23

mg/l

—

Femoral hernia, unilateral

1.11

0.17

1.0

1.1

176.86

245.23

mg/l

—

Inguinal of femoral hernia, unilateral

1.11

0.17

1.0

1.1

176.86

245.23

mg/l

—

Fracture of femur

524

1.07

0.17

1.1

299.77

309.59

mg/l

0.07

459

Fracture of shoulder and upper arm

131

1255

1.04

0.16

1.1

270.93

263.53

mg/l

0.17

112

1123

Hernia of abdominal wall

161

1670

0.96

0.16

1.1

262.43

284.94

mg/l

0.43

144

1503

Other blood glucose lowering drugs, excl. Insulins

371

0.92

0.16

1.1

314.04

296.63

mg/l

0.18

329

Malignant neoplasm of breast, ER-negative, including Hilmo

572

1.06

0.16

1.1

245.07

247.37

mg/l

0.02

512

Ulcerative colitis (strict definition, all Crohn cases excluded)

574

1.06

0.15

1.1

234.47

263.23

mg/l

0.98

510

Primary coxarthrosis, bilateral

691

1.06

0.15

1.1

308.51

305.09

mg/l

0.05

621

Excessive earwax

249

2193

1.03

0.15

1.1

300.46

278.06

mg/l

0.30

212

1965

Other secondary coxarthrosis

0.79

0.15

1.0

1.1

250.83

246.41

mg/l

—

Serous carcinoma of ovary, including Hilmo

0.78

0.15

1.2

1.0

371.33

249.80

mg/l

—

Endovascular or surgical operations to intracerebral aneurysms

149

1.14

0.15

1.0

234.88

302.31

mg/l

1.21

132

Tooth eruption problems

783

0.95

0.15

1.1

190.59

212.68

mg/l

0.49

691

AV-block

349

1.08

0.15

1.0

1.1

288.24

311.35

mg/l

0.36

305

Benign neoplasm: Skin of trunk

119

0.84

0.15

1.0

1.1

166.66

246.13

mg/l

—

102

Other specified disorders of kidney and ureter

1.15

0.15

1.1

956.33

237.34

mg/l

—

Diabetes, varying definitions

522

2968

1.02

0.15

1.1

288.24

260.47

mg/l

1.70

460

2651

Other disorders of breast and lactation associated with childbirth

1.14

0.15

1.0

195.11

193.10

mg/l

—

Benign neoplasm of thyroid gland

1.14

0.15

1.1

351.78

225.21

mg/l

—

Diabetes mellitus in pregnancy

206

1269

1.03

0.15

1.1

201.74

207.63

mg/l

0.23

191

1112

Uterine polyps

106

647

0.96

0.15

1.1

243.62

248.43

mg/l

0.08

576

Type 2 diabetes

487

2764

1.02

0.15

1.1

288.02

261.00

mg/l

1.80

432

2464

Varicose veins

205

1503

1.03

0.14

1.1

276.01

282.88

mg/l

0.13

176

1333

Solid cancers

386

2215

1.02

0.14

1.1

307.17

260.53

mg/l

1.01

342

1977

Malignant neoplasm of prostate

387

1.06

0.14

1.1

322.09

340.45

mg/l

0.27

353

Type 2 diabetes, definitions combined, including avohilmo

445

2620

0.98

0.14

1.1

292.19

263.19

mg/l

1.79

398

2335

Respiratory and cardiovascular disorders specific to the perinatal period

0.81

0.14

1.0

1.1

462.88

212.98

mg/l

—

Abrasion of teeth

148

1528

0.97

0.13

1.1

257.50

253.04

mg/l

0.09

123

1361

Insulin, fast-acting (human)

602

0.95

0.13

1.1

272.96

255.22

mg/l

0.32

540

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

116

1203

0.96

0.13

1.1

302.05

278.84

mg/l

0.51

107

1071

Glucagon-like peptide-1 (GLP-1) analogues

116

1203

0.96

0.13

1.1

302.05

278.84

mg/l

0.51

107

1071

Benign mammary dysplasia

393

1.07

0.13

1.2

1.1

327.47

234.15

mg/l

0.97

349

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

393

1.07

0.13

1.1

285.97

304.94

mg/l

0.29

342

Bicuspidal aortic valve syndrome

107

0.84

0.13

1.1

334.33

294.39

mg/l

—

Congenital malformations of heart and great arteries

495

1.06

0.13

1.1

227.61

261.30

mg/l

1.24

434

Other specified disorders of external ear

1.18

0.12

1.1

209.40

303.95

mg/l

—

malignant neoplasm of male genital organs

437

1.05

0.12

1.1

330.57

334.78

mg/l

0.05

392

Cutaneous abscess, furuncle and carbuncle

115

1111

1.04

0.12

1.1

264.87

254.56

mg/l

0.29

104

991

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

129

899

0.97

0.12

1.0

1.1

300.44

283.79

mg/l

0.28

110

809

Cyst of Bartholin Gland

137

0.87

0.12

1.1

185.25

212.00

mg/l

0.50

117

Other Crohn's disease

278

1.08

0.12

1.0

1.1

224.91

268.22

mg/l

0.78

241

Malignant neoplasm of skin

152

1000

1.03

0.11

1.1

372.75

283.53

mg/l

0.93

129

897

Idiopathic urticaria

1.16

0.11

1.2

1.1

224.60

217.87

mg/l

—

Suppurative and necrotic conditions of lower respiratory tract

136

0.88

0.11

1.1

297.58

299.60

mg/l

0.02

117

Malignant neoplasm of skin, including Hilmo

170

1109

1.03

0.11

1.1

354.67

278.45

mg/l

0.86

144

995

Premature rupture of membranes

125

916

0.97

0.10

1.1

195.15

214.50

mg/l

0.93

115

811

Basal cell carcinoma

123

814

1.03

0.10

1.1

375.57

286.33

mg/l

0.72

106

737

Adhesive middle ear disease

1.09

0.09

1.0

1.1

296.00

221.17

mg/l

—

COPD, hospital admissions

116

949

1.03

0.09

1.1

362.96

311.27

mg/l

0.34

842

Mental and behavioural disorders of puerperium, not classified elsewhere

1.06

0.09

1.0

1.1

255.00

209.26

mg/l

—

COPD, early/later onset

117

954

1.03

0.09

1.1

363.64

310.64

mg/l

0.36

100

845

Mental and behavioural disorders associated with the puerperium

1.04

0.09

1.0

1.1

255.00

199.23

mg/l

—

Benign neoplasm: Lip

1.04

0.09

1.0

1.1

368.40

246.49

mg/l

—

Carcinoma in situ of skin of scalp and neck

1.04

0.09

1.0

1.1

240.00

283.48

mg/l

—

Pedal cyclist injured in noncollision transport accidents

448

1.05

0.09

1.1

228.48

270.09

mg/l

1.87

393

Graves disease, strict definition

399

1.05

0.09

1.2

1.1

238.92

224.32

mg/l

0.20

357

Lichen planus, including avohilmo

584

0.96

0.09

1.1

334.45

273.51

mg/l

0.71

513

Haemangioma, any site

272

1.07

0.09

1.0

1.1

270.65

268.20

mg/l

0.01

241

Injury of muscle and tendon at forearm level

1.11

0.09

1.0

1.1

232.33

270.56

mg/l

—

Pedal cyclist injured in transport accident

962

1.03

0.08

1.1

231.62

256.15

mg/l

1.05

860

Other (not insulin) diabetes medications

452

2684

0.99

0.08

1.1

291.30

265.57

mg/l

1.51

406

2393

Arterial embolism and thrombosis of lower extremity artery

0.82

0.08

1.0

1.1

160.60

270.38

mg/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

716

1.03

0.08

1.1

323.44

270.14

mg/l

0.74

633

Femoral hernia

1.14

0.08

1.0

1.1

181.50

261.73

mg/l

—

Acute posthaemorrhagic anaemia

1.06

0.08

1.1

254.71

266.61

mg/l

—

Personal history of malignant neoplasm

244

1.07

0.08

1.2

1.1

199.83

236.72

mg/l

0.71

221

Maternal care for other known or suspected fetal problems

145

929

0.98

0.07

1.1

196.79

211.72

mg/l

0.60

121

818

Pedal cyclist injured in other and unspecified transport accidents

421

1.05

0.07

1.1

244.05

265.62

mg/l

0.36

368

Long labour

133

1152

0.98

0.07

1.1

205.07

212.98

mg/l

0.33

124

1015

Premenstrual syndrome

0.82

0.07

1.3

1.1

202.17

204.74

mg/l

—

Malignant neoplasm of cervix uteri, including Hilmo

1.08

0.07

1.0

1.1

199.50

204.44

mg/l

—

Campylobacter enteritis

1.08

0.07

1.0

1.1

295.63

233.32

mg/l

—

Artificial opening status

143

0.91

0.07

1.2

1.1

269.77

309.52

mg/l

0.42

126

Seborrhoeic keratosis

692

0.97

0.07

1.1

330.81

284.87

mg/l

0.51

620

Periodontal disease, other/unspecified

0.87

0.07

1.3

1.1

301.57

268.39

mg/l

—

Malignant neoplasm of mesothelium and soft tissue

0.85

0.07

1.4

1.0

280.14

237.76

mg/l

—

Other acute skin changes due to ultraviolet radiation

1.07

0.07

1.2

1.1

187.67

242.42

mg/l

—

Obstructed labour due to malposition and malpresentation of fetus

122

1154

0.98

0.07

1.0

1.1

238.47

212.97

mg/l

0.33

110

1018

Ovarian hyperstimulation (induction)

1.05

0.07

1.1

191.56

198.31

mg/l

—

0.87

0.07

1.1

191.25

201.62

mg/l

—

Malignant neoplasm of stomach

0.88

0.06

1.0

1.1

490.38

262.04

mg/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

0.87

0.06

1.4

1.1

208.13

243.74

mg/l

—

Postpartum hemorraghe, parous women as controls

147

1206

1.02

0.06

1.1

195.38

206.00

mg/l

0.41

129

1075

Other menopausal disorders

108

588

1.02

0.06

1.1

223.54

251.28

mg/l

0.90

521

HSIL lesion of the cervix uteri

102

997

1.02

0.06

1.0

1.1

194.74

210.59

mg/l

0.83

887

Supervision of high-risk pregnancy

115

676

1.02

0.06

1.1

228.29

218.28

mg/l

0.10

104

576

0.87

0.06

1.1

185.00

195.14

mg/l

—

Rubella [German measles]

100

0.90

0.06

1.0

1.1

318.44

325.12

mg/l

—

Myocardial infarction, without ST-elevation

801

1.02

0.06

1.1

314.38

319.39

mg/l

0.09

714

Calcific aortic valvular stenosis, diagnosis (helper)

531

1.03

0.06

1.0

1.1

290.92

323.77

mg/l

0.61

468

Operations 2 for CAVS

531

1.03

0.06

1.0

1.1

290.92

323.77

mg/l

0.61

468

Childhood allergy (age < 16)

741

1.02

0.06

1.1

217.10

218.91

mg/l

0.03

656

Coxarthrosis, primary, with hip surgery

118

1115

0.98

0.06

1.1

299.96

305.79

mg/l

0.11

104

996

Labour and delivery complicated by fetal stress [distress]

154

1018

0.98

0.06

1.1

188.77

205.02

mg/l

0.87

139

891

Congenital malformations of genital organs

453

0.96

0.05

1.1

316.11

218.87

mg/l

0.59

407

Calcific aortic valvular stenosis, operated

532

1.03

0.05

1.0

1.1

290.92

323.87

mg/l

0.61

469

Calcific aortic valvular stenosis

532

1.03

0.05

1.0

1.1

290.92

323.87

mg/l

0.61

469

Carbimazole or st.post thyroidectomy, condition for graves disease

811

1.02

0.05

1.1

242.36

247.16

mg/l

0.09

728

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

682

1.03

0.05

1.1

256.96

254.60

mg/l

0.04

599

Impacted teeth

123

1037

1.02

0.05

1.1

199.39

220.20

mg/l

1.17

108

918

Wet age-related macular degeneration

248

1.05

0.05

1.1

334.33

294.54

mg/l

0.54

217

Benign neoplasm of breast

374

0.96

0.05

1.2

1.1

358.42

226.04

mg/l

0.55

334

Coronary atherosclerosis

202

1289

0.99

0.05

1.1

305.62

317.39

mg/l

0.24

169

1150

Atrial septal defect, secundum type

100

1.10

0.05

1.2

1.1

183.00

223.37

mg/l

0.65

Carcinoma in situ of cervix uteri

545

1.03

0.04

1.1

192.66

204.52

mg/l

0.39

484

malignant neoplasm of male genital organs, including Hilmo

446

1.02

0.04

1.1

327.91

335.12

mg/l

0.09

401

Failed induction of labour

347

1.04

0.04

1.1

179.06

201.12

mg/l

0.89

302

Gonarthrosis, primary, with knee surgery

163

1285

0.99

0.04

1.1

269.79

317.77

mg/l

2.13

137

1143

Diabetes medication

513

3014

0.99

0.04

1.1

289.85

261.80

mg/l

1.69

456

2687

Calcific aortic valvular stenosis, including rheumatic fever

534

1.03

0.04

1.0

1.1

290.92

324.04

mg/l

0.62

470

Mixed hyperlipidaemia

1.10

0.04

1.2

1.1

234.70

292.55

mg/l

—

Umbilical hernia

1007

0.98

0.04

1.1

273.88

295.04

mg/l

0.24

901

Dipeptidyl peptidase 4 (DPP-4) inhibitors

166

1317

0.99

0.04

1.1

340.32

298.34

mg/l

0.76

152

1169

Congenital malformations of ovaries, fallopian tubes and broad ligaments

241

0.95

0.04

1.1

330.06

203.01

mg/l

0.35

214

Other or unspecified ileus, impaction or obstruction

477

1.03

0.04

1.1

278.85

304.37

mg/l

0.51

414

Non-rheumatic valve diseases

155

1092

1.01

0.04

1.0

1.1

285.56

299.16

mg/l

0.29

137

980

Crohn's disease of large intestine

190

1.05

0.04

1.1

277.40

260.17

mg/l

0.15

163

Ventral hernia

724

0.98

0.03

1.1

240.84

275.80

mg/l

1.02

644

Postpartum haemorrhage due to retained placenta

638

1.02

0.03

1.1

187.84

204.42

mg/l

0.76

572

Maternal care for known or suspected abnormality of pelvic organs

145

968

1.01

0.03

1.1

189.53

220.18

mg/l

2.08

130

854

Carcinoma in situ of other and unspecified digestive organs

102

1.08

0.03

1.4

1.1

268.64

294.29

mg/l

0.22

Pyothorax

108

0.93

0.03

1.1

314.60

299.32

mg/l

—

549

1.02

0.03

1.0

1.1

186.02

196.32

mg/l

0.40

493

480

1.02

0.02

1.1

329.63

305.75

mg/l

0.37

421

Malignant neoplasm of prostate, including Hilmo

400

1.02

0.02

1.1

319.10

338.40

mg/l

0.28

364

Delivery, wide proxy

139

745

0.99

0.02

1.1

210.45

226.96

mg/l

0.69

119

648

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

560

0.98

0.02

1.2

1.1

321.86

265.04

mg/l

0.92

491

Psoriatic arthropathies, ICD10

351

1.03

0.02

1.0

1.1

245.16

277.36

mg/l

0.62

306

Embedded and impacted teeth

163

1332

0.99

0.02

1.1

197.21

229.16

mg/l

2.08

146

1183

Single delivery by forceps and vacuum extractor

548

0.99

0.01

1.1

187.95

204.92

mg/l

0.87

482

Postpartum haemorrhage

147

1205

1.01

0.01

1.1

195.38

211.06

mg/l

0.67

129

1060

Benign neoplasm: Skin, unspecified

114

1.05

0.00

1.2

1.1

429.58

248.88

mg/l

0.44

COPD, hospital admissions 1, only main diagnosis

667

0.99

0.00

1.1

379.97

314.06

mg/l

0.29

589

Major coronary heart disease event excluding revascularizations

185

1216

1.00

0.00

1.1

297.65

321.61

mg/l

0.69

163

1082

Chronic periodontitis, complicated

210

2043

1.00

0.00

1.1

308.47

288.10

mg/l

0.65

188

1815

Psoriasis vulgaris

664

0.99

0.00

1.1

279.12

262.83

mg/l

0.19

589

Postpartum hemorraghe, all women as controls

147

1437

1.00

0.00

1.1

195.38

207.07

mg/l

0.47

129

1276

Type 1 diabetes, wide definition, subgroup 1

944

0.99

0.00

1.1

304.13

248.53

mg/l

1.06

853

Fracture of forearm

236

2118

1.00

0.00

1.1

279.75

262.93

mg/l

0.42

196

1897

Contact with machinery

333

0.99

0.00

1.2

1.1

340.07

317.32

mg/l

0.22

288

Type 1 diabetes, wide definition

978

1.00

0.00

1.1

297.61

247.74

mg/l

0.96

884

Valvular heart disease excluding rheumatic fever

155

1109

1.00

0.00

1.0

1.1

285.56

297.46

mg/l

0.25

137

997

Pacemaker

749

1.00

0.00

1.1

300.30

318.21

mg/l

0.31

658

Haemangioma and lymphangioma, any site

295

1.02

0.00

1.0

1.1

267.38

270.08

mg/l

0.01

259

Extreme obesity with alveolar hypoventilation

113

0.97

0.00

1.0

1.1

240.33

274.67

mg/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

628

1.00

0.00

1.2

1.1

308.05

267.20

mg/l

0.65

556

Crushing injury of hip and thigh

0.00

0.0

1.0

—

235.80

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

0.0

1.1

—

230.11

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.2

—

308.83

—

Sequelae of hyperalimentation

0.00

0.0

1.0

—

249.67

—

Malignant neoplasm of other and ill-defined sites

0.00

0.0

1.0

—

160.60

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.0

1.0

—

263.75

—

Deaf mutism, not elsewhere classified

0.00

0.0

1.1

—

310.00

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

305.13

—

Macrocephaly

0.00

0.0

1.0

—

166.00

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.1

—

278.14

—

Congenital retinoschisis

0.00

0.0

1.1

—

287.88

—

Other fibroblastic disorders

0.00

0.0

1.2

—

211.67

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.0

1.0

—

217.40

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

227.60

—

Need for immunization against single bacterial diseases

0.00

0.0

1.0

—

148.11

—

Diphtheria, including avohilmo

0.00

0.0

1.0

—

282.38

—

Eccrine sweat disorders

0.00

0.0

1.0

—

291.00

—

Otorrhoea

0.00

0.0

1.0

—

161.88

—

IgA nephropathy (IgA glomerulonephritis)

0.88

0.00

1.0

1.1

942.83

251.75

mg/l

—

Cystic fibrosis

0.00

-0.00

0.0

1.0

—

193.29

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.2

—

296.60

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.0

—

224.83

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

262.60

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

1.0

—

424.00

—

Cystic kidney disease

0.99

-0.00

1.1

385.25

248.56

mg/l

—

Senility

0.00

-0.00

0.0

1.0

—

194.00

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.1

—

285.29

—

Multiple congenital exostoses, including avohilmo

0.00

-0.00

0.0

1.0

—

147.80

—

Cystic kidney disease, including avohilmo

0.98

-0.00

1.1

400.22

246.68

mg/l

—

Noninfective disorders of pinna

0.00

-0.00

0.0

1.0

—

239.29

—

Injury of blood vessels of thorax

0.00

-0.00

0.0

1.2

—

310.20

—

Profound mental retardation

0.00

-0.00

0.0

1.0

—

203.86

—

Ankylosis of teeth

0.00

-0.00

0.0

1.3

—

244.00

—

Absence of one kidney

0.00

-0.00

0.0

1.1

—

158.00

—

Cleft lip, lip and palate or palate

0.96

-0.00

1.0

1.1

302.00

211.84

mg/l

—

Crohn's disease (strict) with PSC

0.00

-0.00

0.0

1.0

—

262.50

—

Congenital retinoschisis

0.00

-0.00

0.0

1.1

—

293.43

—

Hypergammalglobulinemia, unspecified

0.00

-0.00

0.0

1.0

—

228.00

—

Mechanical strabismus

0.00

-0.00

0.0

1.1

—

229.29

—

Other degenerative disorders of eyelid and periocular area

0.00

-0.00

0.0

1.0

—

253.29

—

Brain mixed glioma, helper endpoint

0.00

-0.00

0.0

1.2

—

255.80

—

Carcinoma in situ of middle ear and respiratory system

0.00

-0.00

0.0

1.1

—

296.71

—

Digestive system disorders of fetus and newborn

0.00

-0.00

0.0

1.0

—

172.50

—

Alcoholic cardiomyopathy

0.00

-0.00

0.0

1.1

—

292.75

—

Erythema multiforme

0.97

-0.00

1.2

1.0

237.83

227.13

mg/l

—

Pterygium

0.97

-0.00

1.2

1.1

293.00

289.66

mg/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.93

-0.00

1.0

1.1

209.80

253.71

mg/l

—

Ototoxic hearing loss

0.00

-0.00

0.0

1.0

—

207.80

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

222.00

—

Induced delusional disorder

0.00

-0.00

0.0

1.2

—

278.80

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

1.1

—

245.71

—

Other renal tubulo-interstitial diseases

0.93

-0.00

1.0

321.14

227.23

mg/l

—

Alzheimer’s disease (undefined)

0.00

-0.00

0.0

1.0

—

190.40

—

Ascorbic acid deficiency

0.00

-0.00

0.0

1.0

—

154.80

—

Immunodeficiency associated with other major defects

0.00

-0.00

0.0

1.0

—

231.29

—

Other combined immunodeficiencies

0.00

-0.00

0.0

1.0

—

194.60

—

Other rupture of muscle

0.00

-0.00

0.0

1.1

—

250.00

—

Haematosalpinx/Haematoma of broad ligament

0.00

-0.00

0.0

1.0

—

171.20

—

Complications associated with artificial fertilization

0.93

-0.00

1.1

191.56

201.30

mg/l

—

Other and unspecified hereditary haemolytic anaemias

0.00

-0.00

0.0

1.2

—

188.20

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.2

—

289.83

—

Benign neoplasm: Vertebral column

0.00

-0.00

0.0

1.1

—

266.78

—

Alpha thalassaemia

0.00

-0.00

0.0

1.0

—

211.20

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

-0.00

0.0

1.0

—

244.89

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.2

—

309.20

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.1

—

236.50

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.0

—

279.20

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.0

—

238.40

—

Malignant neoplasm of small intestine, including Hilmo

0.85

-0.00

1.0

1.1

341.00

248.74

mg/l

—

Paralytic ileus

0.99

-0.00

1.3

1.1

364.00

291.44

mg/l

—

Hereditary angioödema type 1

0.00

-0.00

0.0

1.0

—

300.60

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.2

—

328.00

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.89

-0.00

1.0

1.1

237.60

220.00

mg/l

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.1

—

261.25

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.0

—

95.50

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.1

—

165.33

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.1

—

108.78

—

Absence of one kidney, including avohilmo

0.00

-0.00

0.0

1.1

—

160.63

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

98.52

—

Squamous cell neoplasms and carcinoma of rectum

0.00

-0.00

0.0

1.0

—

203.67

—

Epidermolysis bullosa

0.00

-0.00

0.0

1.0

—

165.60

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.98

-0.00

1.2

1.0

384.00

235.65

mg/l

—

Macular cyst

0.98

-0.00

1.2

1.1

362.33

265.69

mg/l

—

Hirsprung

0.00

-0.00

0.0

1.0

—

452.60

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.0

—

153.86

—

Brain mixed glioma

0.00

-0.00

0.0

1.2

—

222.80

—

Microtia (small ears)

0.00

-0.00

0.0

1.0

—

146.00

—

Folliculitis decalvans

0.00

-0.00

0.0

1.1

—

317.86

—

Congenital glaucoma

0.00

-0.00

0.0

1.0

—

168.17

—

Pectus carinatum, including avohilmo

0.00

-0.00

0.0

1.0

—

141.80

—

Malignant neoplasm of accessory sinuses

0.00

-0.00

0.0

1.0

—

260.00

—

Noonan syndrome

0.00

-0.00

0.0

1.0

—

147.20

—

Hereditary lymphedema, including avohilmo

0.00

-0.00

0.0

1.0

—

283.00

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

1.2

—

189.50

—

Turner's syndrome

0.00

-0.00

0.0

1.0

—

170.40

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

283.00

—

Plasmodium falciparum malaria, including avohilmo

0.00

-0.00

0.0

1.2

—

263.33

—

Shigellosis

0.00

-0.00

0.0

1.2

—

321.50

—

Diphtheria

0.00

-0.00

0.0

1.0

—

256.86

—

Other parasitologically confirmed or unspecified malaria

0.00

-0.00

0.0

1.1

—

236.50

—

Pneumoconiosis due to dust containing silica

0.00

-0.00

0.0

1.2

—

245.20

—

Rubella [German measles], including avohilmo

100

1.00

-0.00

1.0

1.1

305.80

325.12

mg/l

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.2

—

263.33

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

1.0

—

208.00

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Albumin [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS